[
    {
        "ticker": "syk",
        "sector": "Healthcare",
        "data": [
            {
                "index": 0,
                "date": "2023-05-10",
                "press_title": "Stryker declares a $0.75 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2023/Stryker-declares-a-0.75-per-share-quarterly-dividend-93649f0d4/default.aspx",
                "content": "Kalamazoo, Michigan, May 10, 2023 (GLOBE NEWSWIRE) -  Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable July 31, 2023 to shareholders of record at the close of business on June 30, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com For media inquiries please contact: Yin",
                "1d_change": -0.0982038384,
                "index_price": -0.3176306902,
                "norm_price": 0.2194268518
            },
            {
                "index": 1,
                "date": "2023-05-01",
                "press_title": "Stryker reports first quarter 2023 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2023/Stryker-reports-first-quarter-2023-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, May 01, 2023 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the first quarter of 2023: First Quarter Results Reported net sales increased 11.8% to $4.8 billion Organic net sales increased 13.6% Reported operating income margin of 15.4% Adjusted operating income margin ( 1) contracted 70 bps to 21.1% Reported EPS increased 83.3% to $1.54 Adjusted EPS ( 1) increased 8.6% to $2.14 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 11.0 % (2.1)        % 13.1 % 0.7 % 12.4 % Orthopaedics and Spine 12.7 (2.4) 15.1 (0.1) 15.2 Total 11.8 % (2.2) % 14.0 % 0.4 % 13.6 % \"We delivered strong organic sales growth in the first quarter of 2023,\" said Kevin A. Lobo, Chair and CEO. \"Demand remains strong for our products and supply chain pressures are gradually improving.\" Sales Analysis Consolidated net sales of $4.8 billion increased 11.8% in the",
                "1d_change": -1.9429008032,
                "index_price": -1.1459896407,
                "norm_price": -0.7969111624
            },
            {
                "index": 2,
                "date": "2023-03-30",
                "press_title": "Stryker to announce financial results for its first quarter of fiscal year 2023",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2023/Stryker-to-announce-financial-results-for-its-first-quarter-of-fiscal-year-2023/default.aspx",
                "content": "Kalamazoo, Michigan, March 30, 2023 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s first quarter of fiscal year 2023, which ends on Friday, March 31, 2023. Stryker will host a webcast at 4:30pm ET on Monday, May 1, 2023, to discuss results for its first quarter fiscal year 2023.  The webcast can be accessed at Stryker - Events  Presentations .  An archive of the webcast will also be available on the company's website two hours after the live call ends. About Stryker Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology,",
                "1d_change": 1.7620060804,
                "index_price": 1.5226416957,
                "norm_price": 0.2393643847
            },
            {
                "index": 3,
                "date": "2023-03-28",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2023/Stryker-announces-Annual-Meeting-of-Shareholders/default.aspx",
                "content": "Kalamazoo, Michigan, March 28, 2023 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced its 2023 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 10, 2023 – 9:00 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com . To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the \"Stryker Corporation Annual Meeting\" when greeted by the operator. A recording of the annual meeting will also be available from 10:00 a.m., Eastern Time, on Thursday, May 11, 2023 at www.virtualshareholdermeeting.com/SYK2023 until the definitive proxy statement for our 2024 Annual Meeting of Shareholders is filed with the United States Securities and Exchange Commission. Stryker is one of the world’s leading medical",
                "1d_change": 0.6450840859,
                "index_price": 1.3327385105,
                "norm_price": -0.6876544246
            },
            {
                "index": 4,
                "date": "2023-02-09",
                "press_title": "Stryker declares a $0.75 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2023/Stryker-declares-a-0.75-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo Michigan,, Feb. 09, 2023 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable April 28, 2023 to shareholders of record at the close of business on March 31, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.  More information is available at www.stryker.com . Contacts For investor inquiries please contact: Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com For media inquiries please contact: <br",
                "1d_change": -1.9898624371,
                "index_price": -1.3150119932,
                "norm_price": -0.6748504439
            },
            {
                "index": 5,
                "date": "2023-01-31",
                "press_title": "Stryker reports 2022 operating results and 2023 outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2023/Stryker-reports-2022-operating-results-and-2023-outlook/default.aspx",
                "content": "Kalamazoo, Michigan , Jan. 31, 2023 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results Reported net sales increased 10.7% to $5.2 billion Organic net sales increased 13.2% Reported operating income margin of 15.6% Adjusted operating income margin (1) contracted 70 bps to 26.6% Reported EPS decreased 15.0% to $1.47 Adjusted EPS (1) increased 10.7% to $3.00 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 15.6 % (3.7)    % 19.3 % 2.4 % 16.9 % Orthopaedics and Spine 4.3 (4.0) 8.3 (0.1) 8.4 Total 10.7 % (3.8)    % 14.5 % 1.3 % 13.2 % Full Year Results Reported net sales increased 7.8% to $18.4 billion Organic net sales increased 9.7% Reported operating income margin of 15.4% Adjusted operating income margin (1) contracted 180 bps to 23.8% Reported EPS increased 18.4% to $6.17 Adjusted EPS (1)",
                "1d_change": 10.704429844,
                "index_price": 2.3878332062,
                "norm_price": 8.3165966378
            },
            {
                "index": 6,
                "date": "2022-12-28",
                "press_title": "Stryker to host conference call on January 31, 2023",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-host-conference-call-on-January-31-2023/default.aspx",
                "content": "Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker’s Q4 and Full Year 2022 Earnings Call.  After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a day in advance or a minimum of 15 minutes before the start of the call. A simultaneous webcast of the call will be accessible via the Investor Relations page of the Company's website at www.stryker.com. For those",
                "1d_change": 0.7610922454,
                "index_price": 0.5123028346,
                "norm_price": 0.2487894108
            },
            {
                "index": 7,
                "date": "2022-12-07",
                "press_title": "Stryker declares a $0.75 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-declares-a-0.75-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Dec. 07, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable January 31, 2023 to shareholders of record at the close of business on December 30, 2022, representing an increase of  7.9% versus the prior year and previous quarter. “We remain confident in our growth outlook, despite the challenging macroeconomic environment”, said Kevin Lobo, Chair  CEO.  “Consequently, we are proceeding with a steady increase in our dividend to $0.75 per share, reflecting 7.9% growth”. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually.  More",
                "1d_change": 4.3213272167,
                "index_price": 0.7627073073,
                "norm_price": 3.5586199094
            },
            {
                "index": 8,
                "date": "2022-11-03",
                "press_title": "Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-participate-in-the-5th-Annual-Evercore-ISI-HealthCONx-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 03, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Kevin Lobo, Chair and Chief Executive Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 8:50 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. About Stryker Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually.  More information is",
                "1d_change": 0.8531565742,
                "index_price": 0.989246883,
                "norm_price": -0.1360903088
            },
            {
                "index": 9,
                "date": "2022-10-31",
                "press_title": "Stryker reports third quarter 2022 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-reports-third-quarter-2022-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, Oct. 31, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the third quarter of 2022: Third Quarter Results Reported net sales increased 7.7% to $4.5 billion Organic net sales increased 9.9% Reported operating income margin of 18.0% Adjusted operating income margin (1) contracted 310 bps to 22.3% Reported EPS increased 87.7% to $2.14 Adjusted EPS (1) decreased 3.6% to $2.12 Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 10.2 % (3.3)   % 13.5 % 2.7 % 10.8 % Orthopaedics and Spine 4.4 (4.3) 8.7 — 8.7 Total 7.7 % (3.7) % 11.4 % 1.5 % 9.9 % \"We delivered strong organic sales growth in the quarter, despite product shortages and disruptions to full return of surgeries,\" said Kevin A. Lobo, Chair and CEO. \"Worsening foreign currency and ongoing inflation, including premiums on spot buys for key components, pressured our adjusted earnings",
                "1d_change": -3.5167446581,
                "index_price": -0.6677731218,
                "norm_price": -2.8489715364
            },
            {
                "index": 10,
                "date": "2022-09-29",
                "press_title": "Stryker to host conference call on October 31, 2022",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-host-conference-call-on-October-31-2022/default.aspx",
                "content": "Kalamazoo, Michigan, Sept. 29, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q3 2022 Earnings call. After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a day in advance or a minimum of 15 minutes before the start of the call. A simultaneous webcast of the call will be accessible via the Investor Relations page of the Company's website at www.stryker.com . For those not planning",
                "1d_change": -1.0072147109,
                "index_price": -2.8276808269,
                "norm_price": 1.8204661159
            },
            {
                "index": 11,
                "date": "2022-08-22",
                "press_title": "Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-participate-in-the-2022-Wells-Fargo-Securities-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Aug. 22, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 2:35 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. About Stryker Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually.  More",
                "1d_change": -2.8736694569,
                "index_price": -1.6070340751,
                "norm_price": -1.2666353817
            },
            {
                "index": 12,
                "date": "2022-08-03",
                "press_title": "Stryker declares a $0.695 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-declares-a-0.695-per-share-quarterly-dividend-642f14ce3/default.aspx",
                "content": "Kalamazoo Michigan, Aug. 03, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable October 31, 2022 to shareholders of record at the close of business on September 30, 2022, representing an increase of 10.3% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually.  More information is available at www.stryker.com . Contacts For investor inquiries please contact: Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com For media inquiries please contact:",
                "1d_change": -0.2380618413,
                "index_price": 1.0592634067,
                "norm_price": -1.2973252481
            },
            {
                "index": 13,
                "date": "2022-07-26",
                "press_title": "Stryker reports second quarter 2022 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-reports-second-quarter-2022-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, July 26, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the second quarter of 2022: Second Quarter Results  Reported net sales increased 4.6% to $4.5 billion Organic net sales increased 6.1% Reported operating income margin of 17.2% Adjusted operating income margin (1) contracted 220 bps to 23.7% Reported EPS increased 11.0% to $1.72 Adjusted EPS (1) of $2.25 in line with 2021 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 8.0 % (2.6)         % 10.6 % 2.7 % 7.9 % Orthopaedics and Spine 0.5 (3.4) 3.9 — 3.9 Total 4.6 % (3.0) % 7.6 % 1.5 % 6.1 % \"Despite supply shortages we delivered solid organic sales growth in Q2,\" said Kevin A. Lobo, Chair and CEO. \"Negative foreign currency and inflation, including spot buys of materials pressured our adjusted earnings. We are confident in our full year outlook for revenue; however, we",
                "1d_change": 4.3767706349,
                "index_price": 1.7494273759,
                "norm_price": 2.627343259
            },
            {
                "index": 14,
                "date": "2022-06-30",
                "press_title": "Stryker to host conference call on July 26, 2022",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-host-conference-call-on-July-26-2022/default.aspx",
                "content": "Kalamazoo, Michigan, June 30, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 26, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2022 and provide an operational update. Final operating results for the quarter ended June 30, 2022 will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q2 2022 Earnings call . After regi",
                "1d_change": 3.2375201857,
                "index_price": 1.0284102832,
                "norm_price": 2.2091099025
            },
            {
                "index": 15,
                "date": "2022-05-05",
                "press_title": "Stryker announces new Investor Relations leader",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-announces-new-Investor-Relations-leader/default.aspx",
                "content": "Kalamazoo, May 05, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today that Jason Beach will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective July 1, 2022. Preston Wells, Vice President, Investor Relations will be appointed Vice President, Group Chief Financial Officer for Stryker’s Orthopaedics and Spine businesses. Mr. Beach will work closely with Mr. Boehnlein and Mr. Wells to ensure a smooth transition. “I am excited about the commercial experience and financial discipline that Jason will bring to our investor relations team,” said Mr. Boehnlein. “I would also like to thank Preston for strengthening our investor relations capabilities and supporting our company’s growth.” Mr. Beach has more than 20 years of business experience in finance, operations, IT and other global business services. He joined Stryker in 2018 and in his latest leadership role as Vice President, Finance at Stryker’s",
                "1d_change": -1.6411323327,
                "index_price": -3.5672619189,
                "norm_price": 1.9261295862
            },
            {
                "index": 16,
                "date": "2022-05-05",
                "press_title": "Stryker announces board changes following Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-announces-board-changes-following-Annual-Meeting-of-Shareholders/default.aspx",
                "content": "Kalamazoo, May 05, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary K. Brainerd to replace Ms. McCoy as Chair of the Governance and Nominating Committee. Mr. Golston has been a member of Stryker’s Board of Directors since 2011 and has served as Lead Independent Director since 2016 and Chair of the Compensation Committee since 2021. “Allan has provided strong leadership for our independent directors and has helped us build a highly effective and diverse board,” said Kevin A. Lobo, Chair  Chief Executive Officer. Ms. McCoy has been a member of Stryker’s Board of Directors since 2018 and has served as Chair of the Governance and Nominating Committee since 2019. Ms. Brainerd has been a member of Stryker’s Board of Directors since 2017 and has served on each of the board",
                "1d_change": -1.6411323327,
                "index_price": -3.5672619189,
                "norm_price": 1.9261295862
            },
            {
                "index": 17,
                "date": "2022-05-04",
                "press_title": "Stryker declares a $0.695 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-declares-a-0.695-per-share-quarterly-dividend-983f0a3f3/default.aspx",
                "content": "Kalamazoo, May 04, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable July 29, 2022 to shareholders of record at the close of business on June 30, 2022, representing an increase of 10.3% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com For media inquiries please contact: Yin",
                "1d_change": 1.1973794043,
                "index_price": -0.8273723947,
                "norm_price": 2.024751799
            },
            {
                "index": 18,
                "date": "2022-05-02",
                "press_title": "Stryker to participate in the Bank of America Securities 2022 Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-participate-in-the-Bank-of-America-Securities-2022-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, May 02, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the Bank of America Securities 2022 Health Care Conference on Wednesday, May 11, 2022. Andy Pierce, Group President, MedSurg and Neurotechnology and Preston Wells, Vice President, Investor Relations will represent the Company in a presentation scheduled for 11:00 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com .  Source: Stryker Corporation",
                "1d_change": -1.6101275603,
                "index_price": 1.0746098029,
                "norm_price": -2.6847373632
            },
            {
                "index": 19,
                "date": "2022-04-28",
                "press_title": "Stryker reports first quarter 2022 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-reports-first-quarter-2022-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, April 28, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the first quarter of 2022: First Quarter Results Reported net sales increased 8.1% to $4.3 billion Organic net sales increased 9.2% Reported operating income margin of 10.5% Adjusted operating income margin (1) contracted 170 bps to 21.8% Reported EPS increased 6.3% to $0.84 Adjusted EPS (1) increased 2.1% to $1.97 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 10.6 % (1.5) % 12.1 % 1.3 % 10.8 % Orthopaedics and Spine 5.1 (2.1) 7.2 — 7.2 Total 8.1 % (1.8) % 9.9 % 0.7 % 9.2 % \"We delivered solid first quarter results in the face of a challenging macroeconomic environment,\" said Kevin A. Lobo, Chair and CEO. \"We are encouraged by the steady improvement of surgery volumes and the robust demand for our capital products; however, we expect supply chain challenges to persist for",
                "1d_change": -4.2236644851,
                "index_price": -2.1938875656,
                "norm_price": -2.0297769196
            },
            {
                "index": 20,
                "date": "2022-03-30",
                "press_title": "Stryker to host conference call on April 28, 2022",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-host-conference-call-on-April-28-2022/default.aspx",
                "content": "Kalamazoo, Michigan, March 30, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 28, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2022 and provide an operational update.Final operating results for the quarter ended March 31, 2022 will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q1 2022 earnings call . After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a day in advance or a minimum of 15 minutes before the start of the call. A simultaneous webcast of the call will be accessible via the Investor Relations page of the Company's website at www.stryker.com . For",
                "1d_change": -1.3278349717,
                "index_price": -2.0702328449,
                "norm_price": 0.7423978732
            },
            {
                "index": 21,
                "date": "2022-03-24",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-announces-Annual-Meeting-of-Shareholders/default.aspx",
                "content": "Kalamazoo, Michigan, March 24, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced its 2022 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 4, 2022 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com . To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the \"Stryker Corporation Annual Meeting\" when greeted by the operator. A recording of the annual meeting will also be available from 10:30 a.m., Eastern Time, on Thursday, May 5, 2022 at www.virtualshareholdermeeting.com/SYK2022 until the definitive proxy statement for our 2023 Annual Meeting of Shareholders is filed with the United States Securities and Exchange Commission. Stryker is one of the world’s leading medical",
                "1d_change": 3.2180321681,
                "index_price": 1.6086091133,
                "norm_price": 1.6094230548
            },
            {
                "index": 22,
                "date": "2022-02-23",
                "press_title": "Stryker completes acquisition of Vocera Communications",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-completes-acquisition-of-Vocera-Communications/default.aspx",
                "content": "Kalamazoo, MI, Feb. 23, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Vocera Communications, Inc. (NYSE: VCRA), a leader in digital care coordination and communication. “This acquisition provides significant opportunities to advance innovations and accelerate our digital aspirations,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We welcome the Vocera team to Stryker and look forward to working together to enable safer patient care and help our customers improve outcomes.” Vocera brings a highly complementary and innovative portfolio to Stryker’s Medical division that will enhance the company’s Advanced Digital Healthcare offerings and further advance Stryker’s focus on preventing adverse events throughout the continuum of care. The acquisition is expected to have a neutral impact to net earnings per diluted share in 2022. Completion of Tender Offer and Merger The previously announced cash",
                "1d_change": 1.7850361388,
                "index_price": -0.844777644,
                "norm_price": 2.6298137828
            },
            {
                "index": 23,
                "date": "2022-02-15",
                "press_title": "Stryker to participate in Cowen 42nd Annual Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-participate-in-Cowen-42nd-Annual-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 15, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the Cowen 42 nd Annual Health Care Conference on Monday, March 7, 2022. Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a virtual presentation scheduled for 10:30 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600 or",
                "1d_change": 1.8798892669,
                "index_price": 1.0218967748,
                "norm_price": 0.8579924921
            },
            {
                "index": 24,
                "date": "2022-02-02",
                "press_title": "Stryker declares a $0.695 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-declares-a-0.695-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 02, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable April 29, 2022 to shareholders of record at the close of business on March 31, 2022, representing an increase of 10.3% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com For media inquiries please contact: Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or",
                "1d_change": 0.30705552,
                "index_price": -1.9866306746,
                "norm_price": 2.2936861946
            },
            {
                "index": 25,
                "date": "2022-01-27",
                "press_title": "Stryker reports 2021 operating results and 2022 outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-reports-2021-operating-results-and-2022-outlook/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 27, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2021:﻿﻿ Fourth Quarter Results Reported net sales increased 10.3% from 2020 and 13.8% from 2019 to $4.7 billion Organic net sales increased 9.0% from 2020 and 6.2% from 2019 Reported operating income margin of 17.4% Adjusted operating income margin (1) contracted 190 bps to 27.3% Reported EPS increased 16.1% to $1.73 Adjusted EPS (1) decreased 3.6% to $2.71 In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pandemic throughout 2020. As previously disclosed, effective December 31, 2021, we have updated our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure. Fourth Quarter Net Sales Growth Overview From 2020 From 2019",
                "1d_change": -0.5757150592,
                "index_price": 1.1568536481,
                "norm_price": -1.7325687072
            },
            {
                "index": 26,
                "date": "2022-01-25",
                "press_title": "Stryker commences tender offer for all outstanding shares of common stock of Vocera Communications",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-commences-tender-offer-for-all-outstanding-shares-of-common-stock-of-Vocera-Communications/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 25, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) today announced that it is commencing, through a wholly owned subsidiary, Voice Merger Sub Corp., a cash tender offer to purchase all outstanding shares of common stock of Vocera Communications, Inc. (NYSE: VCRA) for $79.25 per share in cash. The offer is being made pursuant to the previously announced merger agreement, dated as of January 6, 2022, among Stryker, Voice Merger Sub Corp. and Vocera. The tender offer is scheduled to expire at one minute past 11:59 p.m. Eastern Time, on February 22, 2022, unless extended in accordance with the terms of the merger agreement. The tender offer is subject to various conditions, including a minimum tender of at least a majority of outstanding shares of Vocera common stock, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions. The transaction is expected to close in the first quarter of",
                "1d_change": 1.5870354206,
                "index_price": -0.3841431991,
                "norm_price": 1.9711786197
            },
            {
                "index": 27,
                "date": "2022-01-06",
                "press_title": "Stryker announces definitive agreement to acquire Vocera Communications",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-announces-definitive-agreement-to-acquire-Vocera-Communications/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 06, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc. (NYSE: VCRA) for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion (including convertible notes). Vocera, which was founded in 2000, has emerged as a leading platform in the digital care coordination and communication category. The importance of this growing segment has continued to expand throughout the pandemic as it aims to reduce cognitive overload for caregivers and enables them to deliver the best patient care possible. Vocera brings a highly complementary and innovative portfolio to Stryker’s Medical division that will address the increasing need for hospitals to connect caregivers and disparate data-generating medical devices, which will help drive efficiencies and improve safety",
                "1d_change": -2.9593614367,
                "index_price": -0.3498021675,
                "norm_price": -2.6095592692
            },
            {
                "index": 28,
                "date": "2022-01-05",
                "press_title": "Stryker to host conference call on January 27, 2022",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2022/Stryker-to-host-conference-call-on-January-27-2022/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 05, 2022 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, January 27, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2021 and provide an operational update. Final operating results for the quarter ended December 31, 2021 will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q4 2021 earnings call . After registering, a confirmation will be sent via email, including dial-in details and unique conference call access codes required for call entry. Registration is open throughout the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a day in advance or a minimum of 15 minutes before the start of the call. A simultaneous webcast of the call will be accessible via the Investor Relations page of the Company's website at www.stryker.com",
                "1d_change": -1.8931911428,
                "index_price": -1.9578248424,
                "norm_price": 0.0646336996
            },
            {
                "index": 29,
                "date": "2021-12-09",
                "press_title": "Stryker declares a $0.695 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-declares-a-0.695-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Dec. 09, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable January 31, 2022 to shareholders of record at the close of business on December 31, 2021, representing an increase of 10.3% versus the prior year and previous quarter. “Despite a challenging environment, we continue to deliver strong sales growth and drive solid financial results, and consistent with our stated capital allocation philosophy, we are raising our dividend 10.3%,” said Kevin Lobo, Chair and Chief Executive Officer. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries",
                "1d_change": 0.069189371,
                "index_price": 0.4460935956,
                "norm_price": -0.3769042246
            },
            {
                "index": 30,
                "date": "2021-10-28",
                "press_title": "Stryker reports third quarter 2021 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-reports-third-quarter-2021-operating-results/default.aspx",
                "content": "Kalamazoo, MI, Oct. 28, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the third quarter of 2021: Third Quarter Results Reported net sales increased 11.3% from 2020 and 16.0% from 2019 to $4.2 billion Organic net sales increased 4.5% from 2020 and 8.4% from 2019 Reported operating income margin of 13.8% Adjusted operating income margin (1) contracted 260 bps to 25.4% Reported EPS decreased 30.1% to $1.14 Adjusted EPS (1) increased 2.8% to $2.20 In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pandemic throughout 2020. Third Quarter Net Sales Growth Overview From 2020 From 2019 Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic Orthopaedics 16.1 % 0.6 % 15.5 % 17.3 % (1.8 ) % 21.3 % 1.4 % 19.9",
                "1d_change": -0.7065653193,
                "index_price": 0.9237031503,
                "norm_price": -1.6302684697
            },
            {
                "index": 31,
                "date": "2021-10-11",
                "press_title": "Stryker to host analyst meeting",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-host-analyst-meeting/default.aspx",
                "content": "Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . The webcast will be archived on the Investor Relations page of this site. To listen to the meeting via phone dial (844) 200-6205 (domestic) or (929) 526-1599 (international) and enter access code 695616. A recording of the meeting will also be available from 8:30 p.m., Eastern Time, on Thursday, November 18, 2021, until 11:59 p.m., Eastern Time, on Thursday, November 25, 2021. To hear this recording, you may dial (866) 813-9403 (domestic) or (929) 458-6194 (international) and enter access code 413779. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers",
                "1d_change": -1.7158491145,
                "index_price": -0.7996515427,
                "norm_price": -0.9161975718
            },
            {
                "index": 32,
                "date": "2021-09-23",
                "press_title": "Stryker to host conference call on October 28, 2021",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-host-conference-call-on-October-28-2021/default.aspx",
                "content": "Kalamazoo, Michigan, Sept. 23, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2021 and provide an operational update. Final operating results for the quarter ended September 30, 2021 will be released at 4:05 p.m. that day. To participate in the conference call dial (833) 979-2711 (domestic) or (236) 714-2206 (international) and enter passcode 7351349. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, October 28, 2021, until 11:59 p.m., Eastern Time, on Thursday, November 4, 2021. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642 (international) and enter passcode",
                "1d_change": 1.3157960983,
                "index_price": 1.0937088862,
                "norm_price": 0.2220872121
            },
            {
                "index": 33,
                "date": "2021-08-30",
                "press_title": "Stryker to participate in Morgan Stanley’s 19th Annual Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-participate-in-Morgan-Stanleys-19th-Annual-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Aug. 30, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in Morgan Stanley’s 19th Annual Global Healthcare Conference on Monday, September 13, 2021. Kevin Lobo, Chair and Chief Executive Officer, will represent the Company in a virtual presentation scheduled for 10:15 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600",
                "1d_change": 1.1115331844,
                "index_price": 0.1972372533,
                "norm_price": 0.914295931
            },
            {
                "index": 34,
                "date": "2021-08-18",
                "press_title": "Stryker President and COO Timothy J. Scannell to retire",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-President-and-COO-Timothy-J.-Scannell-to-retire/default.aspx",
                "content": "Kalamazoo, Michigan, Aug. 18, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today that after an outstanding thirty-one-year career at Stryker, Timothy J. Scannell, President and Chief Operating Officer has notified the company of his intent to retire on March 31, 2023. Effective October 1, 2021 until his retirement, Mr. Scannell will serve as Advisor to the CEO and provide counsel on a range of strategic issues and ensure a smooth transition of his duties, which will be spread between Group Presidents J. Andrew Pierce and Spencer S. Stiles. These responsibilities include oversight of regional businesses, corporate strategy, and business development. Mr. Pierce and Mr. Stiles will continue to serve on the Stryker Leadership Team and will report directly to Kevin A. Lobo, Chair  Chief Executive Officer. Mr. Scannell began his career with Stryker’s Endoscopy business in 1990 where he served in sales and marketing leadership roles before progressing to roles of greater",
                "1d_change": -1.1879565568,
                "index_price": -0.7975881401,
                "norm_price": -0.3903684167
            },
            {
                "index": 35,
                "date": "2021-08-04",
                "press_title": "Stryker declares a $0.63 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-declares-a-0.63-per-share-quarterly-dividend-199843f7d/default.aspx",
                "content": "Kalamazoo, Michigan, Aug. 04, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable October 29, 2021 to shareholders of record at the close of business on September 30, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com For media inquiries please contact: Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or",
                "1d_change": -0.8808805191,
                "index_price": 0.296897836,
                "norm_price": -1.1777783551
            },
            {
                "index": 36,
                "date": "2021-07-27",
                "press_title": "Stryker reports second quarter 2021 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-reports-second-quarter-2021-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, July 27, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the second quarter of 2021: Second Quarter Results Reported net sales increased 55.4% from 2020 and 17.6% from 2019 to $4.3 billion Organic net sales increased 42.9% from 2020 and 9.3% from 2019 Reported operating income margin of 17.0% Adjusted operating income margin ( 1) of 25.9% Reported EPS of $1.55 Adjusted EPS ( 1) of $2.25 In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal baseline for comparison given the variability caused by the COVID-19 pandemic throughout 2020. Second Quarter Net Sales Growth Overview From 2020 From 2019 Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 82.3 % 4.4 % 77.9 % 27.2 % 50.7 % 27.8 % 1.8 % 26.0 % 19.3 % 6.7 % MedSurg 32.3 2.6 29.7 0.1 29.6 9.4 1.1 8.3",
                "1d_change": 1.9837556214,
                "index_price": -0.3576694664,
                "norm_price": 2.3414250878
            },
            {
                "index": 37,
                "date": "2021-06-24",
                "press_title": "Stryker to host conference call on July 27, 2021",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-host-conference-call-on-July-27-2021/default.aspx",
                "content": "Kalamazoo, Michigan, June 24, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2021 and provide an operational update. Final operating results for the quarter ended June 30, 2021 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 4044998 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, July 27, 2021, until 11:59 p.m., Eastern Time, on Tuesday, August 3, 2021. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642 (international) and",
                "1d_change": -0.3536128424,
                "index_price": 0.5543481063,
                "norm_price": -0.9079609487
            },
            {
                "index": 38,
                "date": "2021-05-04",
                "press_title": "Stryker declares a $0.63 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-declares-a-0.63-per-share-quarterly-dividend-13a29df68/default.aspx",
                "content": "Kalamazoo, MI, May 04, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable July 30, 2021 to shareholders of record at the close of business on June 30, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com For media inquiries please contact: Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com <br",
                "1d_change": -3.2994902013,
                "index_price": -0.2747438146,
                "norm_price": -3.0247463867
            },
            {
                "index": 39,
                "date": "2021-04-27",
                "press_title": "Stryker reports first quarter 2021 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-reports-first-quarter-2021-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, April 27, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the first quarter of 2021: The response to the COVID-19 pandemic has included measures to slow the spread of the virus taken by governments and health care authorities globally, including the postponement of elective medical procedures and social contact restrictions. While there is starting to be some recovery in certain geographies, there continues to be a negative impact on our operations and financial results. First Quarter Results Reported net sales increased 10.2% from 2020 and 12.4% from 2019 to $4.0 billion Organic net sales increased 1.8% from 2020 and 4.7% from 2019 Reported operating income margin of 11.6% Adjusted operating income margin ( 1) contracted 50 bps to 23.5% Reported EPS decreased 39.2% to $0.79 Adjusted EPS ( 1) increased 4.9% to $1.93 In addition to sales growth analysis versus 2020, we are including sales growth versus 2019 as 2019 provides a more normal",
                "1d_change": -1.9801221807,
                "index_price": -0.1211954543,
                "norm_price": -1.8589267264
            },
            {
                "index": 40,
                "date": "2021-04-26",
                "press_title": "Stryker to participate in the Bank of America Securities 2021 Virtual Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-participate-in-the-Bank-of-America-Securities-2021-Virtual-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, April 26, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Spencer Stiles, Group President, Orthopaedics  Spine, Robert Cohen, President, Digital, Robotics and Enabling Technologies and Preston Wells, Vice President, Investor Relations will represent the Company in a virtual presentation scheduled for 4:15 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at",
                "1d_change": -1.0376306358,
                "index_price": 0.0403759889,
                "norm_price": -1.0780066247
            },
            {
                "index": 41,
                "date": "2021-03-29",
                "press_title": "Stryker to host conference call on April 27, 2021",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-host-conference-call-on-April-27-2021/default.aspx",
                "content": "Kalamazoo, Michigan, March 29, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2021 and provide an operational update. Final operating results for the quarter ended March 31, 2021 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 8988724 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, April 27, 2021, until 11:59 p.m., Eastern Time, on Tuesday, May 4, 2021. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642 (international)",
                "1d_change": 1.770144954,
                "index_price": -0.2718169439,
                "norm_price": 2.0419618979
            },
            {
                "index": 42,
                "date": "2021-03-24",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-announces-Annual-Meeting-of-Shareholders/default.aspx",
                "content": "Kalamazoo, Michigan, March 24, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced its 2021 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 5, 2021 – 2:00 p.m. Eastern Time Due to concerns regarding the coronavirus outbreak (“COVID-19”) and to assist in protecting the health and well-being of our shareholders and employees, this year’s Annual Meeting of Shareholders of Stryker Corporation will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com . To listen to the meeting as a guest dial (844) 608-0003 (U.S.) or (236) 714-3174 (International) and be prepared to provide conference ID number 1929818 to the operator. A recording of the annual meeting will also be available from 3:00 p.m., Eastern Time, on Thursday, May 6, 2021 at www.virtualshareholdermeeting.com/SYK2021 until the",
                "1d_change": 2.2817995003,
                "index_price": -0.266270848,
                "norm_price": 2.5480703483
            },
            {
                "index": 43,
                "date": "2021-02-17",
                "press_title": "Stryker to participate in the 41st Annual Cowen Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-participate-in-the-41st-Annual-Cowen-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 17, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on Tuesday, March 2, 2021. Preston Wells, Vice President, Investor Relations and Andy Pierce, Group President, MedSurg  Neurotechnology, will represent the Company in a virtual presentation scheduled for 10:30 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells,",
                "1d_change": -0.7954152621,
                "index_price": -0.1157400116,
                "norm_price": -0.6796752506
            },
            {
                "index": 44,
                "date": "2021-02-02",
                "press_title": "Stryker declares a $0.63 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-declares-a-0.63-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 02, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable April 30, 2021 to shareholders of record at the close of business on March 31, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com For media inquiries please contact: Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or",
                "1d_change": 1.8935664033,
                "index_price": 1.0007345566,
                "norm_price": 0.8928318467
            },
            {
                "index": 45,
                "date": "2021-01-27",
                "press_title": "Stryker reports 2020 operating results and 2021 outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-reports-2020-operating-results-and-2021-outlook/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 27, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2020 and 2021 outlook: The response to the COVID-19 pandemic has included measures to slow the spread of the virus taken by governments and health care authorities globally, including the postponement of deferrable medical procedures and social contact restrictions, which have had a significant negative impact on our operations and financial results. Fourth Quarter Results Reported net sales increased 3.2% to $4.3 billion Organic net sales decreased 1.1% Reported operating income margin of 17.6% Adjusted operating income margin(1) expanded 90 bps to 29.2% Reported EPS decreased 21.6% to $1.49 Adjusted EPS(1) increased 12.9% to $2.81 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 4.0 % 1.2 % 2.8 % 8.6 % (5.8 ) % MedSurg 2.3 0.8 1.5 0.2 1.3 Neurotechnology and Spine 3.5",
                "1d_change": -2.1739149113,
                "index_price": -1.3056571256,
                "norm_price": -0.8682577857
            },
            {
                "index": 46,
                "date": "2021-01-05",
                "press_title": "Stryker acquires OrthoSensor",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-acquires-OrthoSensor/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 05, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. “Smart devices and implants will play a big role in orthopaedics and we are excited for OrthoSensor to join Stryker as we continue to innovate and advance smart sensor technologies, including intraoperative sensors, wearables and smart implants across our joint replacement business,” said Spencer Stiles, Stryker’s Group President, Orthopaedics and Spine. “Patient recovery will become more active as real-time measurement on key performance insights drive improved outcomes and patient satisfaction.” OrthoSensor quantifies orthopaedics through intelligent devices and data services that allow surgeons and hospitals to deliver evidence-based treatments for",
                "1d_change": 1.274497926,
                "index_price": 1.3371932341,
                "norm_price": -0.0626953081
            },
            {
                "index": 47,
                "date": "2021-01-04",
                "press_title": "Stryker to host conference call on January 27, 2021",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2021/Stryker-to-host-conference-call-on-January-27-2021/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 04, 2021 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2020 and provide an operational update. Final operating results for the quarter ended December 31, 2020 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 5283279 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Wednesday, January 27, 2021, until 11:59 p.m., Eastern Time, on Wednesday, February 3, 2021. To hear this recording, you may dial (800) 585-8367 (domestic) or (416)",
                "1d_change": -2.3700220886,
                "index_price": -1.0129170109,
                "norm_price": -1.3571050777
            },
            {
                "index": 48,
                "date": "2020-12-02",
                "press_title": "Stryker declares a $0.63 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-declares-a-0.63-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Dec. 02, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable January 29, 2021 to shareholders of record at the close of business on December 31, 2020, representing an increase of 9.6% versus the prior year and previous quarter. “We continue to drive solid financial results in a challenging environment, and consistent with our stated capital allocation philosophy, are raising our dividend 9.6%,\" said Kevin Lobo, Chairman and Chief Executive Officer. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice",
                "1d_change": 1.6398360369,
                "index_price": 0.3529023626,
                "norm_price": 1.2869336743
            },
            {
                "index": 49,
                "date": "2020-11-18",
                "press_title": "Stryker announces pricing of $600 million senior notes offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-announces-pricing-of-600-million-senior-notes-offering/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 18, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) (the “Company”) announced today that it has priced an offering of $600 million aggregate principal amount of its 0.600% Notes due 2023 (the “Notes”). Unless previously redeemed pursuant to their terms, the Notes will mature on December 1, 2023. The offering of the Notes is expected to settle on November 23, 2020, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for general corporate purposes, which may include payments in connection with the redemption of Wright Medical Group N.V.’s (“Wright”) convertible debt, which the Company assumed upon completion of the acquisition of Wright. Citigroup Global Markets Inc., BofA Securities, Inc. and Wells Fargo Securities, LLC are acting as active joint book-running managers for the offering. The offering is being made pursuant to a preliminary prospectus supplement, filed today, to the Company’s",
                "1d_change": 0.9419185279,
                "index_price": -0.8436925325,
                "norm_price": 1.7856110604
            },
            {
                "index": 50,
                "date": "2020-11-17",
                "press_title": "Stryker to participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-to-participate-in-the-3rd-Annual-Evercore-ISI-HealthCONx-Virtual-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 17, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Thursday, December 3, 2020. Preston Wells, Vice President, Investor Relations and Spencer Stiles, Group President, Orthopaedics and Spine, will represent the Company in a presentation scheduled for 8:00 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston",
                "1d_change": -0.2545963467,
                "index_price": -1.1917747139,
                "norm_price": 0.9371783673
            },
            {
                "index": 51,
                "date": "2020-11-11",
                "press_title": "Stryker completes acquisition of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-completes-acquisition-of-Wright-Medical/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 11, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics. “This acquisition enhances our global market position in trauma and extremities, providing significant opportunities to advance innovation and reach more patients,” said Kevin Lobo, Chairman and Chief Executive Officer, Stryker. “We welcome the Wright Medical team to Stryker and look forward to growing the combined business by delivering solutions that improve patient outcomes.” Wright Medical brings a highly complementary product portfolio and customer base to Stryker’s trauma and extremities business. The company is a recognized leader in the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics market segments, which are among the fastest growing segments in orthopaedics.",
                "1d_change": -3.2146296045,
                "index_price": -0.7410202647,
                "norm_price": -2.4736093397
            },
            {
                "index": 52,
                "date": "2020-11-10",
                "press_title": "Stryker announces intention to complete acquisition of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-announces-intention-to-complete-acquisition-of-Wright-Medical/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 10, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that it intends to complete the acquisition of Wright Medical Group N.V. (NASDAQ: WMGI) by effectuating the mergers described in the tender offer statement on Schedule TO filed by Stryker B.V., an indirect, wholly owned subsidiary of Stryker, with the U.S. Securities and Exchange Commission on December 13, 2019, as amended. The previously announced cash tender offer for all outstanding ordinary shares of Wright Medical by Stryker B.V. expired at 5:00 p.m., Eastern Time, on November 10, 2020.  American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has preliminarily advised Stryker B.V. that as of the expiration time, approximately 124,901,861 Wright Medical ordinary shares, representing approximately 96% of the outstanding Wright Medical ordinary shares, were validly tendered pursuant to the tender offer and not properly withdrawn. Subject to the terms and",
                "1d_change": -3.2942580897,
                "index_price": 0.8229135453,
                "norm_price": -4.117171635
            },
            {
                "index": 53,
                "date": "2020-11-09",
                "press_title": "Stryker elects Giovanni Caforio to Board of Directors",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-elects-Giovanni-Caforio-to-Board-of-Directors/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 09, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today that Giovanni Caforio , M.D., Chairman and Chief Executive Officer of Bristol Myers Squibb, has been elected to its Board of Directors, effective December 1, 2020. “Giovanni adds extensive experience to our board as both a physician and business leader,” said Kevin Lobo, Chairman and Chief Executive Officer, Stryker. “As CEO of a leading global biopharmaceutical company, he has advanced scientific innovation that has helped improve the lives of patients. We look forward to welcoming Giovanni to our board.” Dr. Caforio has been CEO of Bristol Myers Squibb since May 2015 and assumed the role of Chairman of the Board in May 2017. As CEO, Dr. Caforio has led the company’s focus on researching and developing transformational medicines, which includes leading portfolios in oncology, hematology, immunology and cardiovascular disease. In 2019, he oversaw the acquisition of Celgene. Dr. Caforio joined",
                "1d_change": -0.3382923814,
                "index_price": -1.0579521103,
                "norm_price": 0.7196597289
            },
            {
                "index": 54,
                "date": "2020-11-04",
                "press_title": "Stryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-announces-receipt-of-all-required-regulatory-approvals-for-proposed-acquisition-of-Wright-Medical/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 04, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that all required regulatory approvals have been obtained for the previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) by Stryker B.V., an indirect, wholly owned subsidiary of Stryker. The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. “We are pleased to receive the necessary regulatory approvals for the proposed acquisition of Wright Medical and to be moving ahead with the offer to the company’s shareholders,” said Kevin Lobo, Chairman and Chief Executive Officer, Stryker. “Wright Medical has built a successful business, and together we look forward to working with customers to continue delivering solutions that improve patient outcomes.” The U.S. Federal Trade Commission voted to approve the transaction on November 3, 2020, and the UK",
                "1d_change": 0.3703831126,
                "index_price": 2.9622980439,
                "norm_price": -2.5919149313
            },
            {
                "index": 55,
                "date": "2020-10-29",
                "press_title": "Stryker reports third quarter 2020 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-reports-third-quarter-2020-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, Oct. 29, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the third quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the postponement of deferrable medical procedures and social contact restrictions, which have had a significant negative impact on our operations and financial results. Third Quarter Results Reported net sales increased 4.2% to $3.7 billion Organic net sales increased 3.3% Reported operating income margin of 23.0% Adjusted operating income margin(1) expanded 260 bps to 28.0% Reported EPS increased 32.5% to $1.63 Adjusted EPS(1) increased 12.0% to $2.14 Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 4.4 % 0.6 % 3.8 % — % 3.8 % MedSurg 3.2 0.3 2.9 0.4 2.5 Neurotechnology and Spine 6.0 0.5 5.5 1.2 4.3",
                "1d_change": -1.4603365589,
                "index_price": -0.2204908018,
                "norm_price": -1.2398457571
            },
            {
                "index": 56,
                "date": "2020-10-26",
                "press_title": "Stryker extends cash tender offer for all outstanding shares of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-extends-cash-tender-offer-for-all-outstanding-shares-of-Wright-Medical-0746a8d34/default.aspx",
                "content": "Kalamazoo, Michigan, Oct. 26, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. The tender offer is now scheduled to expire at 5:00 p.m., Eastern Time, on November 10, 2020, unless the tender offer is further extended or earlier terminated in accordance with the purchase agreement. American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that as of 5:00 p.m., Eastern Time, on October 23, 2020, the last business day prior to the announcement of the extension of the offer, 16,152,437 Wright Medical ordinary shares, representing approximately 12.4% of the",
                "1d_change": -2.4969535448,
                "index_price": -1.4964547305,
                "norm_price": -1.0004988142
            },
            {
                "index": 57,
                "date": "2020-10-13",
                "press_title": "Stryker extends cash tender offer for all outstanding shares of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-extends-cash-tender-offer-for-all-outstanding-shares-of-Wright-Medical-29bdc2028/default.aspx",
                "content": "Kalamazoo, Michigan, Oct. 13, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. The tender offer is now scheduled to expire at 5:00 p.m., Eastern Time, on October 28, 2020, unless the tender offer is further extended or earlier terminated in accordance with the purchase agreement. American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that as of 5:00 p.m., Eastern Time, on October 12, 2020, the last business day prior to the announcement of the extension of the offer, 13,870,057 Wright Medical ordinary shares, representing approximately 10.7% of the",
                "1d_change": -1.2973503906,
                "index_price": -1.2996382262,
                "norm_price": 0.0022878356
            },
            {
                "index": 58,
                "date": "2020-09-29",
                "press_title": "Stryker extends cash tender offer for all outstanding shares of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-extends-cash-tender-offer-for-all-outstanding-shares-of-Wright-Medical-01f44dfdc/default.aspx",
                "content": "Kalamazoo, Michigan, Sept. 29, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. The tender offer is now scheduled to expire at 5:00 p.m., Eastern Time, on October 14, 2020, unless the tender offer is further extended or earlier terminated in accordance with the purchase agreement. American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that as of 5:00 p.m., Eastern Time, on September 28, 2020, the last business day prior to the announcement of the extension of the offer, 13,817,681 Wright Medical ordinary shares (excluding Wright Medical ordinary shares",
                "1d_change": 0.1823505285,
                "index_price": 0.3592054156,
                "norm_price": -0.176854887
            },
            {
                "index": 59,
                "date": "2020-09-28",
                "press_title": "Stryker to host conference call on October 29, 2020",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-to-host-conference-call-on-October-29-2020/default.aspx",
                "content": "Kalamazoo, Mchigan, Sept. 28, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 29, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2020 and provide an operational update. Final operating results for the quarter ended September 30, 2020 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 5297589 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, October 29, 2020, until 11:59 p.m., Eastern Time, on Thursday, November 5, 2020. To hear this recording, you may dial (800) 585-8367 (domestic) or (416)",
                "1d_change": -1.8072026256,
                "index_price": 0.0470718781,
                "norm_price": -1.8542745037
            },
            {
                "index": 60,
                "date": "2020-09-02",
                "press_title": "Stryker to participate in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-to-participate-in-the-Morgan-Stanley-18th-Annual-Virtual-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Sept. 02, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Tuesday, September 15, 2020. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 10:15 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at",
                "1d_change": -0.141313884,
                "index_price": -2.5672477372,
                "norm_price": 2.4259338532
            },
            {
                "index": 61,
                "date": "2020-08-28",
                "press_title": "Stryker extends cash tender offer for all outstanding shares of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-extends-cash-tender-offer-for-all-outstanding-shares-of-Wright-Medical-4b9117ec3/default.aspx",
                "content": "Kalamazoo, Michigan, Aug. 28, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. The tender offer is now scheduled to expire at 5:00 p.m., Eastern Time, on September 30, 2020, unless the tender offer is further extended or earlier terminated in accordance with the purchase agreement. American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that as of 5:00 p.m., Eastern Time, on August 27, 2020, the last business day prior to the announcement of the extension of the offer, 13,610,322 Wright Medical ordinary shares (excluding Wright Medical ordinary shares",
                "1d_change": 0.852857187,
                "index_price": 0.160560553,
                "norm_price": 0.692296634
            },
            {
                "index": 62,
                "date": "2020-07-30",
                "press_title": "Stryker reports second quarter 2020 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-reports-second-quarter-2020-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, July 30, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the second quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the postponement of deferrable medical procedures and social contact restrictions, which have had a significant negative impact on Stryker’s operations and financial results. Second Quarter Results Reported net sales decreased 24.3% to $2.8 billion Organic net sales decreased 24.0% Reported operating loss margin of (0.7%) Adjusted operating income margin(1) of 12.5% Reported EPS decreased 117.5% to ($0.22) Adjusted EPS(1) decreased 67.7% to $0.64 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics (29.9 )% (0.6 )% (29.3 )% — % (29.3 )% MedSurg (17.3 ) (0.9 ) (16.4 ) 0.6 (17.0 ) Neurotechnology and",
                "1d_change": -2.5607813137,
                "index_price": 1.2032608407,
                "norm_price": -3.7640421544
            },
            {
                "index": 63,
                "date": "2020-07-30",
                "press_title": "Stryker declares a $0.575 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-declares-a-0.575-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, July 30, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable October 30, 2020 to shareholders of record at the close of business on September 30, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com For media inquiries please contact: Yin Becker, Vice President, Communications, Public Affairs and Corporate",
                "1d_change": -2.5607813137,
                "index_price": 1.2032608407,
                "norm_price": -3.7640421544
            },
            {
                "index": 64,
                "date": "2020-06-29",
                "press_title": "Stryker extends cash tender offer for all outstanding shares of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-extends-cash-tender-offer-for-all-outstanding-shares-of-Wright-Medical-c72954d2a/default.aspx",
                "content": "Kalamazoo, Michigan, June 29, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. The tender offer is now scheduled to expire at 5:00 p.m., Eastern Time, on August 31, 2020, unless the tender offer is further extended or earlier terminated in accordance with the purchase agreement. American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that as of 5:00 p.m., Eastern Time, on June 26, 2020, the last business day prior to the announcement of the extension of the offer, 10,400,780 Wright Medical ordinary shares (excluding Wright Medical ordinary shares tendered",
                "1d_change": 3.2465702917,
                "index_price": 2.6352357406,
                "norm_price": 0.6113345511
            },
            {
                "index": 65,
                "date": "2020-06-25",
                "press_title": "Stryker to host conference call on July 30, 2020",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-to-host-conference-call-on-July-30-2020/default.aspx",
                "content": "Kalamazoo, Michigan, June 25, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2020 and provide an operational update. Final operating results for the quarter ended June 30, 2020 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 1335868 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, July 30, 2020, until 11:59 p.m., Eastern Time, on Friday, August 7, 2020. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642 (international)",
                "1d_change": -0.9898617976,
                "index_price": -1.2479037643,
                "norm_price": 0.2580419667
            },
            {
                "index": 66,
                "date": "2020-05-26",
                "press_title": "Stryker announces pricing of $2.3 billion senior notes offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-announces-pricing-of-23-billion-senior-notes-offering/default.aspx",
                "content": "Kalamazoo, Michigan, May 26, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) (the “Company”) announced today that it has priced the following senior notes: (i) $650 million aggregate principal amount of the Company’s 1.150% Notes due 2025 (the “2025 Notes”), (ii) $1 billion aggregate principal amount of the Company’s 1.950% Notes due 2030 (the “2030 Notes”), and (iii) $650 million aggregate principal amount of the Company’s 2.900% Notes due 2050 (the “2050 Notes” and, collectively with the 2025 Notes and the 2030 Notes, the “Notes”). Unless previously redeemed pursuant to their terms, if applicable, the 2025 Notes will mature on June 15, 2025, the 2030 Notes will mature on June 15, 2030, and the 2050 Notes will mature on June 15, 2050. The offering of the Notes is expected to settle on June 4, 2020, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering and from its €2.4 billion notes offering completed in December 2019,",
                "1d_change": 0.2974766925,
                "index_price": 1.0556137558,
                "norm_price": -0.7581370633
            },
            {
                "index": 67,
                "date": "2020-05-05",
                "press_title": "Stryker declares a $0.575 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-declares-a-0575-per-share-quarterly-dividend-9080eb24d/default.aspx",
                "content": "Kalamazoo, Michigan, May 05, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on July 31, 2020 to shareholders of record at the close of business on June 30, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine Owen, Vice President, Strategy  Investor Relations at 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Vice President, Communications, Public Affairs and Corporate",
                "1d_change": 2.60439412,
                "index_price": -0.7182915967,
                "norm_price": 3.3226857167
            },
            {
                "index": 68,
                "date": "2020-04-30",
                "press_title": "Stryker reports first quarter 2020 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-reports-first-quarter-2020-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, April 30, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the first quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the deferral of elective medical procedures and social contact restrictions, which have had a significant negative impact on Stryker’s operations and financial results. First Quarter Results Reported net sales increased 2.0% to $3.6 billion Organic net sales increased 2.4% Reported operating income margin of 17.7% Adjusted operating income margin(1) contracted 110 bps to 24.0% Reported EPS increased 19.3% to $1.30 Adjusted EPS(1) decreased 2.1% to $1.84   First Quarter Net Sales Growth Overview   Reported   Foreign Currency Exchange   Constant Currency   Acquisitions   Organic Orthopaedics (2.1 )%   (0.9 )%   (1.2 )%   — %   (1.2 )% MedSurg 6.2     (0.8 )   7.0     0.7",
                "1d_change": -5.5420174829,
                "index_price": -3.5397463023,
                "norm_price": -2.0022711806
            },
            {
                "index": 69,
                "date": "2020-04-27",
                "press_title": "Stryker extends cash tender offer for all outstanding shares of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-extends-cash-tender-offer-for-all-outstanding-shares-of-Wright-Medical-e39eaf381/default.aspx",
                "content": "Kalamazoo, Michigan , April 27, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. The tender offer is now scheduled to expire at 5:00 p.m., Eastern Time, on June 30, 2020, unless the tender offer is further extended or earlier terminated in accordance with the purchase agreement. American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that as of 5:00 p.m., Eastern Time, on April 24, 2020, the last business day prior to the announcement of the extension of the offer, 5,343,007 Wright Medical ordinary shares (excluding Wright Medical ordinary shares tendered",
                "1d_change": -2.6971648955,
                "index_price": 0.3052322793,
                "norm_price": -3.0023971748
            },
            {
                "index": 70,
                "date": "2020-04-09",
                "press_title": "Stryker to host conference call on April 30, 2020",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-to-host-conference-call-on-April-30-2020/default.aspx",
                "content": "Kalamazoo, Michigan, April 09, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2020 and provide an operational update. Final operating results for the quarter ended March 31, 2020 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 4595129 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, April 30, 2020, until 11:59 p.m., Eastern Time, on Thursday, May 7, 2020. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642",
                "1d_change": -2.5685821436,
                "index_price": -0.5561971761,
                "norm_price": -2.0123849675
            },
            {
                "index": 71,
                "date": "2020-03-24",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-announces-Annual-Meeting-of-Shareholders/default.aspx",
                "content": "Kalamazoo, Michigan, March 24, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced its 2020 Annual Meeting of Shareholders is scheduled as follows: May 5, 2020 – 2:00 p.m. Eastern Time Due to concerns regarding the coronavirus outbreak and to assist in protecting the health and well-being of our shareholders and employees, this year’s Annual Meeting of Shareholders of Stryker Corporation will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International). A recording of the annual meeting will also be available from 3:00 p.m., Eastern Time, on Wednesday, May 6, 2020 at www.virtualshareholdermeeting.com/SYK2020 until the definitive proxy statement for our 2021 Annual Meeting of Shareholders is filed with the United",
                "1d_change": 11.140149624,
                "index_price": 5.2965839682,
                "norm_price": 5.8435656558
            },
            {
                "index": 72,
                "date": "2020-03-02",
                "press_title": "Stryker announces new Investor Relations leader",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-announces-new-Investor-Relations-leader/default.aspx",
                "content": "Kalamazoo, Michgan, March 02, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK ) announced today that Preston Wells will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the companys Chief Financial Officer, effective June 1, 2020. After a very successful thirteen-year period, Katherine Owen, Vice President, Strategy and Investor Relations has decided to retire to spend more time with her family. In order to assure a smooth transition of her responsibilities, Ms. Owen will transition to Advisor to the Chief Executive Officer through March 30, 2021. We would like to thank Katherine for the many significant contributions she has made to our company and for her demonstrated commitment to our success and growth, said Kevin Lobo, Strykers Chairman and Chief Executive Officer. Katherine has strengthened our investor relations and business development capabilities, including the completion of many successful",
                "1d_change": -1.911752309,
                "index_price": 0.9685815186,
                "norm_price": -2.8803338276
            },
            {
                "index": 73,
                "date": "2020-02-26",
                "press_title": "Stryker extends cash tender offer for all outstanding shares of Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-extends-cash-tender-offer-for-all-outstanding-shares-of-Wright-Medical/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 26, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical. The tender offer is now scheduled to expire at 5:00 p.m., Eastern Time, on April 30, 2020, unless the tender offer is further extended or earlier terminated in accordance with the purchase agreement. American Stock Transfer  Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that as of 5:00 p.m., Eastern Time, on February 25, 2020, the last business day prior to the announcement of the extension of the offer, 17,446,435 Wright Medical ordinary shares, representing approximately 13.6% of the",
                "1d_change": -6.5178085364,
                "index_price": -5.4096299148,
                "norm_price": -1.1081786216
            },
            {
                "index": 74,
                "date": "2020-02-25",
                "press_title": "Stryker to participate in Cowen 40th Annual Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-to-participate-in-Cowen-40th-Annual-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 25, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) ) will participate in the Cowen 40 th Annual Health Care Conference on Tuesday, March 3, 2020 at the Boston Marriott Copley Place in Boston, Massachusetts. Katherine Owen, Vice President, Strategy  Investor Relations, will represent the Company in a presentation scheduled for 10:40 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine",
                "1d_change": -6.8927842473,
                "index_price": -3.9324363463,
                "norm_price": -2.960347901
            },
            {
                "index": 75,
                "date": "2020-02-25",
                "press_title": "Stryker announces nomination of new Director, Lisa Skeete Tatum",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-announces-nomination-of-new-Director-Lisa-Skeete-Tatum/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 25, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that Lisa Skeete Tatum has been nominated for election to the company’s Board of Directors at Stryker’s 2020 Annual Meeting of Shareholders, which will be held on May 5, 2020. Ms. Skeete Tatum is the Founder and Chief Executive Officer of Landit, Inc., a technology platform created to increase the success and engagement of women and diverse groups in the workplace. Her previous experience includes over a decade as an early stage venture capitalist focused on investments in healthcare technology. Ms. Skeete Tatum also worked for Procter  Gamble and has served on numerous private and public boards. “We are excited about the potential to add Lisa to our board,” said Kevin Lobo, Stryker’s Chairman and Chief Executive Officer. “She brings a strong background in healthcare investing and technology as well as deep insight on talent development that we believe will benefit our board and company.”",
                "1d_change": -6.8927842473,
                "index_price": -3.9324363463,
                "norm_price": -2.960347901
            },
            {
                "index": 76,
                "date": "2020-02-18",
                "press_title": "Stryker named to the 100 Best Companies to Work For list for 10th consecutive year",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-named-to-the-100-Best-Companies-to-Work-For-list-for-10th-consecutive-year/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 18, 2020 (GLOBE NEWSWIRE) - Kalamazoo, Michigan – February 18, 2020 – Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year. The list recognizes companies that have exceptional workplace cultures and Stryker was ranked #8. “Being named to the 100 Best Com",
                "1d_change": 1.8214072598,
                "index_price": 0.5052895995,
                "norm_price": 1.3161176602
            },
            {
                "index": 77,
                "date": "2020-02-05",
                "press_title": "Stryker declares a $0.575 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-declares-a-0575-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 05, 2020 (GLOBE NEWSWIRE) - Kalamazoo, Michigan – February 5, 2020 – Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine Owen, Vice President, Strategy  Investor Relations at 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Vice President,",
                "1d_change": 0.2749238922,
                "index_price": 0.6237743368,
                "norm_price": -0.3488504446
            },
            {
                "index": 78,
                "date": "2020-01-28",
                "press_title": "Stryker reports 2019 results and 2020 outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-reports-2019-results-and-2020-outlook/default.aspx",
                "content": "Kalamazoo, MI, Jan. 28, 2020 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2019 and 2020 outlook: Fourth Quarter Highlights Reported net sales increased 8.8% to $4.1 billion Organic net sales increased 8.0% Reported operating income margin of 22.9% Adjusted operating income margin(1) expanded 80 bps to 28.3% Reported EPS decreased 65.1% to $1.90 Adjusted EPS(1) increased 14.2% to $2.49, exceeding the high end of guidance range Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 6.7 % (0.6 )% 7.3 % — % 7.3 % MedSurg 6.8 (0.6 ) 7.4 0.6 6.8 Neurotechnology and Spine 18.0 (0.2 ) 18.2 5.7 12.5 Total 8.8 % (0.6 )% 9.4 % 1.4 % 8.0 % Full Year Highlights Reported net sales increased 9.4% to $14.9 billion Organic net sales increased 8.1% Reported operating income margin of 18.2% Adjusted operating income margin(1) expanded 40 bps to 26.3% Reported EPS decreased",
                "1d_change": -1.993563775,
                "index_price": 0.5514084813,
                "norm_price": -2.5449722562
            },
            {
                "index": 79,
                "date": "2020-01-06",
                "press_title": "Stryker to host conference call on January 28, 2020",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2020/Stryker-to-host-conference-call-on-January-28-2020/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 06, 2020 (GLOBE NEWSWIRE) - Kalamazoo, Michigan – January 6, 2020 – Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 28, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2019 and provide an operational update. Final operating results for the quarter ended December 31, 2019 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 3198166 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, January 28, 2020, until 11:59 p.m., Eastern Time, on Tuesday, February 4, 2020. To hear this recording, you may dial (800)",
                "1d_change": 0.2003635266,
                "index_price": 0.6063883759,
                "norm_price": -0.4060248493
            },
            {
                "index": 80,
                "date": "2019-12-04",
                "press_title": "Stryker increases dividend 11%, declaring a $0.575 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-increases-dividend-11-declaring-a-0575-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Dec. 04, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on January 31, 2020 to shareholders of record at the close of business on December 31, 2019, representing an increase of approximately 11% versus the prior year and the previous quarter. “We continue to deliver strong financial results, and consistent with our stated capital allocation philosophy, are raising our dividend 11%,\" said Kevin Lobo, Chairman and Chief Executive Officer. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor inquiries please contact: Katherine Owen, Vice",
                "1d_change": -0.0541340512,
                "index_price": 0.4468402481,
                "norm_price": -0.5009742993
            },
            {
                "index": 81,
                "date": "2019-11-25",
                "press_title": "Stryker announces pricing of €2.4 billion senior notes offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-announces-pricing-of-24-billion-senior-notes-offering/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 25, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today that it has priced the following senior notes: (i) €850 million aggregate principal amount of the Company’s 0.25% Notes due 2024 (the “2024 Notes”), (ii) €800 million aggregate principal amount of the Company’s 0.75% Notes due 2029 (the “2029 Notes”) and (iii) €750 million aggregate principal amount of the Company’s 1.00% Notes due 2031 (the “2031 Notes” and, collectively with the 2024 Notes and 2029 Notes, the “Notes”).  Unless previously redeemed pursuant to their terms, if applicable, the 2024 Notes will mature on December 3, 2024, the 2029 Notes will mature on March 1, 2029 and the 2031 Notes will mature on December 3, 2031.  The Notes are expected to settle on December 3, 2019, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering, together with other financing and/or cash on hand, to consummate the Company’s recently",
                "1d_change": 0.0494004224,
                "index_price": 0.7349126253,
                "norm_price": -0.6855122029
            },
            {
                "index": 82,
                "date": "2019-11-04",
                "press_title": "Stryker announces definitive agreement to acquire Wright Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-announces-definitive-agreement-to-acquire-Wright-Medical/default.aspx",
                "content": "Kalamazoo, Michigan, Nov. 04, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including convertible notes). Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. Wright Medical brings a highly complementary product portfolio and customer base to Stryker’s trauma and extremities business. With global sales approaching $1 billion, Wright Medical is a recognized leader in the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets, which are among the fastest growing segments in orthopaedics. Wright Medical’s leading upper extremity portfolio and advanced preoperative planning technology will",
                "1d_change": -3.8463611069,
                "index_price": -0.1411505677,
                "norm_price": -3.7052105392
            },
            {
                "index": 83,
                "date": "2019-10-29",
                "press_title": "Stryker reports third quarter 2019 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-reports-third-quarter-2019-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, Oct. 29, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the third quarter of 2019: Third Quarter Highlights Reported net sales increased 10.6% to $3.6 billion Organic net sales increased 8.6% Reported operating income margin of 17.5% Adjusted operating income margin(1) expanded 50 bps to 25.4% Reported EPS decreased 20.6% to $1.23 Adjusted EPS(1) increased 13.0% to $1.91, at the high end of guidance range Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 7.8 % (1.0 )% 8.8 % — % 8.8 % MedSurg 9.2 (0.8 ) 10.0 1.2 8.8 Neurotechnology and Spine 19.4 (0.8 ) 20.2 12.6 7.6 Total 10.6 % (0.9 )% 11.5 % 2.9 % 8.6 % \"We delivered another strong quarter of results, with organic sales growth of 8.6% and adjusted EPS growth of 13%,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"We expect this momentum to continue, which positions us well to deliver above the high",
                "1d_change": 1.8149051326,
                "index_price": 0.3735144721,
                "norm_price": 1.4413906605
            },
            {
                "index": 84,
                "date": "2019-10-21",
                "press_title": "Stryker completes acquisition of Mobius Imaging and Cardan Robotics",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-completes-acquisition-of-Mobius-Imaging-and-Cardan-Robotics/default.aspx",
                "content": "Kalamazoo, Michigan, Oct. 21, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today it has completed the acquisition of Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics). “Mobius Imaging and Cardan Robotics bring expertise in advanced imaging and robotics, as well as a robust product pipeline, that will provide Stryker the opportunity to increase its presence in Orthopaedics, Spine and Neurotechnology,” said Spencer Stiles, Stryker’s Group President, Orthopaedics and Spine. “With this acquisition, we are positioned to make healthcare better by providing more complete procedural solutions, including sales, service, and support.  We remain committed to our surgeons and helping them achieve the best possible outcomes for their patients.” Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law",
                "1d_change": -3.0940104753,
                "index_price": -0.0163548689,
                "norm_price": -3.0776556064
            },
            {
                "index": 85,
                "date": "2019-09-25",
                "press_title": "Stryker to host conference call on October 29, 2019",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-to-host-conference-call-on-October-29-2019/default.aspx",
                "content": "Kalamazoo, Michigan, Sept. 25, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, October 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2019 and provide an operational update. Final operating results for the quarter ended September 30, 2019 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 6039299 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, October 29, 2019, until 11:59 p.m., Eastern Time, on Tuesday, November 5, 2019. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642",
                "1d_change": -0.5175887153,
                "index_price": 0.3113231093,
                "norm_price": -0.8289118246
            },
            {
                "index": 86,
                "date": "2019-09-04",
                "press_title": "Stryker announces definitive agreement to acquire Mobius Imaging & Cardan Robotics",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-announces-definitive-agreement-to-acquire-Mobius-Imaging--Cardan-Robotics/default.aspx",
                "content": "Kalamazoo, Michigan, Sept. 04, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE: SYK) announced today a definitive agreement to acquire Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics), in an all cash transaction of approximately $370 million upfront and up to $130 million of contingent payments associated with development and commercial milestones. The acquisition provides Stryker’s Spine division with immediate entry into the intra-operative imaging segment and aligns with Stryker’s implant and navigation offerings. Mobius Imaging, founded in 2008, is focused on integrating advanced imaging technologies into medical workflow, which can enhance a clinician’s ability to obtain high-quality images. Its Airo TruCT scanner is a best-in-class mobile, real-time, diagnostic-quality CT imaging system. Cardan Robotics, founded in 2015, is working to develop innovative robotics and navigation technology systems for surgical and",
                "1d_change": 0.4904202314,
                "index_price": 1.7248010123,
                "norm_price": -1.2343807808
            },
            {
                "index": 87,
                "date": "2019-08-21",
                "press_title": "Stryker to participate in Morgan Stanley 17th Annual Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-to-participate-in-Morgan-Stanley-17th-Annual-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Aug. 21, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) ) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019 at the Grand Hyatt New York. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 8:35 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Vice President, Strategy",
                "1d_change": -0.4718945326,
                "index_price": 0.0311299244,
                "norm_price": -0.503024457
            },
            {
                "index": 88,
                "date": "2019-08-12",
                "press_title": "Stryker announces commercial structure realignment",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-announces-commercial-structure-realignment/default.aspx",
                "content": "Kalamazoo, Michigan, Aug. 12, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today an adjustment to its commercial organizational structure. Spencer S. Stiles will serve as Group President of Orthopaedics and Spine and will oversee Stryker’s Joint Replacement, Trauma  Extremities and Spine divisions. J. Andrew Pierce, Group President of MedSurg and Neurotechnology will oversee Stryker’s Instruments, Medical, Endoscopy, Sustainability and Neurotechnology businesses. Mr. Stiles and Mr. Pierce have both served at Stryker for over 20 years and will continue to report to Timothy J. Scannell, President and Chief Operating Officer in their newly expanded roles. Since August of 2018, Mr. Scannell has been responsible for all of the company’s commercial businesses and regions. This change will further accelerate the globalization and collaboration opportunities being unlocked in this structure and leverage the diverse experience of these leaders. Stuart F. Simpson, President of",
                "1d_change": 0.4427045865,
                "index_price": 0.6578227791,
                "norm_price": -0.2151181926
            },
            {
                "index": 89,
                "date": "2019-07-31",
                "press_title": "Stryker declares a $0.52 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-declares-a-052-per-share-quarterly-dividend-fca1f60f1/default.aspx",
                "content": "Kalamazoo, Michigan, July 31, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on October 31, 2019 to shareholders of record at the close of business on September 30, 2019, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Vice President, Strategy  Investor Relations at 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Vice President, Communications, Public Affairs",
                "1d_change": -0.1408946668,
                "index_price": -2.1215045865,
                "norm_price": 1.9806099197
            },
            {
                "index": 90,
                "date": "2019-07-25",
                "press_title": "Stryker reports second quarter 2019 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-reports-second-quarter-2019-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, July 25, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the second quarter of 2019: Second Quarter Highlights Reported net sales increased 9.9% to $3.7 billion Organic net sales increased 8.5% Reported operating income margin of 16.8% Adjusted operating income margin(1) expanded 20 bps to 25.9% Reported EPS increased 5.9% to $1.26 Adjusted EPS(1) increased 12.5% to $1.98, exceeding the high end of guidance range Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 3.7 % (1.9 )% 5.6 % — % 5.6 % MedSurg 11.1 (1.4 ) 12.5 1.0 11.5 Neurotechnology and Spine 18.9 (1.9 ) 20.8 13.4 7.4 Total 9.9 % (1.6 )% 11.5 % 3.0 % 8.5 % \"We are pleased with our second quarter performance, highlighted by 8.5% organic sales growth,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"The durability of our growth is evidenced by continued strength across our businesses and",
                "1d_change": 0.5875590284,
                "index_price": 0.3172683903,
                "norm_price": 0.2702906381
            },
            {
                "index": 91,
                "date": "2019-06-24",
                "press_title": "Stryker to host conference call on July 25, 2019",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-to-host-conference-call-on-July-25-2019/default.aspx",
                "content": "Kalamazoo, Michigan, June 24, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 25, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2019 and provide an operational update. Final operating results for the quarter ended June 30, 2019 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 5290408 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, July 25, 2019, until 11:59 p.m., Eastern Time, on Thursday, August 1, 2019. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642 (international)",
                "1d_change": 0.1030501851,
                "index_price": -1.1668017341,
                "norm_price": 1.2698519192
            },
            {
                "index": 92,
                "date": "2019-05-01",
                "press_title": "Stryker to participate in Bank of America Merrill Lynch 2019 Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-to-participate-in-Bank-of-America-Merrill-Lynch-2019-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, May 01, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019 at the Encore at Wynn Hotel in Las Vegas, Nevada. Glenn Boehnlein, Vice President and Chief Financial Officer, will represent the Company in a presentation scheduled for 10:40 a.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen,",
                "1d_change": 0.0529824069,
                "index_price": -1.1931386369,
                "norm_price": 1.2461210438
            },
            {
                "index": 93,
                "date": "2019-05-01",
                "press_title": "Stryker declares a $0.52 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-declares-a-052-per-share-quarterly-dividend-0b8a1c94b/default.aspx",
                "content": "Kalamazoo, Michigan, May 01, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on July 31, 2019 to shareholders of record at the close of business on June 28, 2019, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Vice President, Strategy  Investor Relations at 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Vice President, Communications, Public Affairs and",
                "1d_change": 0.0529824069,
                "index_price": -1.1931386369,
                "norm_price": 1.2461210438
            },
            {
                "index": 94,
                "date": "2019-04-23",
                "press_title": "Stryker reports first quarter 2019 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-reports-first-quarter-2019-operating-results/default.aspx",
                "content": "Kalamazoo, Michigan, April 23, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the first quarter of 2019: First Quarter Highlights Reported net sales increased 8.5% to $3.5 billion Organic net sales increased 7.3% Reported operating income margin of 15.0% Adjusted operating income margin(1) expanded 10 bps to 25.1% Reported EPS decreased 6.0% to $1.09 Adjusted EPS(1) increased 11.9% to $1.88, exceeding the high end of guidance range First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions Organic Orthopaedics 2.8 % (2.3 )% 5.1 % — % 5.0 % MedSurg 8.2 (1.8 ) 10.0 1.1 8.9 Neurotechnology and Spine 20.7 (2.5 ) 23.2 15.4 7.8 Total 8.5 % (2.1 )% 10.6 % 3.3 % 7.3 % \"With over 7% organic sales growth in the first quarter, our multi-year momentum continued across our businesses and regions,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"We remain committed to providing compelling value to our customers",
                "1d_change": 1.1024318575,
                "index_price": 0.5896322407,
                "norm_price": 0.5127996168
            },
            {
                "index": 95,
                "date": "2019-03-27",
                "press_title": "Stryker announces new Vice President, Chief Legal Officer",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-announces-new-Vice-President-Chief-Legal-Officer/default.aspx",
                "content": "Kalamazoo, Michigan, March 27, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today that Rob Fletcher will be joining the company as Vice President, Chief Legal Officer effective April 22, 2019. Mike Hutchinson will be transitioning from his current role to serve as Advisor to the Chief Executive Officer through May 2020. Mr. Hutchinson has most recently served as Vice President, Chief Legal Officer responsible for the Legal, Compliance and Corporate Secretary functions. “We would like to thank Mike for the many contributions he has made to the company and for his demonstrated commitment to our success and robust growth,” said Kevin Lobo, Chairman and Chief Executive Officer. “Mike has strengthened our global legal and compliance capabilities and guided our company through many complex matters. I wish Mike the best in this new chapter of his career.\" Mr. Fletcher joins Stryker after almost 15 years at Johnson  Johnson during which he held multiple legal leadership roles",
                "1d_change": 0.3769306608,
                "index_price": -0.1520199111,
                "norm_price": 0.528950572
            },
            {
                "index": 96,
                "date": "2019-03-21",
                "press_title": "Stryker to host conference call on April 23, 2019",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-to-host-conference-call-on-April-23-2019/default.aspx",
                "content": "Kalamazoo, Michigan, March 21, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 23, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2019 and provide an operational update. Final operating results for the quarter ended March 31, 2019 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and be prepared to provide conference ID number 4854803 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, April 23, 2019, until 11:59 p.m., Eastern Time, on Tuesday, April 30, 2019. To hear this recording, you may dial (800) 585-8367 (domestic) or (416) 621-4642",
                "1d_change": -0.8331426593,
                "index_price": -0.6787568163,
                "norm_price": -0.154385843
            },
            {
                "index": 97,
                "date": "2019-03-20",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-announces-Annual-Meeting-of-Shareholders/default.aspx",
                "content": "Kalamazoo, Michigan, March 20, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced its 2019 Annual Meeting of Shareholders is scheduled as follows: May 1, 2019 – 2:00 p.m. Eastern Time Radisson Plaza Hotel  Suites at The Kalamazoo Center Kalamazoo, Michigan                 Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. To listen to the meeting dial (866) 393-4306 (U.S.) or (734) 385-2616 (International) and be prepared to provide Conference ID 2479405 to the operator. A recording of the meeting will also be available from 5:00 p.m., Eastern Time, on Wednesday, May 1, 2019, until 11:59 p.m. on Wednesday, May 8, 2019. To hear this recording, dial (855) 859-2056   (U.S.) or (404) 537-3406 (International) and enter Conference ID number 2479405. An archived copy of the webcast will continue to be available on our website until",
                "1d_change": 0.944442342,
                "index_price": 0.8245458964,
                "norm_price": 0.1198964455
            },
            {
                "index": 98,
                "date": "2019-03-14",
                "press_title": "Stryker acquires OrthoSpace, Ltd.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-acquires-OrthoSpace-Ltd/default.aspx",
                "content": "Kalamazoo, Michigan, March 14, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, Israel, in an all cash transaction for an upfront payment of $110 million and future milestone payments of up to an additional $110 million. OrthoSpace’s product portfolio provides a highly differentiated technology for the treatment of massive irreparable rotator cuff tears. The InSpace product is a biodegradable sub-acromial spacer, which is designed to realign the natural biomechanics of the shoulder. The technology has a long clinical history with over 20,000 patients treated across 30 countries. In the U.S., InSpace is currently under clinical study and not approved for use. “The acquisition of OrthoSpace is highly complementary to our existing portfolio and aligns with Stryker’s focus on investing in sports medicine,” said Andy Pierce, Stryker’s Group President,",
                "1d_change": 0.618443456,
                "index_price": 0.4287044634,
                "norm_price": 0.1897389926
            },
            {
                "index": 99,
                "date": "2019-02-25",
                "press_title": "Stryker acquires Arrinex",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-acquires-Arrinex/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 25, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix®, a novel cryoablation technology for the treatment of chronic rhinitis.  This condition, which affects over 24 million people in the U.S. each year, may cause runny nose, congestion, sneezing and nasal itching. Arrinex, which was founded in 2013, began commercializing ClariFix in late 2017 in the U.S. ClariFix further expands Stryker’s Ear, Nose and Throat (ENT) portfolio with a unique product to address a large, underpenetrated segment of the ENT market where Stryker does not currently compete. “The acquisition of Arrinex is highly complementary to Stryker’s ENT portfolio, which is part of our Neurotechnology business,” said Spencer Stiles, Stryker’s Group President, Neurotechnology, Instruments and Spine. “This acquisition aligns with our focus on",
                "1d_change": -2.1053991654,
                "index_price": -0.3740361387,
                "norm_price": -1.7313630267
            },
            {
                "index": 100,
                "date": "2019-02-14",
                "press_title": "Fortune Magazine names Stryker one of the 100 Best Companies to Work For in 9th consecutive year",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Fortune-Magazine-names-Stryker-one-of-the-100-Best-Companies-to-Work-For-in-9th-consecutive-year/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 14, 2019 (GLOBE NEWSWIRE) - Kalamazoo, Michigan – February 14, 2019 – Stryker (NYSE:SYK) announced today it has been named one of Fortune’s 2019 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States. The list recognizes companies that have exceptional workplace cultures. This is the ninth consecutive year Stryker has been named to the list, and the company was ranked #11. The full list and related stories are available at http://fortune.com/best-companies/list . “We are one of the 100 Best Companies to Work For because of our people,” said Katy Fink, Vice President, Chief Human Resources Officer, Stryker. “Our talented employees live our mission and values every day and go above and beyond to make healthcare and our workplace better. We thank them for their passion, commitment and drive to make Stryker a special place to work.” Fortune partners with research firm Great Place to Work (GPTW) to create",
                "1d_change": 0.9795103673,
                "index_price": 1.1565101789,
                "norm_price": -0.1769998117
            },
            {
                "index": 101,
                "date": "2019-02-12",
                "press_title": "Stryker to participate in 8th Annual Leerink Partners Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-to-participate-in-8th-Annual-Leerink-Partners-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 12, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) will participate in the 8th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019 at the Lotte New York Palace in New York, New York. Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 10:30 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact:",
                "1d_change": 0.2320376599,
                "index_price": 1.1049614988,
                "norm_price": -0.872923839
            },
            {
                "index": 102,
                "date": "2019-02-06",
                "press_title": "Stryker declares a $0.52 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-declares-a-052-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Feb. 06, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on April 30, 2019 to shareholders of record at the close of business on March 29, 2019, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Vice President, Strategy  Investor Relations at 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Vice President, Communications, Public Affairs and",
                "1d_change": 0.8907445222,
                "index_price": -1.071672714,
                "norm_price": 1.9624172361
            },
            {
                "index": 103,
                "date": "2019-01-29",
                "press_title": "Stryker reports 2018 results and 2019 outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-reports-2018-results-and-2019-outlook/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 29, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2018 and 2019 outlook: Fourth Quarter Highlights • Reported net sales increased 9.4% to $3.8 billion Organic net sales increased 8.6% Reported operating income margin of 18.4% Adjusted operating income margin(1) expanded 50 bps (30 bps excluding ASC 606(2)) to 27.5% Reported EPS increased 924.2% to $5.44 Adjusted EPS(3) increased 11.2% to $2.18, at the high end of guidance range   Fourth Quarter Net Sales Growth Overview   Reported   Excluding ASC 606 Adoption(2)   Foreign Currency Exchange   Constant Currency   Acquisitions   Organic Orthopaedics 5.4 %   5.9 %   (1.1 )%   7.0 %   — %   7.0 % MedSurg 8.9     9.9     (1.2 )   11.1     1.0     10.1   Neurotechnology and Spine 19.5     20.1     (1.3 )   21.4     13.0     8.4   Total 9.4 %   10.1 %   (1.2 )%   11.3 %   2.7 %   8.6 % Full Year Highlights • Reported net sales increased 9.3% to",
                "1d_change": 9.6215064048,
                "index_price": 1.3487311162,
                "norm_price": 8.2727752886
            },
            {
                "index": 104,
                "date": "2019-01-04",
                "press_title": "Stryker to host conference call on January 29, 2019",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2019/Stryker-to-host-conference-call-on-January-29-2019/default.aspx",
                "content": "Kalamazoo, Michigan, Jan. 04, 2019 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2018 and provide an operational update. Final operating results for the quarter ended December 31, 2018 will be released at 4:05 p.m. that day. To participate in the conference call dial (866) 393-4306 (domestic) or (734) 385-2616 (international) and be prepared to provide conference ID number 5365367 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, January 29, 2019, until 11:59 p.m., Eastern Time, on Tuesday, February 5, 2019. To hear this recording, you may dial (855) 859-2056 (domestic) or (404) 537-3406",
                "1d_change": 1.7579592613,
                "index_price": 2.9556481381,
                "norm_price": -1.1976888768
            },
            {
                "index": 105,
                "date": "2018-12-04",
                "press_title": "Stryker increases dividend 11%, declaring a $0.52 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-increases-dividend-11-declaring-a-052-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan, Dec. 04, 2018 (GLOBE NEWSWIRE) - Kalamazoo, Michigan – December 4, 2018 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on January 31, 2019 to shareholders of record at the close of business on December 31, 2018, representing an increase of approximately 11% versus the prior year and the previous quarter. “We continue to deliver strong financial results, and consistent with our stated capital allocation philosophy, are raising our dividend 11%,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Contacts For investor",
                "1d_change": -2.9316035004,
                "index_price": -5.6720589228,
                "norm_price": 2.7404554224
            },
            {
                "index": 106,
                "date": "2018-11-27",
                "press_title": "Stryker announces pricing of €2.25 billion senior notes offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-pricing-of-225-billion-senior-notes-offering/default.aspx",
                "content": "Stryker (NYSE:SYK) announced today that it has priced the following notes: (i) €550 million aggregate principal amount of the Company’s 1.125% Notes due 2023 (the “2023 Notes”), (ii) €750 million aggregate principal amount of the Company’s 2.125% Notes due 2027 (the “2027 Notes”), (iii) €650 million aggregate principal amount of the Company’s 2.625% Notes due 2030 (the “2030 Notes”) and (iv) €300 million aggregate principal amount of the Company’s Floating Rate Notes due 2020 (the “Floating Rate Notes” and together with the 2023 Notes, 2027 Notes and 2030 Notes, the “Notes”).  Unless previously redeemed pursuant to their terms, if applicable, the 2023 Notes will mature on November 30, 2023 , the 2027 Notes will mature on November 30, 2027 , the 2030 Notes will mature on November 30, 2030 and the Floating Rate Notes will mature on November 30 , 2020.  The Notes are expected to settle on November 30, 2018 , subject to the satisfaction of customary closing conditions. The Company intends",
                "1d_change": 3.5764119469,
                "index_price": 2.9171342531,
                "norm_price": 0.6592776938
            },
            {
                "index": 107,
                "date": "2018-11-20",
                "press_title": "Stryker to participate in Evercore ISI HealthCONx Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-participate-in-Evercore-ISI-HealthCONx-Conference/default.aspx",
                "content": "Stryker (NYSE:SYK) will participate in the Evercore ISI HealthCONx Conference on Wednesday, November 28, 2018 at the Boston Harbor Hotel in Boston, Massachusetts . Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 10:15 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .  The webcast will be archived on the Investor Relations page of this site. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker, 269-385-2600 or katherine.owen@stryker.com For media",
                "1d_change": -1.4421503679,
                "index_price": -0.1762373397,
                "norm_price": -1.2659130282
            },
            {
                "index": 108,
                "date": "2018-11-09",
                "press_title": "Stryker completes acquisition of K2M",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-completes-acquisition-of-K2M/default.aspx",
                "content": "Stryker (NYSE:SYK) has completed the previously announced acquisition of K2M Group Holdings, Inc. , a global leader of complex spine and minimally invasive solutions. \"K2M's broad product portfolio and robust pipeline complement Stryker’s leadership in the spine and neurotechnology markets,\" said Spencer S. Stiles, Group President, Neurotechnology, Instruments and Spine. \"We believe that our combined businesses will offer innovative solutions for our customers while expanding our global footprint.” Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing",
                "1d_change": -0.5823349303,
                "index_price": -2.4898991161,
                "norm_price": 1.9075641858
            },
            {
                "index": 109,
                "date": "2018-10-25",
                "press_title": "Stryker reports third quarter 2018 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-reports-third-quarter-2018-operating-results/default.aspx",
                "content": "Reported net sales increased 7.9% to $3.2 billion Organic net sales increased 7.9% Reported operating income margin of 17.8% Adjusted operating income margin(1) expanded 60 bps (40 bps excluding ASC 606(2)) to 24.9% Reported EPS increased 36.0% to $1.55 Adjusted EPS(3) increased 11.2% to $1.69, at the high end of guidance range Stryker (NYSE:SYK) reported operating results for the third quarter of 2018: Third Quarter Highlights 2018 Net Sales Growth Overview   Reported   Excluding ASC 606 Adoption(2)   Foreign Currency Exchange   Constant Currency   Acquisitions   Organic Orthopaedics 3.4 %   4.0 %   (1.0 )%   5.0 %   - %   5.0 % MedSurg 8.0     9.5     (0.9 )   10.4     1.6     8.8   Neurotechnology and Spine 16.7     17.4     (0.9 )   18.3     6.4     11.9   Total 7.9 %",
                "1d_change": -2.5190144141,
                "index_price": -0.6089443208,
                "norm_price": -1.9100700933
            },
            {
                "index": 110,
                "date": "2018-10-23",
                "press_title": "Stryker completes acquisition of Invuity, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-completes-acquisition-of-Invuity-Inc/default.aspx",
                "content": "Stryker (NYSE:SYK) announced today the completion of its previously announced acquisition of Invuity, Inc.  Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide variety of clinical applications including orthopaedic and spine surgery, general surgery and women's health procedures, and is a recent entrant into the enhanced energy market. Under the terms of the transaction, each outstanding share of Invuity common stock has been converted into the right to receive $7.40 in cash, without interest, subject to any required withholding taxes. As indicated in the September 11, 2018 press release, the transaction is expected to have an immaterial impact to net earnings in 2018. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause",
                "1d_change": -1.6543829111,
                "index_price": -2.4445589117,
                "norm_price": 0.7901760005
            },
            {
                "index": 111,
                "date": "2018-10-04",
                "press_title": "Stryker to host analyst meeting",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-host-analyst-meeting/default.aspx",
                "content": "Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 8, 2018 , at 2:30 p.m. Eastern Time , in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site. To listen to the meeting via phone dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 6393206 to the operator. A recording of the meeting will also be available from 7:30 p.m., Eastern Time, on Thursday, November 8, 2018, until 11:59 p.m., Eastern Time, on Thursday, November 15, 2018. To hear this recording, you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter conference ID number 6393206. Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative",
                "1d_change": -0.4365975383,
                "index_price": -1.1706535796,
                "norm_price": 0.7340560413
            },
            {
                "index": 112,
                "date": "2018-10-01",
                "press_title": "Stryker acquires HyperBranch Medical Technology, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-acquires-HyperBranch-Medical-Technology-Inc/default.aspx",
                "content": "Stryker (NYSE:SYK) announced today the acquisition of privately-held HyperBranch Medical Technology, Inc. for a total equity value of approximately $220 million in an all cash transaction. HyperBranch is dedicated to developing medical devices based on its proprietary polymers and cross-linked hydrogels. Its Adherus AutoSpray Dural Sealant product is one of only two FDA-approved dural sealants on the market. \"The acquisition of HyperBranch supports our growth strategy within our Neurotechnology business,\" said Spencer S. Stiles, Group President, Neurotechnology, Instruments and Spine for Stryker. \"The addition of Adherus to our cranial closure portfolio strengthens our position of excellence in the dural repair space and aligns with Stryker's mission of making healthcare better.\" As a PMA approved and CE cleared hydrogel that is indicated for use as an adjunct to standard methods of dural repair to aid in creating a watertight closure of the dura, the Adherus product is highly",
                "1d_change": -0.4904567311,
                "index_price": -0.0978339652,
                "norm_price": -0.3926227659
            },
            {
                "index": 113,
                "date": "2018-09-20",
                "press_title": "Stryker to host conference call on October 25, 2018",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-host-conference-call-on-October-25-2018/default.aspx",
                "content": "Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 25, 2018 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended September 30, 2018 and provide an operational update. Final operating results for the quarter ended September 30, 2018 will be released at 4:05 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 9086309 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investor Relations page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, October 25, 2018, until 11:59 p.m., Eastern Time, on Thursday, November 1, 2018. To hear this recording, you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter conference ID number",
                "1d_change": 0.2865252112,
                "index_price": 0.339285369,
                "norm_price": -0.0527601578
            },
            {
                "index": 114,
                "date": "2018-09-11",
                "press_title": "Stryker announces definitive agreement to acquire Invuity, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-definitive-agreement-to-acquire-Invuity-Inc/default.aspx",
                "content": "Stryker (NYSE: SYK) announced today a definitive agreement to acquire all the issued and outstanding shares of common stock of Invuity, Inc. (NASDAQ: IVTY) for $7.40 per share, or a total equity value of approximately $190 million . Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide variety of clinical applications including orthopaedic and spine surgery, general surgery, and women's health procedures, and is a recent entrant into the enhanced energy market. Founded in 2004, and headquartered in San Francisco, California , Invuity's portfolio of innovative products is highly complementary to the Surgical portfolio of Stryker's Instruments business. \"Invuity's innovative products in the single-use lighted instrumentation and enhanced energy markets provide best in class illumination and help make surgery safer,\" stated Spencer S. Stiles, Group President, Neurotechnology, Instruments and Spine.  \"I look forward",
                "1d_change": 1.7715912444,
                "index_price": 0.6005654011,
                "norm_price": 1.1710258433
            },
            {
                "index": 115,
                "date": "2018-09-04",
                "press_title": "Stryker to participate in Morgan Stanley 16th Annual Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-participate-in-Morgan-Stanley-16th-Annual-Global-Healthcare-Conference/default.aspx",
                "content": "Stryker (NYSE:SYK) will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday, September 12, 2018 at the Grand Hyatt New York in New York City . Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 9:55 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that",
                "1d_change": -0.8688488478,
                "index_price": -0.2894088139,
                "norm_price": -0.5794400339
            },
            {
                "index": 116,
                "date": "2018-08-30",
                "press_title": "Stryker announces definitive agreement to acquire K2M",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-definitive-agreement-to-acquire-K2M/default.aspx",
                "content": "Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of K2M Group Holdings, Inc. (NASDAQ: KTWO) for $27.50 per share, or a total equity value of approximately $1.4 billion .  K2M, which was founded in 2004, has emerged as a key player in the roughly $10 billion spinal market. With annual sales approaching $300 million, K2M brings to Stryker's Spine division a highly complementary and innovative portfolio, which includes a strong position in the complex spine market. Additionally, K2M's broad portfolio will strengthen Stryker's Spine offering in the core spinal segment, including an attractive minimally invasive spine portfolio, further Stryker's capabilities in additive manufacturing, and expand the Company's global footprint. K2M's compelling product portfolio and sales force focus have driven a double-digit compounded annual growth rate over the past five years. The combined business will have a",
                "1d_change": -0.6669538508,
                "index_price": -0.2557253379,
                "norm_price": -0.4112285128
            },
            {
                "index": 117,
                "date": "2018-08-22",
                "press_title": "Stryker to participate in 2018 Wells Fargo Securities Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-participate-in-2018-Wells-Fargo-Securities-Healthcare-Conference/default.aspx",
                "content": "Stryker (NYSE:SYK) will participate in the 2018 Wells Fargo Securities Healthcare Conference on Thursday, September 6, 2018 at the Westin Copley Place in Boston, Massachusetts . Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 10:20 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that",
                "1d_change": 0.9681479099,
                "index_price": -0.1403583432,
                "norm_price": 1.1085062531
            },
            {
                "index": 118,
                "date": "2018-08-01",
                "press_title": "Stryker declares a $0.47 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-declares-a-047-per-share-quarterly-dividend/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on October 31, 2018 to shareholders of record at the close of business on September 28, 2018 , representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker , Stryker Corporation , 269-385-2600 or yin.becker@stryker.com    This announcement is distributed by",
                "1d_change": 1.8443790993,
                "index_price": 0.2139928584,
                "norm_price": 1.6303862409
            },
            {
                "index": 119,
                "date": "2018-07-24",
                "press_title": "Stryker reports second quarter 2018 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-reports-second-quarter-2018-operating-results/default.aspx",
                "content": "Reported net sales increased 10.3% to $3.3 billion Organic net sales increased 7.9% Reported operating income margin of 20.2% Adjusted operating income margin(1) expanded 70 bps (50 bps excluding ASC 606(2)) to 25.7% Reported EPS increased 15.5% to $1.19 Adjusted EPS(3) increased 15.0% to $1.76, exceeding high end of guidance range Kalamazoo, Michigan - July 24, 2018 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2018: Second Quarter Highlights 2018 Net Sales Growth Overview   Reported   Excluding ASC 606 Adoption(2)   Foreign Currency Exchange   Constant Currency   Acquisitions   Organic Orthopaedics 7.6 %   8.0 %   1.4 %   6.6 %   -     6.6 % MedSurg 8.9     10.0     0.8     9.2     1.9     7.3   Neurotechnology and Spine 19.4     20.1     1.6     18.5     6.1     12.4   Total 10.3 %   11.0 %   1.1 %",
                "1d_change": -3.1886069497,
                "index_price": 0.8921121444,
                "norm_price": -4.0807190942
            },
            {
                "index": 120,
                "date": "2018-07-10",
                "press_title": "Stryker announces organizational changes",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-organizational-changes/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced today that David K. Floyd , Group President, Orthopaedics has notified the Company of his intent to retire on June 30, 2019. Until this date, Mr. Floyd will serve as Group President and Advisor to the CEO and will assist with transitioning his responsibilities to our newly appointed leaders while also contributing to strategic growth projects. Mr. Floyd joined Stryker in 2012 after 25 successful years in the medical technology industry.  David has served as a key member of Stryker's leadership team and enjoyed terrific success leading our Orthopaedics group. \"We are grateful for David's leadership and his many contributions to Stryker's success. His businesses consistently outgrew the market and David spearheaded several key acquisitions, including Mako. I wish David and his family all the very best in retirement,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. We are now shifting responsibility for all of our operating businesses",
                "1d_change": -0.4382310233,
                "index_price": -0.5241504733,
                "norm_price": 0.08591945
            },
            {
                "index": 121,
                "date": "2018-06-25",
                "press_title": "Stryker announces definitive agreement to acquire SafeAir AG",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-definitive-agreement-to-acquire-SafeAir-AG/default.aspx",
                "content": "Kalamazoo, Michigan - June 25, 2018 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire SafeAir AG , a Swiss medical device company dedicated to the design, development and manufacture of innovative surgical smoke evacuation solutions. The company's smoke evacuation products help reduce staff and patient exposure to hazards associated with surgical smoke. \"The acquisition of SafeAir AG is highly complementary to the Surgical business of Stryker's Instruments division, and strengthens our smoke evacuation portfolio in both the U.S. and Europe,\" said Timothy J. Scannell, Group President, MedSurg and Neurotechnology. \"This acquisition aligns with Stryker's focus of providing solutions that result in a higher quality of care and level of safety for both healthcare professionals and patients.\" The transaction is subject to customary closing conditions and is expected to close in the fourth quarter of 2018. Forward-looking statements This press release",
                "1d_change": 0.615393827,
                "index_price": -0.730056715,
                "norm_price": 1.3454505421
            },
            {
                "index": 122,
                "date": "2018-06-19",
                "press_title": "Stryker to host conference call on July 24, 2018",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-host-conference-call-on-July-24-2018/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, July 24, 2018 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended June 30, 2018 and provide an operational update. Final operating results for the quarter ended June 30, 2018 will be released at 4:05 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 7449506 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investors page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, July 24, 2018, until 11:59 p.m., Eastern Time, on Tuesday, July 31, 2018. To hear this recording, you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter conference ID number 7449506.",
                "1d_change": 0.2595018837,
                "index_price": 0.5532449524,
                "norm_price": -0.2937430686
            },
            {
                "index": 123,
                "date": "2018-05-04",
                "press_title": "Stryker to participate in Bank of America Merrill Lynch 2018 Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-participate-in-Bank-of-America-Merrill-Lynch-2018-Health-Care-Conference/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2018 Health Care Conference on Tuesday, May 15, 2018 at the Encore at Wynn Hotel in Las Vegas, Nevada .  Glenn Boehnlein, Vice President and Chief Financial Officer, will represent the Company in a presentation scheduled for 10:00 a.m. Pacific Time . A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment",
                "1d_change": 0.9493702956,
                "index_price": 1.9149651798,
                "norm_price": -0.9655948842
            },
            {
                "index": 124,
                "date": "2018-05-02",
                "press_title": "Stryker declares a $0.47 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-declares-a-047-per-share-quarterly-dividend-20180502000000/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on July 31, 2018 to shareholders of record at the close of business on June 29, 2018 , representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker , Stryker Corporation , 269-385-2600 or yin.becker@stryker.com    This announcement is distributed by Nasdaq",
                "1d_change": -0.8692618151,
                "index_price": -0.932035226,
                "norm_price": 0.0627734108
            },
            {
                "index": 125,
                "date": "2018-05-01",
                "press_title": "Stryker to participate in Deutsche Bank's 43rd Annual Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-participate-in-Deutsche-Banks-43rd-Annual-Health-Care-Conference/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) will participate in Deutsche Bank's 43 rd Annual Health Care Conference on Tuesday, May 8, 2018 at the Intercontinental Hotel Boston .  Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 8:00 a.m. Eastern Time . A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could",
                "1d_change": -1.3710287825,
                "index_price": -0.2765915034,
                "norm_price": -1.0944372791
            },
            {
                "index": 126,
                "date": "2018-04-26",
                "press_title": "Stryker reports first quarter 2018 operating results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-reports-first-quarter-2018-operating-results/default.aspx",
                "content": "Reported net sales increased 9.7% to $3.2 billion Organic net sales increased 7.0% despite one less selling day Reported operating income margin of 18.2% Adjusted operating income margin(2) expanded 70 bps (50 bps excluding ASC 606(1)) to 25.0% Reported EPS decreased 0.9% to $1.16 Adjusted EPS(3) increased 13.5% to $1.68, exceeding high end of guidance range Kalamazoo, Michigan - April 26, 2018 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2018: First Quarter Highlights 2018 Net Sales Growth Overview     Reported   Excluding ASC 606 Adoption(1)   Foreign Currency Exchange   Constant Currency   Acquisitions   Organic Orthopaedics   7.1 %   7.7 %   3.0 %   4.7 %   -     4.7 % Medsurg   9.3     11.1     2.0     9.1     1.3     7.8   Neurotechnology and Spine   16.1     16.7     3.2     13.5     3.4",
                "1d_change": 2.759693301,
                "index_price": 0.6839185728,
                "norm_price": 2.0757747282
            },
            {
                "index": 127,
                "date": "2018-04-03",
                "press_title": "Stryker announces organizational changes:  Lonny J. Carpenter to retire",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-organizational-changes--Lonny-J-Carpenter-to-retire/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced today that after 30 years of distinguished service, Lonny Carpenter , Group President, Global Quality and Business Operations has notified the Company of his intent to retire on March 31, 2019 . Mr. Carpenter will transfer his responsibility for Global Quality and Operations to Viju Menon, as outlined below, and retain responsibilities for our regional business operations outside of the U.S. and Asia-Pacific.  He will also remain involved with our Cost Transformation for Growth program. Mr. Carpenter began his career with Stryker in 1989 at the Instruments division where he excelled in various manufacturing and operations roles.  He then proceeded to take on numerous operations and commercial business roles across the Company, including President of Medical and Group President, Instruments and Medical.  In 2011, he became Group President, Global Quality and Operations and in 2014, his role was expanded to include responsibility for commercial",
                "1d_change": 1.4417515088,
                "index_price": 1.9858668008,
                "norm_price": -0.544115292
            },
            {
                "index": 128,
                "date": "2018-03-22",
                "press_title": "Stryker to host conference call on April 26, 2018",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-host-conference-call-on-April-26-2018/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, April 26, 2018 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended March 31, 2018 and provide an operational update. Final operating results for the quarter ended March 31, 2018 will be released at 4:05 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 1797708 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com . The call will be archived on the Investors page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, April 26, 2018, until 11:59 p.m., Eastern Time, on Thursday, May 3, 2018. To hear this recording, you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter conference ID number 1797708.",
                "1d_change": -3.826869343,
                "index_price": -3.9833748258,
                "norm_price": 0.1565054828
            },
            {
                "index": 129,
                "date": "2018-03-21",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-Annual-Meeting-of-Shareholders/default.aspx",
                "content": "2:00 p.m. Eastern Time Radisson Plaza Hotel & Suites at The Kalamazoo Center Kalamazoo, Michigan  Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available in the Events & Presentations area of the Investor section of our website at www.investorevents.stryker.com . To listen to the meeting dial (844) 826-0610 (U.S.) or (973) 453-3249 (International) and be prepared to provide Conference ID 9378529 to the operator. A recording of the meeting will also be available from 5:00 p.m., Eastern Time, on Wednesday, May 2, 2018, until 11:59 p.m. on Wednesday, May 9, 2018. To hear this recording, dial (855) 859-2056 (U.S.) or (404) 537-3406 (International) and enter Conference ID number 9378529. An archived copy of the webcast will continue to be available on our website until June 30, 2018 . Forward-looking statements This press release contains information that includes or is based on forward-looking",
                "1d_change": -3.7373209501,
                "index_price": -2.6969898289,
                "norm_price": -1.0403311212
            },
            {
                "index": 130,
                "date": "2018-02-28",
                "press_title": "Stryker completes acquisition of Entellus Medical",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-completes-acquisition-of-Entellus-Medical/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Entellus Medical.  Entellus is a high-growth global medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of various ear, nose and throat (ENT) disease states. As indicated in the December 7, 2017 press release, the transaction is expected to be dilutive to Stryker's 2018 adjusted net earnings per diluted share by approximately $0.04 and accretive thereafter.[1] Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could",
                "1d_change": -3.6914029852,
                "index_price": -2.8424006559,
                "norm_price": -0.8490023293
            },
            {
                "index": 131,
                "date": "2018-02-26",
                "press_title": "Stryker Corporation announces pricing of $600 million senior notes offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-Corporation-announces-pricing-of-600-million-senior-notes-offering/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced today that it has priced an offering to sell $600 million of senior unsecured notes due 2028 (the \"Notes\").  The Notes will bear interest at 3.650% per year and, unless previously redeemed, will mature on March 7 , 2028.  The Notes are expected to settle on March 7, 2018 , subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering to repay $600 million of the Company's 1.300% notes due April 1, 2018 at maturity. Goldman Sachs & Co. LLC , Morgan Stanley and Wells Fargo Securities are acting as active joint book-running managers for the offering. This offering was made pursuant to a prospectus supplement, filed today, to the Company's prospectus, dated February 12, 2016 , filed as part of the Company's effective shelf registration statement. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the notes may be obtained by contacting: (i) Goldman",
                "1d_change": 0.5910757551,
                "index_price": -0.4769953413,
                "norm_price": 1.0680710964
            },
            {
                "index": 132,
                "date": "2018-02-15",
                "press_title": "Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for eighth consecutive year",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-Corporation-named-one-of-Fortune-Magazines-100-Best-Companies-to-Work-For-for-eighth-consecutive-year/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced today that it has been named one of Fortune's 2018 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States . The list recognizes companies that have exceptional workplace cultures. This is the eighth consecutive year Stryker has been named to the list, and the company was ranked #16 out of 100. The full list and related stories are available at http://fortune.com/best-companies/list . \"It is an honor to be named one of Fortune's 100 Best Companies to Work For again this year,\" said Katy Fink, Vice President, Chief Human Resources Officer. \"This recognition is a result of our passionately driven people who produce remarkable results and work to win together as a team every day. We are proud of the work they do to make healthcare better.\" Great Place to Work (GPTW) scores each company on its analysis of anonymous employee responses to more than 50 questions on the Trust Index Survey . In",
                "1d_change": 1.5387163035,
                "index_price": 0.6866215007,
                "norm_price": 0.8520948028
            },
            {
                "index": 133,
                "date": "2018-02-14",
                "press_title": "Stryker crosses the 95% thresholds in VEXIM and announces its intention to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-crosses-the-95-thresholds-in-VEXIM-and-announces-its-intention-to-file-a-proposed-public-buy-out-offer-followed-by-a-squeeze-out-for-the-outstanding-shares-of-VEXIM/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that it has crossed the 95% thresholds in VEXIM and intends to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM , in accordance with French tender offer laws and regulations. After the acquisition of 92.19% of the share capital and 91.56% of the voting rights of VEXIM following a simplified public tender offer opened from November 16, 2017 to December 6, 2017, Stryker acquired 300,016 additional shares on the market (at a maximum price of EUR 20, i.e., the price paid in the simplified public tender offer) and crossed upwards the 95% thresholds in share capital and voting rights of VEXIM. Stryker now holds indirectly, through its French subsidiary Stryker France MM Holdings SAS, 8,716,415 shares and voting rights of VEXIM, representing 95.48% of the share capital and at least 95.14% of the voting rights. As a result, Stryker intends to file, within the coming weeks, a proposed public buy-out",
                "1d_change": 3.0528549211,
                "index_price": 2.9287489625,
                "norm_price": 0.1241059586
            },
            {
                "index": 134,
                "date": "2018-02-07",
                "press_title": "Stryker declares a $0.47 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-declares-a-047-per-share-quarterly-dividend-20180207000000/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on April 30, 2018 to shareholders of record at the close of business on March 29, 2018 , representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker , Stryker Corporation , 269-385-2600 or yin.becker@stryker.com    This announcement is distributed by Nasdaq",
                "1d_change": -3.7767672814,
                "index_price": -4.2599748614,
                "norm_price": 0.48320758
            },
            {
                "index": 135,
                "date": "2018-01-30",
                "press_title": "Stryker reports 2017 results and 2018 outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-reports-2017-results-and-2018-outlook/default.aspx",
                "content": "Kalamazoo, Michigan - January 30, 2018 - Stryker Corporation (NYSE:SYK) reported 2017 operating results for the fourth quarter and full year and 2018 outlook: Fourth Quarter Highlights Net sales grew 10.0% to $3.5 billion (8.7% constant currency) Orthopaedics 8.1 % or 6.8 % constant currency MedSurg 10.9 % or 9.8 % constant currency Neurotechnology and Spine 11.5 % or 10.3 % constant currency Reported net earnings per diluted share decreased 149.3% to a net loss per diluted share of $0.66 Adjusted net earnings per diluted share(1) increased 10.1% to $1.96 Full Year Highlights Net sales grew 9.9% to $12.4 billion (9.8% constant currency) Orthopaedics 6.6 % or 6.5 % constant currency MedSurg 13.6 % or 13.4 % constant currency Neurotechnology and Spine 8.2 % or 8.3 % constant currency Reported net earnings per diluted share decreased 38.4% to $2.68 Adjusted net earnings per diluted share(1) increased 11.9% to $6.49 \"As pre-announced, we delivered excellent organic sales",
                "1d_change": -1.8858708141,
                "index_price": -0.3162369797,
                "norm_price": -1.5696338344
            },
            {
                "index": 136,
                "date": "2018-01-09",
                "press_title": "Stryker provides 2017 preliminary net sales results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-provides-2017-preliminary-net-sales-results/default.aspx",
                "content": "Kalamazoo, Michigan - January 9, 2018 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2017 were: Preliminary Fourth Quarter Highlights Net sales grew 10.0% to $3.5 billion (8.7% constant currency) Orthopaedics 8.1 % or 6.8 % constant currency MedSurg 10.9 % or 9.8 % constant currency Neurotechnology and Spine 11.5 % or 10.3 % constant currency Preliminary Full Year Highlights Net sales grew 9.9% to $12.4 billion (9.8% constant currency) Orthopaedics 6.6 % or 6.5 % constant currency MedSurg 13.6 % or 13.4 % constant currency Neurotechnology and Spine 8.2 % or 8.3 % constant currency Preliminary consolidated net sales of $3.5 billion and $12.4 billion increased 10.0% and 9.9% as reported in the fourth quarter and full year. Excluding the impact of foreign currency and acquisitions, net sales increased 8.1% and 7.1% in the fourth quarter and full year. Based on our year-to-date performance, we expect 2017 adjusted net",
                "1d_change": -2.5072015093,
                "index_price": -0.1062473627,
                "norm_price": -2.4009541466
            },
            {
                "index": 137,
                "date": "2018-01-08",
                "press_title": "Stryker announces nomination of two new Directors, Sheri S. McCoy and Rajeev Suri",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-announces-nomination-of-two-new-Directors-Sheri-S-McCoy-and-Rajeev-Suri/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that Sherilyn (Sheri) S. McCoy and Rajeev Suri have been nominated for election to the Company's Board of Directors at Stryker's 2018 Annual Meeting of Shareholders, which is expected to be held on May 2 , 2018.  Their successful elections would bring the total size of the Company's Board to ten members. Ms. McCoy brings a wealth of healthcare and consumer experience gained during a 30-year career at Johnson & Johnson that included leadership of large medical device, pharmaceutical and consumer businesses.  She is currently Chief Executive Officer of Avon Products, a personal care products company. She has held her current position for five years, and has announced that she will be retiring on March 31, 2018. She is also a member of the Board of Directors of AstraZeneca, a global, science-led biopharmaceutical company. Mr. Suri is President and Chief Executive Officer of Nokia , a leading global technology company. Mr. Suri has deep technology",
                "1d_change": 0.0622141567,
                "index_price": 0.3133118306,
                "norm_price": -0.2510976739
            },
            {
                "index": 138,
                "date": "2018-01-02",
                "press_title": "Stryker to participate in 36th Annual J.P. Morgan Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2018/Stryker-to-participate-in-36th-Annual-JP-Morgan-Healthcare-Conference/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) will participate in the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at the Westin St. Francis hotel in San Francisco .  Kevin A. Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 8:00 a.m. Pacific Time . A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could",
                "1d_change": 1.3476721724,
                "index_price": 1.0810699908,
                "norm_price": 0.2666021816
            },
            {
                "index": 139,
                "date": "2017-12-12",
                "press_title": "Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-announces-Mr-Howard-E-Cox-Jr-will-retire-from-Board-of-Directors/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced today that after 44 years of distinguished service, Mr. Howard E. Cox, Jr. has notified the Company that he will not stand for re-election at Stryker's 2018 Annual Meeting of Shareholders, which is expected to be held on May 2 , 2018.  In light of Mr. Cox's immense contributions to the Company since before it was a publicly traded company to its current position as a leading global medical technology firm, he will be named Director Emeritus. Mr. Cox has held various leadership positions with Greylock and its affiliated venture capital partnerships since 1971 and is currently a Special Limited Partner. He is also currently a Director, Secretary of Defense Business Board, and a member of the Harvard Medical School Board of Fellows and the Investment Committees of the Dana Farber Cancer Institute and the Boston Museum of Fine Arts.  His broad and deep experience as a board member and extensive experience in venture capital have enabled the",
                "1d_change": 0.1826213947,
                "index_price": 0.0420645979,
                "norm_price": 0.1405567968
            },
            {
                "index": 140,
                "date": "2017-12-11",
                "press_title": "Stryker announces the success of the simplified tender offer for outstanding shares of VEXIM",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-announces-the-success-of-the-simplified-tender-offer-for-outstanding-shares-of-VEXIM/default.aspx",
                "content": "Stryker Corporation (NYSE:SYK) announced that the simplified public tender offer for the shares and BSAAR warrants of VEXIM , a French medical device company listed on the Euronext Growth stock exchange in France , has closed. VEXIM , headquartered in Balma, France , specializes in the development and sale of vertebral compression fracture (VCF) solutions. The public tender offer was opened from November 16, 2017 to December 6, 2017.  The results were published today by the French financial market authority (Autorité des marchés financiers, the \"AMF\").  Stryker, which already owned over 50% of the share capital and voting rights of VEXIM at the date of the filing of the public tender offer with the AMF, acquired an additional 4,036,406 shares during the offer period, as well as 226,520 BSAAR warrants that it has exercised for new shares of VEXIM. Stryker now holds 8,416,399 shares of VEXIM representing 92.19 % of its share capital and at least 91.56% of its voting rights. Stryker is",
                "1d_change": 1.2103957401,
                "index_price": 0.447435186,
                "norm_price": 0.762960554
            },
            {
                "index": 141,
                "date": "2017-12-07",
                "press_title": "Stryker announces definitive agreement to acquire Entellus",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-announces-definitive-agreement-to-acquire-Entellus/default.aspx",
                "content": "Kalamazoo, Michigan – December 7, 2017 – Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share, or an equity value of approximately $662 million. Entellus is a high-growth global medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of various ear, nose and throat (ENT) disease states. Founded in 2006, and headquartered in Plymouth, Minnesota, the company has a broad portfolio of ENT products, including the XprESS ® Multi-Sinus Dilation System and the LATERA ® Absorbable Nasal Implant, which are highly complementary to the existing ENT portfolio of Stryker’s Instruments business. “Entellus is a leader in the ENT segment and offers a comprehensive portfolio of products that enable physicians to conveniently and comfortably perform a broad range of ENT procedures,” stated Timothy J. Scannell,",
                "1d_change": -0.1908856392,
                "index_price": 0.871963688,
                "norm_price": -1.0628493272
            },
            {
                "index": 142,
                "date": "2017-12-06",
                "press_title": "Stryker increases dividend 11%, declaring a $0.47 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-increases-dividend-11-declaring-a-047-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan – December 6, 2017 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on January 31, 2018 to shareholders of record at the close of business on December 29, 2017, representing an increase of approximately 11% versus the prior year and the previous quarter. “Our financial strength is reflected in the 11% increase in our dividend for 2018 as we continue to execute on our capital allocation strategy,” said Kevin A. Lobo, Chairman and Chief Executive Officer. “With strong organic sales growth and leveraged adjusted earnings gains, we believe we are well positioned to continue to deliver dividend increases in line with our adjusted earnings growth.” Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and",
                "1d_change": -0.6417628475,
                "index_price": 0.4072837228,
                "norm_price": -1.0490465703
            },
            {
                "index": 143,
                "date": "2017-10-26",
                "press_title": "Stryker reports third quarter 2017 results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-reports-third-quarter-2017-results/default.aspx",
                "content": "Kalamazoo, Michigan - October 26, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2017: Third Quarter Highlights Net sales grew 6.1% to $3.0 billion (5.8% constant currency) Orthopaedics 5.1 % or 4.8 % constant currency MedSurg 6.7 % or 6.2 % constant currency Neurotechnology and Spine 6.9 % or 7.0",
                "1d_change": 5.9659403885,
                "index_price": 0.8132282223,
                "norm_price": 5.1527121662
            },
            {
                "index": 144,
                "date": "2017-10-24",
                "press_title": "Stryker to acquire VEXIM",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-acquire-VEXIM/default.aspx",
                "content": "Kalamazoo, Michigan – October 24, 2017 – Stryker Corporation (NYSE:SYK) announced that it has acquired control of VEXIM, a French medical device company listed on the Euronext Growth stock exchange in France. VEXIM, headquartered in Balma, France, specializes in the development and sale of vertebral compression fracture (VCF) solutions. The company’s flagship product is the SpineJack® system, a mechanical expandable VCF implant for fracture reduction and stabilization. The VEXIM portfolio is highly complementary to the Interventional Spine (IVS) business of Stryker’s Instruments division whose key products include an extensive and innovative portfolio for vertebral augmentation, vertebroplasty and radiofrequency ablation procedures, along with a diagnostic tool and decompression treatment advances for contained disc herniations. VEXIM had sales of €18.5M in 2016 which was 33% growth over 2015 revenue. VEXIM has a direct sales force in Europe with sales in France, Germany, Spain, and",
                "1d_change": 0.3662111992,
                "index_price": -0.4501108736,
                "norm_price": 0.8163220728
            },
            {
                "index": 145,
                "date": "2017-09-21",
                "press_title": "Stryker to host conference call on October 26, 2017",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-host-conference-call-on-October-26-2017/default.aspx",
                "content": "Kalamazoo, Michigan – September 21, 2017 – Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 26, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2017 and provide an operational update. Final operating results for the quarter ended September 30, 2017 will be released at 4:00 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 77238428 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on the Investors page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, October 26, 2017, until 11:59 p.m., Eastern Time, on Thursday, November 2, 2017. To hear this recording, you may dial (855) 859-2056 (domestic) or (404) 537-3406",
                "1d_change": -1.0007555304,
                "index_price": -0.1974223475,
                "norm_price": -0.8033331829
            },
            {
                "index": 146,
                "date": "2017-09-06",
                "press_title": "Stryker to participate in Morgan Stanley 15th Annual Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-participate-in-Morgan-Stanley-15th-Annual-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan – September 6, 2017 – Stryker Corporation (NYSE:SYK) will participate in the Morgan Stanley 15th Annual Global Healthcare Conference on Tuesday, September 12, 2017 at the Grand Hyatt Hotel in New York, New York.  Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 10:35 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures",
                "1d_change": 0.2249957954,
                "index_price": 0.0515199984,
                "norm_price": 0.173475797
            },
            {
                "index": 147,
                "date": "2017-09-01",
                "press_title": "Stryker completes acquisition of NOVADAQ Technologies Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-completes-acquisition-of-NOVADAQ-Technologies-Inc/default.aspx",
                "content": "Kalamazoo, Michigan – September 1, 2017 – Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of NOVADAQ Technologies Inc.  NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures. As indicated in the June 19, 2017 press release, the transaction is expected to be dilutive to Stryker’s 2017 adjusted net earnings per diluted share by $0.03 - $0.05. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to:",
                "1d_change": 0.0494061922,
                "index_price": -0.6741592677,
                "norm_price": 0.7235654598
            },
            {
                "index": 148,
                "date": "2017-08-23",
                "press_title": "Stryker provides an update regarding Sage warning letter and revised financial guidance",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-provides-an-update-regarding-Sage-warning-letter-and-revised-financial-guidance/default.aspx",
                "content": "Kalamazoo, Michigan – August 23, 2017 – Stryker Corporation (NYSE: SYK) announced today that the company has informed the U.S. Food and Drug Administration (FDA) of a voluntary product recall involving specific lots of Oral Care products sold through the company’s Sage Products business unit (Sage). The recalled products contain Oral Care solutions manufactured for Sage by a third-party supplier and were distributed between July 2015 and August 2017. The recall is being initiated due to a potential for cross-contamination of Oral Care solutions manufactured by the third party on equipment shared with non-pharmaceutical products, as stated in a Warning Letter from FDA dated July 17, 2017. To date, Stryker has not been made aware of any serious adverse events associated with the Oral Care products recall. However, there have been some reports of minor irritation and allergic reaction. Stryker has discontinued business with the third-party supplier and all Oral Care solutions are being",
                "1d_change": -1.6069883446,
                "index_price": -0.2423118029,
                "norm_price": -1.3646765416
            },
            {
                "index": 149,
                "date": "2017-08-02",
                "press_title": "Stryker announces election of new Director, Mary K. Brainerd",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-announces-election-of-new-Director-Mary-K-Brainerd/default.aspx",
                "content": "Kalamazoo, Michigan - August 2, 2017 - Stryker Corporation (NYSE:SYK) announced the addition of a new member to its Board of Directors with the election of Mary K. Brainerd as a Director, effective August 1, 2017. Ms. Brainerd was most recently President and Chief Executive Officer of HealthPartners, the largest, consumer-governed, nonprofit health care organization in the United States. She retired on June 1, 2017 after serving for 15 years as President and Chief Executive Officer. Prior to that, she held various executive roles with HealthPartners since 1992 and with Blue Cross and Blue Shield of Minnesota from 1984 to 1992. Ms. Brainerd received a B.A. from the University of Minnesota and a M.B.A. from the University of St. Thomas. She previously served on the boards of Possis Medical, Inc. and SurModics, Inc. and is one of the founding Chief Executive Officers and former Chair of the Itasca Project, a group of 40 government, civic and business leaders addressing issues that impact",
                "1d_change": -0.9017849199,
                "index_price": -0.3325015774,
                "norm_price": -0.5692833425
            },
            {
                "index": 150,
                "date": "2017-08-02",
                "press_title": "Stryker declares a $0.425 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-declares-a-0425-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan - August 2, 2017 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.425 per share payable on October 31, 2017 to shareholders of record at the close of business on September 29, 2017, representing an increase of 12% versus the prior year and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.  Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker,",
                "1d_change": -0.9017849199,
                "index_price": -0.3325015774,
                "norm_price": -0.5692833425
            },
            {
                "index": 151,
                "date": "2017-07-27",
                "press_title": "Stryker reports second quarter 2017 results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-reports-second-quarter-2017-results/default.aspx",
                "content": "Kalamazoo, Michigan - July 27, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2017: Second Quarter Highlights Net sales grew 6.1% to $3.0 billion (6.9% constant currency) Orthopaedics 5.5 % or 6.5% constant currency MedSurg 6.2 % or 6.8% constant currency Neurotechnology and Spine 6.9 % or 7.9% constant currency Adjusted net earnings per diluted share(1) increased 10.1% to $1.53 Reported net earnings per diluted share increased 3.0% to $1.03 \"Our growth momentum continued in the second quarter as we continue to drive share gains through new products and strong commercial execution,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"We are raising our full year guidance for both organic sales growth and EPS, which reflects our expectations for continued strong performance throughout the year.\" Sales Analysis Consolidated net sales of $3.0 billion increased 6.1% in the quarter as reported and 6.9% in constant currency, as foreign",
                "1d_change": 1.366692799,
                "index_price": -0.4312087573,
                "norm_price": 1.7979015562
            },
            {
                "index": 152,
                "date": "2017-06-22",
                "press_title": "Stryker to host conference call on July 27, 2017",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-host-conference-call-on-July-27-2017/default.aspx",
                "content": "Kalamazoo, Michigan - June 22, 2017 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 27, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2017 and provide an operational update. Final operating results for the quarter ended June 30, 2017 will be released at 4:00 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 26061645 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on the Investors page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, July 27, 2017, until 11:59 p.m., Eastern Time, on Thursday, August 3, 2017. To hear this recording you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter",
                "1d_change": 0.4747869801,
                "index_price": 0.0369169695,
                "norm_price": 0.4378700106
            },
            {
                "index": 153,
                "date": "2017-06-19",
                "press_title": "Stryker announces definitive agreement to acquire NOVADAQ Technologies Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-announces-definitive-agreement-to-acquire-NOVADAQ-Technologies-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - June 19, 2017- Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire NOVADAQ Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ) for US$11.75 per share, or US$701 million with a net purchase price of US$654 million, reflecting net cash of approximately US$47 million. NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures.  NOVADAQ was founded in 2000 and is headquartered in Mississauga, Canada. \"This acquisition aligns with Stryker's focus on enabling our customers to see and do more by enhancing cross-specialty surgical visualization,\" stated Timothy J. Scannell, Group President, MedSurg and NeuroTechnology. \"NOVADAQ'S unique innovative technology complements Stryker's advanced imaging portfolio and expands our product offerings into open and",
                "1d_change": -1.184560695,
                "index_price": -0.226506012,
                "norm_price": -0.958054683
            },
            {
                "index": 154,
                "date": "2017-05-31",
                "press_title": "Stryker to participate in Goldman Sachs 38th Annual Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-participate-in-Goldman-Sachs-38th-Annual-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 31, 2017 - Stryker Corporation (NYSE:SYK) will participate in the Goldman Sachs 38th Annual Global Healthcare Conference on Wednesday, June 14, 2017 at the Terranea Resort in Rancho Palos Verdes, California.  Glenn Boehnlein, Vice President and Chief Financial Officer, will represent the Company in a presentation scheduled for 9:20 a.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures",
                "1d_change": 1.4789510493,
                "index_price": 0.5938197178,
                "norm_price": 0.8851313316
            },
            {
                "index": 155,
                "date": "2017-05-08",
                "press_title": "Stryker Orthopaedics 2016 Settlement Program reaches milestone",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-Orthopaedics-2016-Settlement-Program-reaches-milestone/default.aspx",
                "content": "95% of Registered Eligible U.S. Patients Enrolled in Program Kalamazoo, Michigan - May 8, 2017- Stryker Corporation (NYSE:SYK) announced that Howmedica Osteonics Corp. (referred to as \"Stryker Orthopaedics\"), a subsidiary of Stryker Corporation, has informed the courts in the New Jersey Multicounty and Federal Multidistrict litigations that 95% of additional registered eligible patients have enrolled in the Settlement Program under the Master Settlement Agreement announced in December 2016. As a result, Stryker Orthopaedics will move forward with the 2016 Settlement Program that provides for compensation to additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery, prior to December 19, 2016. Shortly, the Claims Processor will begin notifying claimants and their attorneys regarding compensation payments.  The exact timing and amount of payments will depend on factors and",
                "1d_change": -0.682111562,
                "index_price": -0.1259958459,
                "norm_price": -0.5561157161
            },
            {
                "index": 156,
                "date": "2017-05-04",
                "press_title": "Stryker to participate in Bank of America Merrill Lynch 2017 Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-participate-in-Bank-of-America-Merrill-Lynch-2017-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 4, 2017 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2017 Health Care Conference on Wednesday, May 17, 2017 at the Encore at Wynn Hotel in Las Vegas, Nevada.  Glenn Boehnlein, Vice President and Chief Financial Officer, will represent the Company in a presentation scheduled for 10:00 a.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures",
                "1d_change": 0.2353641867,
                "index_price": 0.3959504622,
                "norm_price": -0.1605862756
            },
            {
                "index": 157,
                "date": "2017-05-03",
                "press_title": "Stryker declares a $0.425 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-declares-a-0425-per-share-quarterly-dividend-20170503000000/default.aspx",
                "content": "Kalamazoo, Michigan - May 3, 2017 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.425 per share payable on July 31, 2017 to shareholders of record at the close of business on June 30, 2017, representing an increase of 12% versus the prior year and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.  Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Stryker",
                "1d_change": -0.7556578938,
                "index_price": 0.1263860318,
                "norm_price": -0.8820439256
            },
            {
                "index": 158,
                "date": "2017-04-25",
                "press_title": "Stryker reports first quarter 2017 results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-reports-first-quarter-2017-results/default.aspx",
                "content": "Kalamazoo, Michigan - April 25, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2017: First Quarter Highlights Net sales grew 18.4% to $2.96 billion (18.8% constant currency) MedSurg 36.2 % or 36.6% constant currency Orthopaedics 7.4 % or 7.8% constant currency Neurotechnology and Spine 7.3 % or 7.7% constant currency Reported net earnings per diluted share increased 9.3% to $1.17 Adjusted net earnings per diluted share(1) increased 19.4% to $1.48 \"Our positive momentum continued in the first quarter, as we demonstrated our ongoing commitment to deliver organic sales growth at the high end of med-tech and leveraged earnings gains,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"Our results were well-balanced across business segments and geographies, and position us well for another strong year in 2017.\" Sales Analysis Consolidated net sales of $2.96 billion increased 18.4% in the quarter as reported and 18.8% in constant",
                "1d_change": 0.9251560705,
                "index_price": 0.2487985729,
                "norm_price": 0.6763574977
            },
            {
                "index": 159,
                "date": "2017-03-27",
                "press_title": "Stryker to host conference call on April 25, 2017",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-host-conference-call-on-April-25-2017/default.aspx",
                "content": "Kalamazoo, Michigan - March 27, 2017 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, April 25, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2017 and provide an operational update. Final operating results for the quarter ended March 31, 2017 will be released at 4:00 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 26016220 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on the Investors page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Tuesday, April 25, 2017, until 11:59 p.m., Eastern Time, on Tuesday, May 2, 2017. To hear this recording you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter",
                "1d_change": 0.5275035976,
                "index_price": 1.2490602392,
                "norm_price": -0.7215566416
            },
            {
                "index": 160,
                "date": "2017-03-20",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-announces-Annual-Meeting-of-Shareholders-20170320000000/default.aspx",
                "content": "Kalamazoo, Michigan - March 20, 2017 - Stryker Corporation (NYSE:SYK) announced that its 2017 Annual Meeting of Shareholders is scheduled as follows: May 3, 2017 - 2:00 p.m. Eastern Time Radisson Plaza Hotel & Suites at The Kalamazoo Center Kalamazoo, Michigan                 Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available in the Events & Presentations area of the Investor section of our website at www.investorevents.stryker.com. The telephone number to listen to the meeting is (844) 826-0610 (U.S.) or (973) 453-3249 (International) and the Conference ID is 78762706. A recording of the meeting will also be available from 5:00 p.m., Eastern Time, on Wednesday, May 3, 2017, until 11:59 p.m. on Wednesday, May 10, 2017. To hear this recording, dial (855) 859-2056 (U.S.) or (404) 537-3406 (international) and enter Conference ID # 78762706. An archived copy of the webcast will continue to be available on our website",
                "1d_change": -0.1813015155,
                "index_price": -1.4598838925,
                "norm_price": 1.278582377
            },
            {
                "index": 161,
                "date": "2017-03-14",
                "press_title": "Stryker enabling surgeons to have a more predictable surgical experience with launch of Mako robotic-arm assisted total knee application",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-enabling-surgeons-to-have-a-more-predictable-surgical-experience-with-launch-of-Mako-robotic-arm-assisted-total-knee-application/default.aspx",
                "content": "The first and only robotic technology that can be used across the joint replacement service line to perform total knee, total hip and partial knee replacements now available Kalamazoo, Michigan - March 14, 2017 - Stryker Corporation (NYSE:SYK) announced the commercial launch of the highly anticipated robotic-arm assisted total knee arthroplasty application for use with its Mako System at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Diego. This latest advancement distinguishes the Mako System as the first and only robotic technology that can be used across the joint replacement service line to perform total knee, total hip and partial knee replacements. Mako Total Knee combines Stryker's advanced robotic technology with its clinically proven Triathlon Total Knee System (\"GetAroundKnee\"), enabling surgeons to have a more predictable surgical experience with increased accuracy. 1 Through CT-based 3D modeling of bone anatomy, surgeons can use the Mako System",
                "1d_change": 1.513201126,
                "index_price": 0.7005509198,
                "norm_price": 0.8126502062
            },
            {
                "index": 162,
                "date": "2017-03-09",
                "press_title": "Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for seventh consecutive year",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-Corporation-named-one-of-Fortune-Magazines-100-Best-Companies-to-Work-For-for-seventh-consecutive-year/default.aspx",
                "content": "Kalamazoo, Michigan - March 9, 2017 - Stryker Corporation (NYSE:SYK) announced today that it has been named one of Fortune's 2017 100 Best Companies to Work For in its 20 th annual survey of top-rated workplaces in the United States. The list recognizes companies that have exceptional workplace cultures. This is the seventh consecutive year Stryker has been named to the list, and the company was ranked #19 out of 100. The full list and related stories are available at http://beta.fortune.com/best-companies/ . \"We are thrilled once again to be named to Fortune's 100 Best Companies to Work For,\" said Katy Fink, Vice President, Chief Human Resources Officer. \"This recognition speaks to what makes us special-it's about the people! We are honored to work with great people who are driven, ethical, caring and humble. They live our mission and values every day, and they are the reason that Stryker is one of the best places to work.\" Stryker is one of the world's leading medical technology",
                "1d_change": 0.6384317698,
                "index_price": 0.3839714679,
                "norm_price": 0.2544603019
            },
            {
                "index": 163,
                "date": "2017-02-21",
                "press_title": "Stryker to participate in Cowen & Company 37th Annual Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-participate-in-Cowen--Company-37th-Annual-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - February 21, 2017 - Stryker Corporation (NYSE:SYK) will participate in the Cowen & Company 37th Annual Health Care Conference on Monday, March 6, 2017 at the Boston Marriott Copley Place in Boston, Massachusetts.  Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 1:20 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing",
                "1d_change": 1.0055810822,
                "index_price": 0.3347760736,
                "norm_price": 0.6708050087
            },
            {
                "index": 164,
                "date": "2017-02-08",
                "press_title": "Stryker declares a $0.425 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-declares-a-0425-per-share-quarterly-dividend-20170208000000/default.aspx",
                "content": "Kalamazoo, Michigan - February 8, 2017 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.425 per share payable on April 28, 2017 to shareholders of record at the close of business on March 31, 2017, representing an increase of 12% versus the prior year and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.  Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Stryker",
                "1d_change": 0.7946949762,
                "index_price": 0.7938084653,
                "norm_price": 0.0008865109
            },
            {
                "index": 165,
                "date": "2017-01-24",
                "press_title": "Stryker reports 2016 results and 2017 outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-reports-2016-results-and-2017-outlook/default.aspx",
                "content": "Kalamazoo, Michigan - January 24, 2017 - Stryker Corporation (NYSE:SYK) reported 2016 operating results for the fourth quarter and full year and 2017 outlook: Fourth Quarter Highlights Net sales grew 16.2% to $3.2 billion (16.8% constant currency) Orthopaedics 5.3 % or 5.7% constant currency MedSurg 31.1 % or 32.1% constant currency Neurotechnology and Spine 8.7 % or 8.6% constant currency Reported net earnings per diluted share decreased 2.9% to $1.34 Adjusted net earnings per diluted share(1) increased 14.1% to $1.78 Full Year Highlights Net sales grew 13.9% to $11.3 billion (14.3% constant currency) Orthopaedics 4.7 % or 5.1% constant currency MedSurg 25.6 % or 26.3% constant currency Neurotechnology and Spine 9.9 % or 9.8% constant currency Reported net earnings per diluted share increased 15.1% to $4.35 Adjusted net earnings per diluted share(1) increased 13.3% to $5.80 \"I am pleased with our performance in both the fourth quarter and the full year 2016,\" said Kevin",
                "1d_change": -0.3302663299,
                "index_price": 1.3266024539,
                "norm_price": -1.6568687838
            },
            {
                "index": 166,
                "date": "2017-01-10",
                "press_title": "Stryker provides 2016 preliminary net sales results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-provides-2016-preliminary-net-sales-results/default.aspx",
                "content": "Kalamazoo, Michigan - January 10, 2017 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2016 were: Preliminary Fourth Quarter Highlights Net sales grew 16.3% to $3.2 billion (16.8% constant currency) Orthopaedics 5.3 % or 5.7% constant currency MedSurg 31.4 % or 32.4% constant currency Neurotechnology and Spine 8.3 % or 8.2% constant currency Preliminary Full Year Highlights Net sales grew 13.9% to $11.3 billion (14.3% constant currency) Orthopaedics 4.7 % or 5.1% constant currency MedSurg 25.7 % or 26.4% constant currency Neurotechnology and Spine 9.8 % or 9.7% constant currency Preliminary consolidated net sales of $3.2 billion and $11.3 billion increased 16.3% and 13.9% as reported in the fourth quarter and full year. Excluding the impact of foreign currency and acquisitions, net sales increased 6.7% and 6.4% in the fourth quarter and full year. The acquisitions of Sage Products LLC and Physio-Control International,",
                "1d_change": 3.3155560843,
                "index_price": 0.2461235118,
                "norm_price": 3.0694325726
            },
            {
                "index": 167,
                "date": "2017-01-03",
                "press_title": "Stryker to participate in 35th Annual J.P. Morgan Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2017/Stryker-to-participate-in-35th-Annual-JP-Morgan-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - January 3, 2017 - Stryker Corporation (NYSE:SYK) will participate in the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2017 at the Westin St. Francis hotel in San Francisco.  Kevin A. Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 7:30 a.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally,",
                "1d_change": 0.2414766608,
                "index_price": 0.8446518393,
                "norm_price": -0.6031751785
            },
            {
                "index": 168,
                "date": "2016-12-19",
                "press_title": "Stryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Orthopaedics-to-compensate-additional-eligible-US-patients-who-had-surgery-to-replace-their-Rejuvenate-Modular-Neck-andor-ABG-II-Modular-Neck-Hip-Stems/default.aspx",
                "content": "Kalamazoo, Michigan - December 19, 2016 - Stryker Corporation (NYSE:SYK) announced that Howmedica Osteonics Corp. (referred to as \"Stryker Orthopaedics\"), a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG II Modular-Neck plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations reached an agreement to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery, prior to December 19, 2016.  This follows an initial 2014 Settlement Program that covered patients who had a revision surgery prior to November 3, 2014.  In that initial program, over 95% of eligible patients enrolled.  Under this new agreement, additional patients are now eligible to participate and may apply for compensation. The Settlement Agreement will help bring to a close significant Rejuvenate Modular-Neck and ABG",
                "1d_change": 0.6192133943,
                "index_price": 0.5073199934,
                "norm_price": 0.1118934009
            },
            {
                "index": 169,
                "date": "2016-12-07",
                "press_title": "Stryker increases 2017 annual dividend by 12% and declares a $0.425 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-increases-2017-annual-dividend-by-12-and-declares-a-0425-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan - December 7, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.425 per share payable on January 31, 2017 to shareholders of record at the close of business on December 30, 2016, representing an increase of 12% versus the prior year and the previous quarter. \"Our 12% increase in the dividend for 2017 reflects the strength of our balance sheet and our consistent capital allocation approach which uses acquisitions, dividends and share repurchases to drive shareholder value,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"Our continued strong performance should enable us to continue to drive future dividend increases roughly at or above our earnings growth.\" Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical",
                "1d_change": 2.8742028333,
                "index_price": 1.5791171552,
                "norm_price": 1.2950856781
            },
            {
                "index": 170,
                "date": "2016-11-14",
                "press_title": "Stryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable orthopaedic care in India",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-announces-multi-year-partnership-with-Indo-UK-Institute-of-Health-to-deliver-affordable-orthopaedic-care-in-India/default.aspx",
                "content": "Kalamazoo, Michigan - November 14, 2016 - Stryker Corporation (NYSE:SYK), one of the world's leading medical technology companies, announced today a multi-year collaboration with Indo UK Institute of Health's (IUIH) Medicity Program to serve as a preferred partner in the orthopaedic areas of hip, knee, and trauma products and services. Stryker and IUIH's new relationship will provide greater access to affordable primary joint replacements and other healthcare services to patients in India. The unprecedented 20-year partnership between Stryker and IUIH, a forward-looking healthcare provider, will create and deliver real value throughout the continuum of orthopaedic care, driven by a combination of Stryker's quality implants and products, streamlined patient pathways and world-class commercial services. \"We are proud to partner with Indo UK Institute of Health to make quality healthcare more accessible and affordable to the people of India, not only through the broad portfolio of",
                "1d_change": -0.5376402835,
                "index_price": 0.6764845155,
                "norm_price": -1.2141247989
            },
            {
                "index": 171,
                "date": "2016-11-08",
                "press_title": "Stryker to participate in Stifel 2016 Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-participate-in-Stifel-2016-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - November 8, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Stifel 2016 Healthcare Conference on Wednesday, November 16, 2016 at the Lotte New York Palace Hotel. Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 10:15 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": -2.8991749373,
                "index_price": 1.5411965154,
                "norm_price": -4.4403714527
            },
            {
                "index": 172,
                "date": "2016-10-27",
                "press_title": "Stryker reports third quarter 2016 results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-reports-third-quarter-2016-results/default.aspx",
                "content": "Kalamazoo, Michigan - October 27, 2016 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2016: Third Quarter Highlights Net sales grew 17.1% to $2.8 billion (16.7% constant currency) Orthopaedics 5.6 % or 5.3% constant currency MedSurg 33.0 % or 33.0% constant currency Neurotechnology and Spine 9.7 % or 8.7% constant currency Reported net earnings per diluted share increased 19.0% to $0.94 Adjusted net earnings per diluted share(1) increased 11.2% to $1.39 \"Our third quarter results again demonstrate our ability to consistently deliver strong organic sales growth at the high end of med tech,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"Our acquisitions are performing well and contributed to solid overall earnings performance.\" Sales Analysis Consolidated net sales of $2.8 billion increased 17.1% in the quarter as reported and 16.7% in constant currency, as foreign currency exchange rates favorably impacted net sales by 0.4%. Excluding",
                "1d_change": 3.2991918466,
                "index_price": -0.8300444041,
                "norm_price": 4.1292362508
            },
            {
                "index": 173,
                "date": "2016-10-11",
                "press_title": "Stryker to host analyst meeting",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-host-analyst-meeting-20161011000000/default.aspx",
                "content": "Kalamazoo, Michigan - October 11, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host an Analyst Meeting on Wednesday, November 9, 2016, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. Kevin Lobo, Chairman and Chief Executive Officer, will host the meeting with presentations by leaders of the Company's key business units.                 To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 58033847 to the operator. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com . A recording of the call will also be available from 7:30 p.m., Eastern Time, on Wednesday, November 9, 2016, until 11:59 p.m., Eastern Time, on Wednesday, November 16, 2016. To hear this recording you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter conference ID number 58033847. Forward-looking statements This",
                "1d_change": -3.2215764499,
                "index_price": -1.0363862192,
                "norm_price": -2.1851902307
            },
            {
                "index": 174,
                "date": "2016-09-26",
                "press_title": "Stryker to host conference call on October 27, 2016",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-host-conference-call-on-October-27-2016/default.aspx",
                "content": "Kalamazoo, Michigan - September 26, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 27, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2016 and provide an operational update. Final operating results for the quarter ended September 30, 2016 will be released at 4:00 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 57981183 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on the Investors page of this site. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, October 27, 2016, until 11:59 p.m., Eastern Time, on Thursday, November 3, 2016. To hear this recording you may dial (855) 859-2056 (domestic) or (404) 537-3406",
                "1d_change": 0.5263449578,
                "index_price": 0.064348966,
                "norm_price": 0.4619959918
            },
            {
                "index": 175,
                "date": "2016-09-07",
                "press_title": "Stryker to participate in Morgan Stanley Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-participate-in-Morgan-Stanley-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - September 7, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at the Grand Hyatt New York.  Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 8:45 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment",
                "1d_change": -1.3667609594,
                "index_price": -0.1774113125,
                "norm_price": -1.1893496469
            },
            {
                "index": 176,
                "date": "2016-08-31",
                "press_title": "Stryker to participate in 11th Annual Wells Fargo Securities Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-participate-in-11th-Annual-Wells-Fargo-Securities-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - August 31, 2016 - Stryker Corporation (NYSE:SYK) will participate in the 11th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2016 at the The Westin Boston Waterfront in Boston, Massachusetts.  Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 9:55 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products;",
                "1d_change": -0.5900977754,
                "index_price": -0.1243724164,
                "norm_price": -0.465725359
            },
            {
                "index": 177,
                "date": "2016-07-27",
                "press_title": "Stryker declares a $0.38 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-declares-a-038-per-share-quarterly-dividend/default.aspx",
                "content": "Kalamazoo, Michigan - July 27, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on October 31, 2016 to shareholders of record at the close of business on September 30, 2016, representing an increase of 10% versus the prior year and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.  Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Stryker",
                "1d_change": -1.0612587058,
                "index_price": 0.0115204185,
                "norm_price": -1.0727791243
            },
            {
                "index": 178,
                "date": "2016-07-21",
                "press_title": "Stryker reports second quarter 2016 results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-reports-second-quarter-2016-results/default.aspx",
                "content": "Kalamazoo, Michigan - July 21, 2016 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2016: Second Quarter Highlights Net sales grew 16.8% to $2.8 billion (17.0% constant currency) Orthopaedics 4.6 % or 4.8% constant currency MedSurg 33.8 % or 34.2% constant currency Neurotechnology and Spine 9.3 % or 9.0% constant currency Reported net earnings per diluted share decreased 2.9% to $1.00 Adjusted net earnings per diluted share(1) increased 15.8% to $1.39 \"With organic sales growth of 6.6% we delivered another solid quarter, once again demonstrating the strength of our diversified model,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"This growth, combined with strong expense controls, positions us well to deliver on our updated full year financial guidance.\" Sales Analysis Consolidated net sales of $2.8 billion increased 16.8% in the quarter as reported and 17.0% in constant currency, as foreign currency exchange rates negatively impacted",
                "1d_change": -4.4262325846,
                "index_price": 0.0974753065,
                "norm_price": -4.5237078911
            },
            {
                "index": 179,
                "date": "2016-06-16",
                "press_title": "Stryker to host conference call on July 21, 2016",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-host-conference-call-on-July-21-2016/default.aspx",
                "content": "Kalamazoo, Michigan - June 16, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 21, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2016 and provide an operational update. Final operating results for the quarter ended June 30, 2016 will be released at 4:00 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 57934209 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, July 21, 2016, until 11:59 p.m., Eastern Time, on Thursday, July 28, 2016. To hear this recording you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter conference ID",
                "1d_change": 0.3060061799,
                "index_price": 0.2346377183,
                "norm_price": 0.0713684616
            },
            {
                "index": 180,
                "date": "2016-05-31",
                "press_title": "Stryker to participate in Goldman Sachs 37th Annual Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-participate-in-Goldman-Sachs-37th-Annual-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 31, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016 at the Terranea Resort in Rancho Palos Verdes, California.  Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 1:20 p.m. Pacific Time (4:20 p.m. Eastern Time). A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products;",
                "1d_change": 0.2776233431,
                "index_price": -0.0380980912,
                "norm_price": 0.3157214343
            },
            {
                "index": 181,
                "date": "2016-05-17",
                "press_title": "Stryker to participate in UBS 2016 Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-participate-in-UBS-2016-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 17, 2016 - Stryker Corporation (NYSE:SYK) will participate in the UBS 2016 Global Healthcare Conference on Tuesday, May 24, 2016 at the Grand Hyatt New York in New York, New York.  Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 11:00 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": -1.9934456826,
                "index_price": -0.8502529333,
                "norm_price": -1.1431927493
            },
            {
                "index": 182,
                "date": "2016-05-02",
                "press_title": "Stryker to participate in Bank of America Merrill Lynch 2016 Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-participate-in-Bank-of-America-Merrill-Lynch-2016-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 2, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016 at the Encore at Wynn Hotel in Las Vegas, Nevada.  Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a presentation scheduled for 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time). A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-looking statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products;",
                "1d_change": -0.1465266802,
                "index_price": -0.184155264,
                "norm_price": 0.0376285838
            },
            {
                "index": 183,
                "date": "2016-04-29",
                "press_title": "Stryker acquires Stanmore Implants Worldwide Limited",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-acquires-Stanmore-Implants-Worldwide-Limited/default.aspx",
                "content": "Kalamazoo, Michigan - April 29, 2016 - Stryker Corporation (NYSE:SYK) announced today it has acquired Stanmore Implants Worldwide Limited from SIW Holdings Limited in an all cash transaction for £35.6 million.  Stanmore Implants is an innovative orthopaedic business focused on serving the needs of surgeons that treat adult and juvenile orthopaedic oncology.  Stanmore Implants' portfolio includes both patient specific and off-the-shelf implant systems aimed at limb salvage. \"The acquisition of Stanmore Implants provides Stryker with differentiated technologies designed to provide the most effective solutions for orthopaedic oncology surgeons. This addition underscores Stryker's commitment to our core joint replacement business and expands our presence in the global orthopaedic oncology market,\" said David Floyd, Group President, Stryker Orthopaedics. \"The combination of Stryker's commitment to orthopaedic oncology and Stanmore's novel orthopaedic oncology solutions provides a unique",
                "1d_change": 2.9379430214,
                "index_price": 0.4616952574,
                "norm_price": 2.476247764
            },
            {
                "index": 184,
                "date": "2016-04-27",
                "press_title": "Stryker declares a $0.38 per share quarterly dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-declares-a-038-per-share-quarterly-dividend-20160427000000/default.aspx",
                "content": "Kalamazoo, Michigan - April 27, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on July 29, 2016, to shareholders of record at the close of business on June 30, 2016, representing an increase of 10% versus the prior year, and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.  Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Stryker",
                "1d_change": -0.6936642077,
                "index_price": -0.7958348339,
                "norm_price": 0.1021706262
            },
            {
                "index": 185,
                "date": "2016-04-21",
                "press_title": "Stryker announces completion of the acquisition of vertebral compression fracture portfolio from BD",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-announces-completion-of-the-acquisition-of-vertebral-compression-fracture-portfolio-from-BD/default.aspx",
                "content": "Kalamazoo, Michigan - April 21, 2016 - Stryker Corporation (NYSE: SYK) announced today it has completed the acquisition of the CareFusion vertebral compression fracture (VCF) portfolio of products from BD (Becton, Dickinson and Company) in an all cash transaction.  The portfolio is comprised of minimally-invasive systems used in vertebroplasty and vertebral augmentation procedures.  BD acquired these assets as a part of CareFusion's portfolio in March of 2015. \"The acquisition of BD's VCF portfolio is highly complementary to Stryker Instruments' Interventional Spine (IVS) business and is aligned with IVS's strategy of expanding its VCF footprint,\" stated Timothy J. Scannell, Group President, MedSurg and Neurotechnology.  \"It also further strengthens Stryker's brand in the Neurotechnology space.\" With this acquisition, Stryker can provide its customers a comprehensive product portfolio containing some of the least minimally invasive vertebral compression fracture treatment options",
                "1d_change": -2.8336326707,
                "index_price": -0.502491388,
                "norm_price": -2.3311412827
            },
            {
                "index": 186,
                "date": "2016-04-20",
                "press_title": "Stryker reports first quarter 2016 results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-reports-first-quarter-2016-results/default.aspx",
                "content": "Kalamazoo, Michigan - April 20, 2016 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2016: First Quarter Highlights Net sales grew 4.9% to $2.5 billion (6.1% constant currency) Orthopaedics 3.3 % or 4.6% constant currency MedSurg 3.4 % or 4.6% constant currency Neurotechnology and Spine 12.0 % or 13.1% constant currency Reported net earnings per diluted share increased 84.5% to $1.07 Adjusted net earnings per diluted share(1) increased 11.7% to $1.24 \"We are pleased by our first quarter performance and expect the momentum to continue,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"As a result, we have raised our full year guidance for both sales and adjusted net earnings.\" Sales Analysis Consolidated net sales of $2.5 billion increased 4.9% in the quarter as reported and 6.1% in constant currency, as foreign currency exchange rates negatively impacted net sales by 1.3%. Acquisitions did not significantly impact net sales in the",
                "1d_change": -0.2287067142,
                "index_price": -0.4800447127,
                "norm_price": 0.2513379985
            },
            {
                "index": 187,
                "date": "2016-04-05",
                "press_title": "Stryker completes acquisition of Physio-Control International, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-completes-acquisition-of-Physio-Control-International-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - April 5, 2016 - Stryker Corporation (NYSE: SYK) announced today the completion of its previously announced acquisition of Physio-Control International, Inc. (Physio-Control).  Physio-Control develops, manufactures and markets monitors/defibrillators, automated external defibrillators (AEDs) and CPR-assist devices along with data management and support services. As indicated in the February 16, 2016 press release, the transaction is expected to be slightly accretive to Stryker's 2016 adjusted net earnings per diluted share and to be accretive thereafter. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that",
                "1d_change": -0.5913437309,
                "index_price": 0.2012867277,
                "norm_price": -0.7926304586
            },
            {
                "index": 188,
                "date": "2016-04-01",
                "press_title": "Stryker completes the acquisition of Synergetics USA, Inc.'s Neuro Portfolio",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-completes-the-acquisition-of-Synergetics-USA-Incs-Neuro-Portfolio/default.aspx",
                "content": "Kalamazoo, Michigan - April 1, 2016 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Synergetics USA, Inc.'s Neuro Portfolio. The portfolio includes the Malis generator, Spetzler Malis disposable forceps, and Stryker's existing Sonopet tips and RF generator. As indicated in the February 10, 2016 press release, this transaction is expected to be neutral to Stryker's 2016 adjusted net earnings per diluted share and accretive thereafter. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures",
                "1d_change": 2.3872626707,
                "index_price": 0.4602694973,
                "norm_price": 1.9269931735
            },
            {
                "index": 189,
                "date": "2016-04-01",
                "press_title": "Stryker completes acquisition of Sage Products, LLC",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-completes-acquisition-of-Sage-Products-LLC/default.aspx",
                "content": "Kalamazoo, Michigan - April 1, 2016 - Stryker Corporation (NYSE: SYK) announced today the completion of its previously announced acquisition of Sage Products, LLC (\"Sage\").  Sage's products include solutions for oral care, skin preparation and protection, patient cleaning and hygiene, turning and positioning devices and heel care boots. As indicated in the February 1, 2016 press release, the transaction is expected to be accretive to Stryker's 2016 adjusted net earnings per diluted share and to be accretive thereafter. Forward-looking statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our",
                "1d_change": 2.3872626707,
                "index_price": 0.4602694973,
                "norm_price": 1.9269931735
            },
            {
                "index": 190,
                "date": "2016-03-23",
                "press_title": "Stryker announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-announces-Annual-Meeting-of-Shareholders-20160323000000/default.aspx",
                "content": "Kalamazoo, Michigan - March 23, 2016 - Stryker Corporation (NYSE:SYK) announced that its 2016 Annual Meeting of Shareholders is scheduled as follows: April 27, 2016 - 2:00 p.m. Eastern Time Radisson Plaza Hotel & Suites at The Kalamazoo Center Kalamazoo, Michigan                 Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available in the Events & Presentations area of the Investor section of our website at www.investorevents.stryker.com. The telephone number to listen to the meeting is (844) 826-0610 (U.S.) or (973) 453-3249 (International) and the Conference ID is 58126774. A recording of the meeting will also be available from 5:00 p.m., Eastern Time, on Wednesday, April 27, 2016, until 11:59 p.m. on Thursday, June 30, 2016. To hear this recording, dial (855) 859-2056 (U.S.) or (404) 537-3406 (international) and enter Conference ID # 58126774. An archived copy of the webcast will continue to be available on our",
                "1d_change": 0.3136251548,
                "index_price": -0.6193752166,
                "norm_price": 0.9330003714
            },
            {
                "index": 191,
                "date": "2016-03-18",
                "press_title": "Stryker to host conference call on April 20, 2016",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-host-conference-call-on-April-20-2016/default.aspx",
                "content": "Kalamazoo, Michigan - March 18, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Wednesday, April 20, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2016 and provide an operational update. Final operating results for the quarter ended March 31, 2016 will be released at 4:00 p.m. that day. To participate in the conference call dial (844) 826-0610 (domestic) or (973) 453-3249 (international) and be prepared to provide conference ID number 57643412 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Wednesday, April 20, 2016, until 11:59 p.m., Eastern Time, on Wednesday, April 27, 2016. To hear this recording you may dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and enter",
                "1d_change": 0.9632010004,
                "index_price": 0.5088741948,
                "norm_price": 0.4543268057
            },
            {
                "index": 192,
                "date": "2016-03-03",
                "press_title": "Stryker Corporation Announces Pricing of $3.5 Billion Senior Notes Offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Corporation-Announces-Pricing-of-35-Billion-Senior-Notes-Offering/default.aspx",
                "content": "Kalamazoo, Michigan - March 3, 2016 - Stryker Corporation (NYSE:SYK) announced today that it has priced an offering to sell $3.5 billion of senior unsecured notes consisting of the following tranches (the \"Notes\"): $750 million of 3-year fixed rate notes due March 8, 2019 bearing interest at 2.000% per year $750 million of 5-year fixed rate notes due March 15, 2021 bearing interest at 2.625% per year $1,000 million of 10-year fixed rate notes due March 15, 2026 bearing interest at 3.500% per year $1,000 million of 30-year fixed rate notes due March 15, 2046 bearing interest at 4.625% per year The Notes are expected to settle on March 10, 2016, subject to customary closing conditions. The Company intends to use the net proceeds from the offering along with the Company's cash on hand to fund the previously announced acquisitions of Sage Products, LLC and Physio-Control International Inc., to repay all of the Company's 2.00% Notes due September 30, 2016 at their maturity and for general",
                "1d_change": 1.4016181375,
                "index_price": 0.7195043335,
                "norm_price": 0.682113804
            },
            {
                "index": 193,
                "date": "2016-03-03",
                "press_title": "Stryker Corporation named one of Fortune magazine's \"100 Best Companies to Work For\" for sixth consecutive year",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Corporation-named-one-of-Fortune-magazines-100-Best-Companies-to-Work-For-for-sixth-consecutive-year/default.aspx",
                "content": "Kalamazoo, Michigan - March 3, 2016 - Stryker Corporation (NYSE:SYK) announced today that it has been named as one of the Fortune's 2016 100 Best Companies to Work For in its 19th annual survey of top-rated workplaces in the United States. The list recognizes companies that have exceptional workplace cultures. This is the sixth consecutive year Stryker has been named to the list, and the company was ranked 21 out of 100. The full list and related stories are available at http://fortune.com/best-companies/. \"It is an honor to be named one of the 100 Best Companies to Work For again this year,\" said Katy Fink, Vice President, Human Resources. \"This is a testament to our focus on people and our culture that invests in employee growth and development. We greatly appreciate the contributions of our employees, their drive to make healthcare better, and their passion in making Stryker a great place to work.\" Stryker is one of the world's leading medical technology companies and, together",
                "1d_change": 1.4016181375,
                "index_price": 0.7195043335,
                "norm_price": 0.682113804
            },
            {
                "index": 194,
                "date": "2016-02-29",
                "press_title": "Stryker to Participate in Cowen & Company 36th Annual Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-Participate-in-Cowen--Company-36th-Annual-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - February 29, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Cowen & Company 36th Annual Health Care Conference on Monday, March 7, 2016 at the Boston Marriott Copley Place in Boston, Massachusetts.  Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 1:20 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing",
                "1d_change": -0.1189115871,
                "index_price": 1.5780812843,
                "norm_price": -1.6969928714
            },
            {
                "index": 195,
                "date": "2016-02-22",
                "press_title": "Stryker to Participate in Canaccord Genuity 2016 Musculoskeletal Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-Participate-in-Canaccord-Genuity-2016-Musculoskeletal-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - February 22, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Canaccord Genuity 2016 Musculoskeletal Conference on Tuesday, March 1, 2016 at the Hyatt Regency in Orlando, Florida. William J. Huffnagle, President, Reconstructive Division, will represent the Company in a presentation scheduled for 1:00 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": 0.3742326018,
                "index_price": -0.1649909613,
                "norm_price": 0.5392235631
            },
            {
                "index": 196,
                "date": "2016-02-16",
                "press_title": "Stryker Announces Definitive Agreement to Acquire Physio-Control International, Inc. for $1.28 Billion",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Announces-Definitive-Agreement-to-Acquire-Physio-Control-International-Inc-for-128-Billion/default.aspx",
                "content": "Kalamazoo, Michigan - February 16, 2016 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire 100% of the stock of Physio-Control International, Inc. (\"Physio-Control\") in an all cash transaction for $1.28 billion.  Physio-Control, which is a portfolio company of Bain Capital Private Equity, develops, manufactures and markets monitors/defibrillators, automated external defibrillators (AEDs) and CPR-assist devices along with data management and support services. The company was founded in 1955 and has a long history of innovation with products that target urgent patient care, specifically designed to improve survival rates and patient outcomes. The company's portfolio is highly complementary to Stryker Medical's EMS (Emergency Medical Services) offering and will drive a greater balance between capital and disposables. Physio-Control also brings an enhanced presence and infrastructure that will expand Stryker's global footprint. Physio-Control sales for",
                "1d_change": -2.243203157,
                "index_price": 2.8741660574,
                "norm_price": -5.1173692143
            },
            {
                "index": 197,
                "date": "2016-02-10",
                "press_title": "Stryker Declares a $0.38 per Share Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Declares-a-038-per-Share-Quarterly-Dividend-20160210000000/default.aspx",
                "content": "Kalamazoo, Michigan - February 10, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on April 29, 2016, to shareholders of record at the close of business on March 31, 2016, representing an increase of 10% versus the prior year, and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.  Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Stryker",
                "1d_change": -1.3830815139,
                "index_price": -1.53191879,
                "norm_price": 0.1488372761
            },
            {
                "index": 198,
                "date": "2016-02-10",
                "press_title": "Stryker Announces Definitive Agreement to Acquire Synergetics USA, Inc.'s Neuro Portfolio",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Announces-Definitive-Agreement-to-Acquire-Synergetics-USA-Incs-Neuro-Portfolio/default.aspx",
                "content": "Kalamazoo, Michigan - February 10, 2016 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire all of the assets associated with Synergetics USA, Inc.'s neuro portfolio in an all cash transaction. The portfolio includes the Malis generator, Spetzler Malis disposable forceps, and Stryker's existing Sonopet tips and RF generator.  The Synergetics' portfolio achieved OEM sales in 2015 of approximately $31 million. \"The acquisition of the Synergetics neuro portfolio is highly complementary to Stryker Instruments' Neuro Spine & ENT (NSE) business and is aligned with NSE's strategy of expanding its neurosurgical product offering,\" stated Timothy J. Scannell, Group President, MedSurg and Neurotechnology. The closing of the transaction is subject to expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions.  Upon closing, the transaction is expected to be neutral to",
                "1d_change": -1.3830815139,
                "index_price": -1.53191879,
                "norm_price": 0.1488372761
            },
            {
                "index": 199,
                "date": "2016-02-01",
                "press_title": "Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Announces-Definitive-Agreement-to-Acquire-Sage-Products-LLC-from-Madison-Dearborn-Partners-for-2775-Billion/default.aspx",
                "content": "Kalamazoo, Michigan - February 1, 2016 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire Sage Products, LLC (\"Sage\") from Madison Dearborn Partners in an all cash transaction for $2.775 billion.  The transaction includes an anticipated future tax benefit which is expected to exceed $500 million and to positively impact cash flows over approximately 15 years. Sage develops, manufactures and distributes disposable products targeted at reducing \"Never Events,\" primarily in the intensive care unit and MedSurg hospital unit setting. Sage sales for fiscal 2015 totaled $430 million, up 13% over the prior year. \"The company's established leadership team and innovative products that help prevent hospital acquired conditions have driven consistent double-digit sales growth,\" stated Kevin A. Lobo, Chairman and Chief Executive Officer. \"This acquisition aligns with Stryker's focus on offering products and services that support a mindset of prevention,",
                "1d_change": 2.2619553685,
                "index_price": -1.7818905423,
                "norm_price": 4.0438459108
            },
            {
                "index": 200,
                "date": "2016-01-26",
                "press_title": "Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Announces-the-Retirement-of-William-R-Jellison-and-the-promotion-of-Glenn-S-Boehnlein-to-Vice-President-Chief-Financial-Officer/default.aspx",
                "content": "Kalamazoo, Michigan - January 26, 2016 - Stryker Corporation (NYSE: SYK) announced today that William R. Jellison will retire from his role as Vice President, Chief Financial Officer. Bill's decision follows an impressive 36 year career, the last three of which have been with Stryker. Bill will pursue his interests of becoming more involved with board roles, having recently joined the board of PolyOne Corporation, and devoting more time to his family.  He will remain as CFO through the first quarter of 2016 to ensure a smooth transition. Glenn S. Boehnlein, who currently serves as Group CFO for MedSurg & Neurotechnology (MSNT), will assume the role of Vice President, Chief Financial Officer effective April 1, 2016. \"I want to thank Bill for his leadership since joining Stryker as he helped advance a series of key priorities, including implementing a layered hedging program, executing on a number of acquisitions, and facilitating the establishment of our European regional",
                "1d_change": 4.1582084771,
                "index_price": 0.2209252618,
                "norm_price": 3.9372832153
            },
            {
                "index": 201,
                "date": "2016-01-26",
                "press_title": "Stryker Reports 2015 Results and 2016 Outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Reports-2015-Results-and-2016-Outlook/default.aspx",
                "content": "Kalamazoo, Michigan - January 26, 2016 - Stryker Corporation (NYSE:SYK) reported 2015 operating results for the fourth quarter and full year and 2016 outlook: Fourth Quarter Highlights Net sales grew 3.7% to $2.7 billion (7.0% constant currency) Orthopaedics 3.3 % or 7.1% constant currency MedSurg 3.0 % or 5.6% constant currency Neurotechnology and Spine 6.5 % or 9.9% constant currency Reported net earnings per diluted share increased 106.0% to $1.38 Adjusted net earnings per diluted share(1) increased 8.3% to $1.56 Full Year Highlights Net sales grew 2.8% to $9.9 billion (7.0% constant currency) Orthopaedics 1.7 % or 6.7% constant currency MedSurg 3.0 % or 6.2% constant currency Neurotechnology and Spine 5.0 % or 9.5% constant currency Reported net earnings per diluted share increased 182.1% to $3.78 Adjusted net earnings per diluted share(1) increased 8.2% to $5.12 \"With 2015 organic sales growth of 6.1%, bolstered by a strong fourth quarter increase of 6.4%, our top",
                "1d_change": 4.1582084771,
                "index_price": 0.2209252618,
                "norm_price": 3.9372832153
            },
            {
                "index": 202,
                "date": "2016-01-12",
                "press_title": "Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-Provides-2015-Preliminary-Sales-Results-and-Increases-Adjusted-Earnings-Guidance/default.aspx",
                "content": "Kalamazoo, Michigan - January 12, 2016 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2015 were: Preliminary Fourth Quarter Highlights Net sales grew 3.7% to $2.7 billion (7.0% constant currency) Orthopaedics 3.3 % or 7.1% constant currency MedSurg 3.0 % or 5.6% constant currency Neurotechnology and Spine 6.5 % or 9.9% constant currency Preliminary Full Year Highlights Net sales grew 2.8% to $9.9 billion (7.0% constant currency) Orthopaedics 1.7 % or 6.7% constant currency MedSurg 3.0 % or 6.2% constant currency Neurotechnology and Spine 5.0 % or 9.5% constant currency Preliminary net sales for the fourth quarter and full year 2015 were $2.7 billion and $9.9 billion, respectively, increases of 3.7% and 2.8%, respectively. Excluding the impact of foreign currency and acquisitions, preliminary net sales increased 6.4% in the fourth quarter and 6.1% for the full year. We have increased our full year adjusted net earnings per",
                "1d_change": 1.4332006883,
                "index_price": -1.9864742882,
                "norm_price": 3.4196749765
            },
            {
                "index": 203,
                "date": "2016-01-04",
                "press_title": "Stryker to Participate in 34th Annual J.P. Morgan Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2016/Stryker-to-Participate-in-34th-Annual-JP-Morgan-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - January 4, 2016 - Stryker Corporation (NYSE:SYK) will participate in the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016 at the Westin St. Francis Hotel in San Francisco, California. Kevin A. Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 7:30 a.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures",
                "1d_change": -0.6381379212,
                "index_price": -1.065596474,
                "norm_price": 0.4274585528
            },
            {
                "index": 204,
                "date": "2015-12-10",
                "press_title": "Stryker Declares a $0.38 per Share Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Declares-a-038-per-Share-Quarterly-Dividend-20151210000000/default.aspx",
                "content": "Kalamazoo, Michigan - December 10, 2015 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on January 29, 2016, to shareholders of record at the close of business on December 31, 2015, representing an increase of 10% versus the prior year, and 10% versus the previous quarter. \"As part of our capital allocation strategy, we are committed to consistent growth in our dividend which is reflected in the announced 10% increase for 2016,\" said Kevin. A. Lobo, Chairman and Chief Executive Officer. \"We will continue to utilize our balance sheet for acquisitions that support our growth goals, dividends and share repurchases to help drive shareholder value.\" Forward Looking Statement This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to",
                "1d_change": -0.1952377892,
                "index_price": -1.7670735839,
                "norm_price": 1.5718357947
            },
            {
                "index": 205,
                "date": "2015-10-26",
                "press_title": "Stryker Corporation Announces Pricing of $750 Million Senior Notes Offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Corporation-Announces-Pricing-of-750-Million-Senior-Notes-Offering/default.aspx",
                "content": "Kalamazoo, Michigan - October 26, 2015 - Stryker Corporation (NYSE:SYK) announced today that it has priced an offering to sell $750 million of senior unsecured notes due 2025 (the \"Notes\"). The Notes will bear interest at 3.375% per year and, unless previously redeemed, will mature on November 1, 2025. The Notes are expected to settle on October 29, 2015, subject to customary closing conditions. The Company intends to use the net proceeds from the offering to repay $200 million of existing commercial paper at its maturity and for working capital and other general corporate purposes, including acquisitions, stock repurchases and other business opportunities. Barclays Capital Inc., Citigroup Global Markets Inc. and Goldman, Sachs & Co. are acting as active joint book-running managers for the offering. This offering was made pursuant to a prospectus supplement to the Company's prospectus, dated February 28, 2013, filed as part of the Company's effective shelf registration statement.",
                "1d_change": -0.5541401595,
                "index_price": -0.4448535994,
                "norm_price": -0.1092865601
            },
            {
                "index": 206,
                "date": "2015-10-22",
                "press_title": "Stryker Reports Third Quarter 2015 Results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Reports-Third-Quarter-2015-Results/default.aspx",
                "content": "Kalamazoo, Michigan - October 22, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2015: Third Quarter Highlights       Net sales grew 1.3% to $2.4 billion (5.9% constant currency) Orthopaedics 0.3 % or 5.8% constant currency MedSurg 0.6 % or 4.1% constant currency Neurotechnology and Spine 5.0 % or 9.9% constant currency Reported diluted net earnings per share increased 393.8% to $0.79 Adjusted diluted net earnings per share(1) increased 8.7% to $1.25 \"We delivered another solid quarter with organic sales again exceeding 5%, putting us on pace to achieve our sales and adjusted EPS targets for 2015,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"I am pleased with our disciplined execution as we work with our customers to make healthcare better.\" Sales Analysis Consolidated net sales of $2.4 billion increased 1.3% in the quarter as reported and 5.9% in constant currency, as net sales were negatively impacted by 4.6% due to the",
                "1d_change": -6.0673241457,
                "index_price": 2.5670385258,
                "norm_price": -8.6343626715
            },
            {
                "index": 207,
                "date": "2015-09-18",
                "press_title": "Stryker to Host Conference Call on October 22, 2015",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Host-Conference-Call-on-October-22-2015/default.aspx",
                "content": "Kalamazoo, Michigan - September 18, 2015 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 22, 2015 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2015 and provide an operational update. Final operating results for the quarter ended September 30, 2015 will be released at 4:00 p.m. that day. To participate in the conference call dial (866) 436-9172 (domestic) or (630) 691-2760 (international) and be prepared to provide confirmation number 38313505 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:30 p.m., Eastern Time, on Thursday, October 22, 2015, until 11:59 p.m., Eastern Time, on Thursday, October 29, 2015. To hear this recording you may dial (888) 843-7419 (domestic) or (630) 652-3042 (international)",
                "1d_change": 0.0803245793,
                "index_price": -1.1535541373,
                "norm_price": 1.2338787166
            },
            {
                "index": 208,
                "date": "2015-09-08",
                "press_title": "Stryker to Participate in 2015 Morgan Stanley Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Participate-in-2015-Morgan-Stanley-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - September 8, 2015 - Stryker Corporation (NYSE:SYK) will participate in the 2015 Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015 at the Grand Hyatt New York. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled for 9:10 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment",
                "1d_change": 0.4625399325,
                "index_price": 0.7589951771,
                "norm_price": -0.2964552446
            },
            {
                "index": 209,
                "date": "2015-09-01",
                "press_title": "Stryker Completes Acquisition of Muka Metal, A.S.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Completes-Acquisition-of-Muka-Metal-AS/default.aspx",
                "content": "Kalamazoo, Michigan - September 1, 2015 - Stryker Corporation (NYSE: SYK) announced today the completion of its previously announced acquisition of Muka Metal, A.S. (\"Muka\"). Muka is a privately held business headquartered in Kayseri, Turkey that sells hospital beds, stretchers and related patient room furniture and accessories that serve markets across Turkey and other regions globally. As indicated in the July 20, 2015 press release, the transaction is expected to be neutral to Stryker's 2015 earnings per share excluding acquisition, integration-related and intangible amortization charges. About Stryker Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes. Stryker is active in over 100 countries around the",
                "1d_change": 0.423114965,
                "index_price": -1.0893538083,
                "norm_price": 1.5124687733
            },
            {
                "index": 210,
                "date": "2015-08-28",
                "press_title": "Stryker to Participate in 2015 Wells Fargo Securities Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Participate-in-2015-Wells-Fargo-Securities-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - August 28, 2015 - Stryker Corporation (NYSE:SYK) will participate in the 2015 Wells Fargo Securities Healthcare Conference on Wednesday, September 9, 2015 at the Hyatt Regency Boston. Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 10:35 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": -1.703037028,
                "index_price": -0.7037899434,
                "norm_price": -0.9992470846
            },
            {
                "index": 211,
                "date": "2015-08-06",
                "press_title": "Stryker Receives FDA Clearance For Mako Total Knee Application",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Receives-FDA-Clearance-For-Mako-Total-Knee-Application/default.aspx",
                "content": "Kalamazoo, Michigan - August 6, 2015 - Stryker Orthopaedics, a division of Stryker Corporation (NYSE:SYK), today announced that its 510(k) submission for the Mako total knee application has received market clearance by the U.S. Food and Drug Administration. This clearance expands Stryker's current Mako offering of partial knee and total hip applications to provide a comprehensive solution in the robotic reconstructive service line. \"The ability to include a Mako total knee application with our market leading Triathlon Total Knee System represents a key milestone in reconstructive surgery,\" said David K. Floyd, Group President, Orthopaedics. \"We are excited about the opportunity to transform orthopaedics by furthering the growth of robotic-arm assisted surgery, and by enhancing the surgeon and patient experience.\" With the clearance of the total knee application, Stryker is preparing to initiate a limited market release by year end. Forward-Looking Statements This press release",
                "1d_change": -2.0110804067,
                "index_price": -1.1157232189,
                "norm_price": -0.8953571879
            },
            {
                "index": 212,
                "date": "2015-08-06",
                "press_title": "Stryker to Participate in Canaccord Genuity 35th Annual Growth Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Participate-in-Canaccord-Genuity-35th-Annual-Growth-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - August 6, 2015 - Stryker Corporation (NYSE:SYK) will participate in the Canaccord Genuity 35 th Annual Growth Conference on Wednesday, August 12, 2015 at the InterContinental Boston. Katherine Owen, Vice President, Strategy and Investor Relations, will represent the Company in a presentation scheduled for 9:30 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": -2.0110804067,
                "index_price": -1.1157232189,
                "norm_price": -0.8953571879
            },
            {
                "index": 213,
                "date": "2015-07-29",
                "press_title": "Stryker Declares a $0.345 per Share Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Declares-a-0345-per-Share-Quarterly-Dividend/default.aspx",
                "content": "Kalamazoo, Michigan - July 29, 2015 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.345 per share payable on October 30, 2015, to shareholders of record at the close of business on September 30, 2015, representing an increase of 13% versus the prior year, and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker,",
                "1d_change": -0.2160090559,
                "index_price": 0.6606153007,
                "norm_price": -0.8766243566
            },
            {
                "index": 214,
                "date": "2015-07-23",
                "press_title": "Stryker Reports Second Quarter 2015 Results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Reports-Second-Quarter-2015-Results/default.aspx",
                "content": "Stryker Reports Second Quarter 2015 Results",
                "1d_change": 1.9907194949,
                "index_price": -1.6594143912,
                "norm_price": 3.650133886
            },
            {
                "index": 215,
                "date": "2015-07-20",
                "press_title": "Stryker Announces Definitive Agreement to Acquire Muka Metal, A.S.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Announces-Definitive-Agreement-to-Acquire-Muka-Metal-AS/default.aspx",
                "content": "Kalamazoo, Michigan - July 20, 2015 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire Muka Metal, A.S. (\"Muka\") in an all cash transaction. Muka, headquartered in Kayseri, Turkey, sells hospital beds, stretchers and related patient room furniture and accessories that serve markets across Turkey and other regions globally. \"The acquisition of Muka aligns with our strategy to expand our global presence through existing channels with an established and trusted brand,\" said Timothy J. Scannell, Stryker Group President, MedSurg and Neurotechnology. \"This acquisition will bolster Stryker Medical's bed and stretcher offerings, and is a compelling opportunity to drive growth in Turkey and other regions around the world.\" Stryker and Muka have maintained a relationship under a distribution agreement for Latin America since 2012, and with this acquisition Stryker will expand its global presence in key markets with a product portfolio that complements and",
                "1d_change": 0.7975442982,
                "index_price": -0.3605181582,
                "norm_price": 1.1580624564
            },
            {
                "index": 216,
                "date": "2015-06-22",
                "press_title": "Stryker to Host Conference Call on July 23, 2015",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Host-Conference-Call-on-July-23-2015/default.aspx",
                "content": "Kalamazoo, Michigan - June 22, 2015 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 23, 2015 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2015 and provide an operational update. Final operating results for the quarter ended June 30, 2015 will be released at 4:00 p.m. that day. To participate in the conference call dial (866) 436-9172 (domestic) or (630) 691-2760 (international) and be prepared to provide confirmation number 38313498 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:30 p.m., Eastern Time, on Thursday, July 23, 2015, until 11:59 p.m., Eastern Time, on Thursday, July 30, 2015. To hear this recording you may dial (888) 843-7419 (domestic) or (630) 652-3042 (international) and enter the passcode",
                "1d_change": -0.9107327372,
                "index_price": 0.5507933076,
                "norm_price": -1.4615260449
            },
            {
                "index": 217,
                "date": "2015-06-12",
                "press_title": "Stryker Orthopaedics Settlement Program Reaches Milestone - - 95% of Registered Eligible U.S. Patients Enrolled in Program",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Orthopaedics-Settlement-Program-Reaches-Milestone-----95-of-Registered-Eligible-US-Patients-Enrolled-in-Program/default.aspx",
                "content": "Kalamazoo, Michigan - June 12, 2015 - Howmedica Osteonics Corp. (referred to as \"Stryker Orthopaedics\"), a subsidiary of Stryker Corporation (NYSE:SYK), has informed the courts in the New Jersey Multicounty and Federal Multidistrict litigations that 95% of registered eligible patients have enrolled in the Settlement Program under the Master Settlement Agreement announced in November 2014. As a result, Stryker Orthopaedics will move forward with the Settlement Program. The Master Settlement Agreement was established to compensate eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery. Shortly, the Claims Processor will begin notifying claimants and their attorneys regarding compensation payments, the exact timing and amount of payments will depend on factors and circumstances specific to each claim. It is expected that payments will begin this July and the majority of payments will be",
                "1d_change": -1.5210880596,
                "index_price": -1.1034191963,
                "norm_price": -0.4176688632
            },
            {
                "index": 218,
                "date": "2015-05-15",
                "press_title": "Stryker to Participate in Jefferies 2015 Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Participate-in-Jefferies-2015-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 15, 2015 - Stryker Corporation (NYSE:SYK) will participate in the Jefferies 2015 Healthcare Conference on Tuesday, June 2, 2015 at the Grand Hyatt Hotel in New York, New York. Adam Bisnett, Director, Investor Relations and Strategy, will represent the Company in a presentation scheduled for 11:00 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": 1.4080029912,
                "index_price": 0.3348620597,
                "norm_price": 1.0731409315
            },
            {
                "index": 219,
                "date": "2015-05-06",
                "press_title": "Stryker to Participate in UBS Global Healthcare Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Participate-in-UBS-Global-Healthcare-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 6, 2015 - Stryker Corporation (NYSE:SYK) will participate in the UBS Global Healthcare Conference on Tuesday, May 19, 2015 at the Sheraton New York Times Square Hotel in New York, New York. David Floyd, Group President, Orthopaedics, will represent the Company in a presentation scheduled for 2:30 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": -0.8206182122,
                "index_price": -0.1561307359,
                "norm_price": -0.6644874763
            },
            {
                "index": 220,
                "date": "2015-05-05",
                "press_title": "Stryker to Participate in Bank of America Merrill Lynch 2015 Health Care Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Participate-in-Bank-of-America-Merrill-Lynch-2015-Health-Care-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - May 5, 2015 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015 at the Encore at the Wynn Hotel in Las Vegas, Nevada. Bill Jellison, Vice President, Chief Financial Officer, will represent the Company in a presentation scheduled for 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products;",
                "1d_change": -0.7022720638,
                "index_price": -1.5614249931,
                "norm_price": 0.8591529293
            },
            {
                "index": 221,
                "date": "2015-04-29",
                "press_title": "Stryker Declares a $0.345 per Share Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Declares-a-0345-per-Share-Quarterly-Dividend-20150429000000/default.aspx",
                "content": "Kalamazoo, Michigan - April 29, 2015 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.345 per share payable on July 31, 2015, to shareholders of record at the close of business on June 30, 2015, representing an increase of 13% versus the prior year, and unchanged from the previous quarter. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world. Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media",
                "1d_change": -2.9379787718,
                "index_price": -1.2936874118,
                "norm_price": -1.64429136
            },
            {
                "index": 222,
                "date": "2015-04-21",
                "press_title": "Stryker Reports First Quarter 2015 Results",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Reports-First-Quarter-2015-Results/default.aspx",
                "content": "Kalamazoo, Michigan - April 21, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2015: First Quarter Highlights Updates full year organic sales growth guidance to 5.0% to 6.0% Updates full year adjusted diluted net earnings per share guidance to $4.95 to $5.10 Net sales grew 3.2% to $2.4 billion (7.4% constant currency) - Orthopaedics                                 2.4%  or   7.5% constant currency - MedSurg                                       4.6%  or   7.7% constant currency - Neurotechnology and Spine         2.1%  or   6.6% constant currency Reported diluted net earnings per share increased 222.2% to $0.58 Adjusted diluted net earnings per share(1) increased 4.7% to $1.11 \"We are pleased with our first quarter results, with another strong quarter of nearly 6% organic sales growth and disciplined expense management,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"We expect this",
                "1d_change": 2.540161115,
                "index_price": 0.2438325525,
                "norm_price": 2.2963285625
            },
            {
                "index": 223,
                "date": "2015-03-19",
                "press_title": "Stryker Announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Announces-Annual-Meeting-of-Shareholders-20150319000000/default.aspx",
                "content": "Kalamazoo, Michigan - March 19, 2015 - Stryker Corporation (NYSE:SYK) announced that its 2015 Annual Meeting of Shareholders is scheduled as follows: April 29, 2015 - 2:00 p.m. Eastern Time             Radisson Plaza Hotel & Suites at The Kalamazoo Center             Kalamazoo, Michigan             Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available in the Calendar of Events area of the Investor section of our website at www.investorevents.stryker.com. The telephone number to listen to the meeting is 888-771-4371 (U.S.) or 847-585-4405 (International) and the passcode is 38946241. A recording of the meeting will also be available from 4:30 p.m., Eastern Time, on Tuesday [CORRECTION:  Wednesday,] April 29, 2015, until 11:59 p.m. on Monday, June 29, 2015. To hear this recording, dial 888-843-7419 (U.S.) or 630-652-3042 (international) and enter the passcode 3894 6241#. An archived copy of the webcast will continue to",
                "1d_change": 0.6727697502,
                "index_price": 0.4463809029,
                "norm_price": 0.2263888473
            },
            {
                "index": 224,
                "date": "2015-03-18",
                "press_title": "Stryker to Host Conference Call on April 21, 2015",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Host-Conference-Call-on-April-21-2015/default.aspx",
                "content": "Kalamazoo, Michigan - March 18, 2015 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, April 21, 2015 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2015 and provide an operational update. Final operating results for the quarter ended March 31, 2015 will be released at 4:00 p.m. that day. To participate in the conference call dial (866) 436-9172 (domestic) or (630) 691-2760 (international) and be prepared to provide confirmation number 38313484 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:30 p.m., Eastern Time, on Tuesday, April 21, 2015, until 11:59 p.m., Eastern Time, on Tuesday, April 28, 2015. To hear this recording you may dial (888) 843-7419 (domestic) or (630) 652-3042 (international) and enter the passcode",
                "1d_change": 2.1374220885,
                "index_price": 0.7863957979,
                "norm_price": 1.3510262906
            },
            {
                "index": 225,
                "date": "2015-03-11",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Present-at-Investor-Conference/default.aspx",
                "content": "Kalamazoo, Michigan - March 11, 2015 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: March 24, 2015 - 1:00 p.m. Pacific Time 2015 Canaccord Genuity Musculoskeletal Conference Las Vegas, Nevada A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 90 days. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the",
                "1d_change": 1.729220836,
                "index_price": 1.0290670282,
                "norm_price": 0.7001538079
            },
            {
                "index": 226,
                "date": "2015-03-05",
                "press_title": "Stryker Corporation Named One of Fortune Magazine's \"100 Best Companies to Work For®\" For 5th Consecutive Year",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Corporation-Named-One-of-Fortune-Magazines-100-Best-Companies-to-Work-For-For-5th-Consecutive-Year/default.aspx",
                "content": "Fifth consecutive year Stryker has been named to this list Ranked 19 out of 100 Kalamazoo, Michigan - March 5, 2015 - Stryker Corporation (NYSE:SYK) announced today that it has been named as one of the 2015 FORTUNE 100 Best Companies to Work For ® in its 18 th annual survey of top-rated workplaces in the United States. The list recognizes companies that have exceptional workplace cultures. This is the fifth consecutive year Stryker has been named to the list, and the company was ranked 19 out of 100. The full list and related stories are available at http://fortune.com/best-companies/ . \"We are honored to be named one of the 100 Best Companies to Work For and appreciate the contributions of all our employees,\" said Steve Benscoter, Vice President, Global Human Resources. \"Talent and culture are our most powerful competitive advantages and are exemplified with 'People' designated as a core value.  Our investment in employee growth and development is a top priority and is evident as we",
                "1d_change": -2.5313931767,
                "index_price": -1.3170741079,
                "norm_price": -1.2143190688
            },
            {
                "index": 227,
                "date": "2015-03-03",
                "press_title": "Stryker Announces New $2 Billion Share Repurchase Authorization",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Announces-New-2-Billion-Share-Repurchase-Authorization/default.aspx",
                "content": "Kalamazoo, Michigan - March 3, 2015- Stryker Corporation (NYSE:SYK) announced today that its Board of Directors has authorized a new $2 billion share repurchase program. The program is in addition to $583 million of existing authorization remaining under the Company's current share repurchase programs, bringing the Company's total share repurchase authorization to $2.583 billion. \"We remain committed to pursuing a capital allocation strategy that includes acquisitions, dividends and share repurchases,\" said Kevin A. Lobo, Chairman and Chief Executive Officer. \"While M&A activity across the breadth of our product and service offerings will remain the primary focus of our long-term growth strategy, this new authorization recognizes that the strength of our balance sheet is sufficient to enable more significant share repurchases. We believe that efficiently deploying our balance sheet will enable growth in sales and earnings and maximize shareholder returns.\" The share repurchases will",
                "1d_change": -3.6159045506,
                "index_price": -0.821049984,
                "norm_price": -2.7948545666
            },
            {
                "index": 228,
                "date": "2015-02-23",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Present-at-Investor-Conference-20150223000000/default.aspx",
                "content": "Kalamazoo, Michigan - February 23, 2015 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: March 2, 2015 - 1:30 p.m. Eastern Time 2015 Cowen Health Care Conference Boston, Massachusetts A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 90 days. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or",
                "1d_change": -0.3899606215,
                "index_price": 0.2670742525,
                "norm_price": -0.657034874
            },
            {
                "index": 229,
                "date": "2015-02-11",
                "press_title": "Stryker Declares a 13% Increase in Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Declares-a-13-Increase-in-Quarterly-Dividend/default.aspx",
                "content": "Kalamazoo, Michigan - February 11, 2015 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has increased its dividend 13% by declaring a quarterly dividend of $0.345 per share payable on April 30, 2015, to shareholders of record at the close of business on March 31, 2015. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world. Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: Yin Becker, Stryker Corporation,",
                "1d_change": 0.4819286646,
                "index_price": 0.9542792762,
                "norm_price": -0.4723506116
            },
            {
                "index": 230,
                "date": "2015-02-03",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Present-at-Investor-Conference-20150203000000/default.aspx",
                "content": "Kalamazoo, Michigan - February 3, 2015 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: February 12, 2015 - 8:30 a.m. Eastern Time Leerink Global Healthcare Conference New York, New York A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 90 days. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or",
                "1d_change": 0.3460468259,
                "index_price": 0.9208893779,
                "norm_price": -0.5748425519
            },
            {
                "index": 231,
                "date": "2015-01-27",
                "press_title": "Stryker Reports 2014 Results and 2015 Outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Reports-2014-Results-and-2015-Outlook/default.aspx",
                "content": "Kalamazoo, Michigan - January 27, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the fourth quarter and full year of 2014: Fourth Quarter Highlights              Net sales grew 6.1% to $2.6 billion (8.6% constant currency) Orthopaedics (1) 1.7%  or   4.5% constant currency MedSurg                                                      12.1%  or 14.1% constant currency Neurotechnology and Spine                          3.9%  or   7.0% constant currency Reported diluted net earnings per share decreased 33.7% to $0.67 Adjusted diluted net earnings per share(2) increased 11.6% to $1.44 Full Year Highlights          Net sales grew 7.3% to $9.7 billion (8.3% constant currency) Orthopaedics                                                 5.2%  or   6.3% constant currency MedSurg                                                      10.8%  or 11.7% constant currency Neurotechnology and Spine                          5.0%  or   6.2% constant currency Reported diluted",
                "1d_change": 1.0997372515,
                "index_price": -2.2825323846,
                "norm_price": 3.3822696361
            },
            {
                "index": 232,
                "date": "2015-01-13",
                "press_title": "Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Provides-2014-Preliminary-Results-and-Updates-2015-Foreign-Exchange-Outlook/default.aspx",
                "content": "Kalamazoo, Michigan - January 13, 2015 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2014 were: Preliminary Fourth Quarter Highlights ·           Net sales growth of 6.1% to $2.6 billion or 8.6% constant currency -  Orthopaedics (1) 1.7% or 4.5% constant currency -  MedSurg                                        12.1% or 14.1% constant currency -  Neurotechnology and Spine             3.9% or   7.0% constant currency ·           Reported diluted net earnings per share of $0.61 - $0.70 ·           Adjusted diluted net earnings per share(2) of $1.43 - $1.45 Preliminary Full Year Highlights ·           Net sales growth of 7.3% to $9.7 billion or 8.3% constant currency                -  Orthopaedics                                     5.2% or  6.3% constant currency                -  MedSurg                                         10.8% or 11.7% constant currency                -  Neurotechnology and",
                "1d_change": -1.5120885919,
                "index_price": -1.0098065564,
                "norm_price": -0.5022820356
            },
            {
                "index": 233,
                "date": "2015-01-05",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-to-Present-at-Investor-Conference-20150105000000/default.aspx",
                "content": "Kalamazoo, Michigan - January 5, 2015 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: January 14, 2015 - 8:00 a.m. Pacific Time 33rd Annual J.P. Morgan Healthcare Conference San Francisco, California A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 90 days. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect",
                "1d_change": 1.7205897797,
                "index_price": -2.5881203247,
                "norm_price": 4.3087101044
            },
            {
                "index": 234,
                "date": "2015-01-05",
                "press_title": "Stryker Acquires the Assets of CHG Hospital Beds, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2015/Stryker-Acquires-the-Assets-of-CHG-Hospital-Beds-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - January 5, 2015 - Stryker Corporation (NYSE: SYK) announced today the asset acquisition of privately-held CHG Hospital Beds, Inc. (\"CHG\") in an all cash transaction. CHG, headquartered in London, Ontario, Canada, sells innovative hospital beds that serve markets across Canada, the United States and the United Kingdom. Founded in 2003, CHG designs, manufactures and markets a series of low-height hospital beds and related accessories. CHG's beds allow a patient's feet to sit flat on the floor while he/she is sitting at the edge of the bed. The low-height design helps reduce the risk of patient falls that are related to entering and exiting hospital beds. Among CHG's innovative offerings is the recently launched Spirit One bed which is an expandable low-height bariatric bed for the acute care segment. \"The acquisition of CHG aligns with Stryker's commitment to offering products that enhance the quality of care for both patients and healthcare professionals; in",
                "1d_change": 1.7205897797,
                "index_price": -2.5881203247,
                "norm_price": 4.3087101044
            },
            {
                "index": 235,
                "date": "2014-12-08",
                "press_title": "Stryker Resolves Government Investigation of OtisMed Matter",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Resolves-Government-Investigation-of-OtisMed-Matter/default.aspx",
                "content": "Kalamazoo, Michigan - December 8, 2014 -Stryker Corporation (NYSE:SYK) announced today that it has entered into a settlement with the U.S. Department of Justice (DOJ) in connection with the DOJ's civil and criminal investigations into the sales and marketing of the OtisKnee prior to Stryker's acquisition of OtisMed in November 2009. Stryker and OtisMed will pay $79,560,400 plus interest. In resolving the OtisMed matter, the DOJ acknowledged that OtisMed's criminal conduct \"occurred prior to Stryker's acquisition of OtisMed and without Stryker's prior knowledge or acquiescence.\" Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100",
                "1d_change": -0.1165253344,
                "index_price": -0.7291908532,
                "norm_price": 0.6126655188
            },
            {
                "index": 236,
                "date": "2014-12-03",
                "press_title": "Stryker Declares a 13% Increase in Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Declares-a-13-Increase-in-Quarterly-Dividend-20141203000000/default.aspx",
                "content": "Kalamazoo, Michigan - December 3, 2014 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has increased its dividend 13% by declaring a quarterly dividend of $0.345 per share payable on January 30, 2015, to shareholders of record at the close of business on December 31, 2014. \"Our strong balance sheet and cash flow support another double-digit increase to our dividend rate,\" said Kevin A. Lobo, Chairman and Chief Executive Officer of Stryker. Forward-Looking Statements This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": -0.2543105399,
                "index_price": 0.2157405147,
                "norm_price": -0.4700510546
            },
            {
                "index": 237,
                "date": "2014-11-05",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Present-at-Investor-Conference-20141105000000/default.aspx",
                "content": "Kalamazoo, Michigan - November 5, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: November 18, 2014 - 10:55 a.m. Eastern Time Stifel 2014 Healthcare Conference New York, New York A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 90 days. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or",
                "1d_change": 0.5985645238,
                "index_price": 0.7837654492,
                "norm_price": -0.1852009254
            },
            {
                "index": 238,
                "date": "2014-11-03",
                "press_title": "Stryker Orthopaedics Announces Settlement Agreement To Compensate Eligible U.S. Patients Who Had Surgery To Replace Their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Orthopaedics-Announces-Settlement-Agreement-To-Compensate-Eligible-US-Patients-Who-Had-Surgery-To-Replace-Their-Rejuvenate-Modular-Neck-andor-ABG-II-Modular-Neck-Hip-Stems/default.aspx",
                "content": "Kalamazoo, Michigan - November 3, 2014 - Howmedica Osteonics Corp. (referred to as \"Stryker Orthopaedics\"), a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG II Modular-Neck plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations announced a Settlement Agreement to compensate eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery, prior to November 3, 2014. The Settlement Agreement follows from a successful early mediation program initiated by New Jersey Superior Court Judge Brian R. Martinotti and efforts by the chief mediator, former United States Magistrate Judge Diane M. Welsh.  The success of the mediation process led to the resolution of multiple suits and claims pending in the federal courts and other states. \"The health and well-being of patients is Stryker's top priority,\" said Bill",
                "1d_change": 0.3308461163,
                "index_price": -0.3036621155,
                "norm_price": 0.6345082318
            },
            {
                "index": 239,
                "date": "2014-10-16",
                "press_title": "Stryker Reports Third Quarter 2014 Results and 2014 Outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Reports-Third-Quarter-2014-Results-and-2014-Outlook/default.aspx",
                "content": "Kalamazoo, Michigan - October 16, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2014: Net sales grew 11.1% to $2.4 billion Reconstructive 8.5% MedSurg 16.3% Neurotechnology and Spine 6.5% Reported diluted net earnings per share decreased 40.7% $0.16 Adjusted diluted net earnings per share(1) increased 10.6% to $1.15 Sales Analysis Consolidated net sales of $2.4 billion increased 11.1% in the quarter compared to prior year. Net sales in the quarter grew by 10.2% due to increased unit volume and changes in product mix and 3.4% as a result of acquisitions. Net sales in the quarter were unfavorably impacted by 2.3% due to changes in price and 0.2% by the impact of foreign currency exchange rates. Excluding the impact of acquisitions, net sales increased 7.8% in constant currency. Reconstructive net sales of $1.0 billion increased 8.5% in the quarter, as reported, and 8.6% in constant currency. Net sales grew by 8.2% due to increased unit volume",
                "1d_change": 2.1051225014,
                "index_price": 1.6329611839,
                "norm_price": 0.4721613174
            },
            {
                "index": 240,
                "date": "2014-09-08",
                "press_title": "Stryker to Host Conference Call on October 16, 2014",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Host-Conference-Call-on-October-16-2014/default.aspx",
                "content": "Kalamazoo, Michigan - September 8, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 16, 2014 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2014 and provide an operational update. Final operating results for the quarter ended September 30, 2014 will be released at 4:00 p.m. that day. To participate in the conference call dial (866) 436-9172 (domestic) or (630) 691-2760 (international) and be prepared to provide confirmation number 36096197 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, October 16, 2014, until 11:59 p.m., Eastern Time, on Thursday, October 23, 2014. To hear this recording you may dial (888) 843-7419 (domestic) or (630) 652-3042 (international) and",
                "1d_change": -0.3821329603,
                "index_price": -0.9419496234,
                "norm_price": 0.5598166631
            },
            {
                "index": 241,
                "date": "2014-09-03",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Present-at-Investor-Conference-20140903000000/default.aspx",
                "content": "Kalamazoo, Michigan - September 3, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: September 18, 2014 - 9:30 a.m. Eastern Time (2:30 p.m. British Summer Time) Bank of America Merrill Lynch Global Healthcare Conference 2014 London, England A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 30 days. Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including",
                "1d_change": -0.2039884264,
                "index_price": -0.2963442947,
                "norm_price": 0.0923558683
            },
            {
                "index": 242,
                "date": "2014-08-01",
                "press_title": "Stryker Completes Acquisition of North American Assets of Small Bone Innovations, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Completes-Acquisition-of-North-American-Assets-of-Small-Bone-Innovations-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - August 1, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its acquisition of substantially all of the North American assets of Small Bone Innovations, Inc. (\"SBi\"). A separate closing will be held later this year, following receipt of applicable regulatory approvals, for the acquisition of the assets of the French and German operations, through which the international business of SBi has been conducted. SBi is a privately held business headquartered in Morrisville, Pennsylvania that was founded by Viscogliosi Brothers, LLC. SBi products are designed and promoted for upper and lower extremity small bone indications, with a focus on small joint replacement. The assets to be acquired include the Scandinavian Total Ankle Replacement System (STAR Ankle). The STAR Ankle is the only PMA approved, cementless, three-piece total ankle replacement system and is the most published total ankle replacement product in the world. With the addition of the",
                "1d_change": 1.0920758375,
                "index_price": 0.4739550721,
                "norm_price": 0.6181207654
            },
            {
                "index": 243,
                "date": "2014-07-22",
                "press_title": "Stryker Announces Appointment of Kevin A. Lobo as Chairman of the Board of Directors",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Announces-Appointment-of-Kevin-A-Lobo-as-Chairman-of-the-Board-of-Directors/default.aspx",
                "content": "Kalamazoo, Michigan - July 22, 2014 - Stryker Corporation (NYSE:SYK) announced that Kevin A. Lobo, President and Chief Executive Officer, has been appointed Chairman of the Board, in addition to his current responsibilities, effective July 22, 2014. William U. Parfet, Stryker's Non-Executive Chairman, will again assume the role of Lead Independent Director. Mr. Lobo joined Stryker in April 2011 and served as Group President of Stryker Orthopaedics prior to his appointment as President and Chief Executive Officer in October, 2012. \"On behalf of the entire Board, we are excited about the outlook for Stryker and the leadership demonstrated by Kevin with our employees, customers and shareholders which is the driving force behind today's announcement,\" stated Mr. Parfet. \"We believe the Company is well positioned to build on our history while continuing to adapt to the changing needs of the healthcare market place.\" In announcing these changes, the Board expressed their appreciation of Mr.",
                "1d_change": -0.1588995728,
                "index_price": 0.5717125377,
                "norm_price": -0.7306121105
            },
            {
                "index": 244,
                "date": "2014-07-21",
                "press_title": "Stryker Declares a $0.305 Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Declares-a-0305-Quarterly-Dividend/default.aspx",
                "content": "Kalamazoo, Michigan - July 21, 2014- Stryker Corporation (NYSE:SYK) announced that its Board of Directors has maintained a dividend consistent with that of the prior quarter, by declaring a quarterly dividend of $0.305 per share payable on October 31, 2014, to shareholders of record at the close of business on September 30, 2014. This represents an increase of 15% compared to the prior year. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world. Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or",
                "1d_change": -8.6461e-06,
                "index_price": 0.3327388791,
                "norm_price": -0.3327475252
            },
            {
                "index": 245,
                "date": "2014-07-18",
                "press_title": "Stryker to Host Analyst Meeting",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Host-Analyst-Meeting-20140718000000/default.aspx",
                "content": "Kalamazoo, Michigan - July 18, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host an Analyst Meeting on Wednesday, September 17, 2014, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. Kevin Lobo, President and Chief Executive Officer, will host the meeting with presentations by leaders of the Company's key business units.             A simultaneous webcast of the meeting will be available on Stryker's website at www.stryker.com via the Investor page. The webcast will be archived on this site for 90 days. To hear the meeting via telephone, dial (866) 436-9172 (domestic) or (630) 691-2760 (international) and be prepared to provide confirmation number 37534749 to the operator.                         A recording of the meeting will be available from 6:30 p.m. Eastern Time, on September 17, 2014, until 11:59 p.m. Eastern Time, on December 17, 2014. To hear this recording, dial (888) 843-7419 (domestic) or (630) 652-3042 (international) and enter passcode 37534749 #. This",
                "1d_change": -0.6741334627,
                "index_price": 0.6125750921,
                "norm_price": -1.2867085548
            },
            {
                "index": 246,
                "date": "2014-07-17",
                "press_title": "Stryker Reports Second Quarter 2014 Results and 2014 Outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Reports-Second-Quarter-2014-Results-and-2014-Outlook/default.aspx",
                "content": "Kalamazoo, Michigan - July 17, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2014: Net sales grew 6.8% to $2.4 billion         ·     Reconstructive                                   6.5% ·     MedSurg                                            8.8% ·     Neurotechnology and Spine              3.8%       Reported diluted net earnings per share unchanged at $0.56       Adjusted diluted net earnings per share(1) increased 1% to $1.08                 \"We delivered another solid quarter of sales growth, with organic sales up 5%,\" said Kevin A. Lobo, President and Chief Executive Officer. \"This top line performance helped us achieve an adjusted EPS of $1.08, while investing in innovation and integrating acquisitions to support future growth.\" Sales Analysis Consolidated net sales of $2.4 billion increased 6.8% in the quarter compared to prior year. Net sales in the quarter grew by 6.8% due to increased unit volume and changes in product mix and",
                "1d_change": 0.4260441616,
                "index_price": -0.0773437393,
                "norm_price": 0.5033879009
            },
            {
                "index": 247,
                "date": "2014-06-30",
                "press_title": "Stryker Announces Definitive Agreement to Acquire Assets of Small Bone Innovations, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Announces-Definitive-Agreement-to-Acquire-Assets-of-Small-Bone-Innovations-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - June 30, 2014 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire assets of Small Bone Innovations, Inc. (\"SBi\") in an all cash transaction for up to $375 million. The net cost to Stryker after taking into account the present value of the tax benefits as a result of the asset purchase structure will be up to $285 million. Founded in 2004, SBi is a privately held business headquartered in Morrisville, Pennsylvania with facilities in France and Germany. SBi products are designed and promoted for upper and lower extremity small bone indications, with a focus on small joint replacement. The assets to be acquired include the Scandinavian Total Ankle Replacement System (STAR Ankle). The STAR Ankle, sold globally in over 40 countries, is the only PMA approved, cementless, three-piece total ankle replacement system and is the most published total ankle replacement product in the world. With the addition of the STAR Ankle to the Stryker Foot",
                "1d_change": 1.6491370706,
                "index_price": 0.6349658225,
                "norm_price": 1.0141712482
            },
            {
                "index": 248,
                "date": "2014-06-12",
                "press_title": "Stryker to Host Conference Call on July 17, 2014",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Host-Conference-Call-on-July-17-2014/default.aspx",
                "content": "Kalamazoo, Michigan - June 12, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 17, 2014 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2014 and provide an operational update. Final operating results for the quarter ended June 30, 2014 will be released at 4:00 p.m. that day. To participate in the conference call dial (866) 436-9172 (domestic) or (630) 691-2760 (international) and be prepared to provide confirmation number 36096195 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Thursday, July 17, 2014, until 11:59 p.m., Eastern Time, on Thursday, July 24, 2014. To hear this recording you may dial (888) 843-7419 (domestic) or (630) 652-3042 (international) and enter the passcode",
                "1d_change": -1.6538975369,
                "index_price": -0.3713505743,
                "norm_price": -1.2825469626
            },
            {
                "index": 249,
                "date": "2014-05-22",
                "press_title": "Stryker to Present at Investor Conferences",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Present-at-Investor-Conferences/default.aspx",
                "content": "Kalamazoo, Michigan - May 22, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conferences: June 2, 2014 - 10:30 a.m. Eastern Time Jefferies 2014 Healthcare Conference New York, New York June 10, 2014 - 8:40 a.m. Pacific Time Goldman Sachs 35 th Annual Global Healthcare Conference Rancho Palos Verdes, California June 18, 2014 - 10:05 a.m. Eastern Time Wells Fargo Securities 2014 Healthcare Conference Boston, Massachusetts A simultaneous webcast of the Company's presentations will be available on Stryker's website at www.stryker.com .  The presentations will be archived for 30 days. Forward-Looking Statements Certain statements made in these presentations may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or",
                "1d_change": -0.1370477727,
                "index_price": 0.6492971803,
                "norm_price": -0.7863449529
            },
            {
                "index": 250,
                "date": "2014-05-05",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Present-at-Investor-Conference-20140505000000/default.aspx",
                "content": "Kalamazoo, Michigan - May 5, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: May 13, 2014 - 8:00 a.m. Pacific Time Bank of America Merrill Lynch 2014 Health Care Conference Las Vegas, Nevada A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 30 days.  Forward-Looking Statements This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely",
                "1d_change": 1.7079525801,
                "index_price": -0.6280374281,
                "norm_price": 2.3359900082
            },
            {
                "index": 251,
                "date": "2014-04-28",
                "press_title": "Stryker Corporation Announces Pricing of $1.0 Billion Senior Notes Offering",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Corporation-Announces-Pricing-of-10-Billion-Senior-Notes-Offering/default.aspx",
                "content": "Kalamazoo, Michigan - April 28, 2014 - Stryker Corporation (NYSE:SYK) (the \"Company\") announced today that it has priced an offering to sell $600 million of senior unsecured notes due 2024 (the \"2024 Notes\") and $400 million of senior unsecured notes due 2044 (the \"2044 Notes\" and, together with the 2024 Notes, the \"Notes\"). The 2024 Notes will bear interest at 3.375% per year and, unless previously redeemed, will mature on May 15, 2024. The 2044 Notes will bear interest at 4.375% per year and, unless previously redeemed, will mature on May 15, 2044. The Notes are expected to settle on May 1, 2014, subject to customary closing conditions. The Company intends to use the net proceeds from the offering for refinancing of indebtedness, including existing commercial paper at maturity and all of our 3.00% Notes due January 15, 2015 at maturity, working capital and other general corporate purposes, including acquisitions, stock repurchases and other business opportunities. Barclays Capital",
                "1d_change": 0.9884247538,
                "index_price": 0.7096706312,
                "norm_price": 0.2787541227
            },
            {
                "index": 252,
                "date": "2014-04-23",
                "press_title": "Stryker Reports First Quarter 2014 Results and 2014 Outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Reports-First-Quarter-2014-Results-and-2014-Outlook/default.aspx",
                "content": "Kalamazoo, Michigan - April 23, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2014: First Quarter Highlights Net sales growth of 5.3% to $2.3 billion · Reconstructive                                   4.5% or 5.9% constant currency · MedSurg                                            5.8% or 6.8% constant currency · Neurotechnology and Spine              5.9% or 7.0% constant currency  Reported diluted net earnings per share decreased 77.2% to $0.18 Adjusted diluted net earnings per share(1) decreased 2.8% to $1.06  \"The strength of our diversified model was once again demonstrated in the first quarter with solid organic growth of 5%. Our continued investments in internal innovation, coupled with our recent acquisitions, position us well to meet our customers' evolving needs,\" stated Kevin A. Lobo, President and Chief Executive Officer. Sales Analysis Consolidated net sales of $2.3 billion increased",
                "1d_change": -1.1042879587,
                "index_price": -0.0377918218,
                "norm_price": -1.0664961369
            },
            {
                "index": 253,
                "date": "2014-04-22",
                "press_title": "Stryker Declares a $0.305 Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Declares-a-0305-Quarterly-Dividend-20140422000000/default.aspx",
                "content": "Kalamazoo, Michigan - April 22, 2014 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has maintained a dividend consistent with that of the prior quarter, by declaring a quarterly dividend of $0.305 per share payable on July 31, 2014, to shareholders of record at the close of business on June 30, 2014. This represents an increase of 15% compared to the prior year. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world. Please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or",
                "1d_change": -1.56910599,
                "index_price": 0.1503723672,
                "norm_price": -1.7194783572
            },
            {
                "index": 254,
                "date": "2014-04-15",
                "press_title": "Stryker Completes Acquisition of Berchtold Holding AG",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Completes-Acquisition-of-Berchtold-Holding-AG/default.aspx",
                "content": "Kalamazoo, Michigan - April 15, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Berchtold Holding AG (Berchtold), a provider of customer-centric healthcare equipment for over 90 years. Berchtold's product portfolio includes surgical tables, equipment booms, and surgical lighting systems geared towards maximizing efficiency and safety in operating rooms and ICUs. Combining these complementary solutions with Stryker Endoscopy's existing operating room equipment portfolio creates a comprehensive, quality-focused offering equipped to satisfy a wide range of customer needs around the globe. As indicated in the February 18, 2014 press release, the transaction is expected to be neutral to Stryker's 2014 earnings per share excluding acquisition, integration-related and intangible amortization charges. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make",
                "1d_change": -1.0499559002,
                "index_price": 1.6570875123,
                "norm_price": -2.7070434125
            },
            {
                "index": 255,
                "date": "2014-03-31",
                "press_title": "Stryker Announces Legal Function Leadership Change",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Announces-Legal-Function-Leadership-Change/default.aspx",
                "content": "Kalamazoo, Michigan - March 31, 2014 - Stryker Corporation (NYSE:SYK) announced that Curtis E. Hall, Vice President and Chief Legal Officer, has elected to shift to a part-time role as Senior Legal Counsel, and transition the leadership of the Corporation's Legal and Compliance function to Michael D. Hutchinson, General Counsel. Mr. Hall has led Stryker's Legal function since becoming the Company's first General Counsel in 1994. \"I would like to thank Curtis for his many contributions to Stryker throughout his career, including building the global legal and compliance organizations. He has demonstrated consistently strong judgment, leadership and commitment to the growth of the Company,\" said Kevin A. Lobo, President and Chief Executive Officer. \"We are pleased that he will continue to be involved with Stryker as Senior Legal Counsel, reporting to Mike, and dealing with complex legal matters.\" Mr. Hutchinson will expand his role to include Corporate Compliance and the Corporate",
                "1d_change": 1.3434352998,
                "index_price": 1.3980220352,
                "norm_price": -0.0545867354
            },
            {
                "index": 256,
                "date": "2014-03-24",
                "press_title": "Stryker to Host Conference Call on April 23, 2014",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Host-Conference-Call-on-April-23-2014/default.aspx",
                "content": "Kalamazoo, Michigan - March 24, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Wednesday, April 23, 2014 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2014 and provide an operational update. Final operating results for the quarter ended March 31, 2014 will be released at 4:00 p.m. that day. To participate in the conference call dial (800) 708-4540 (domestic) or (847) 619-6397 (international) and be prepared to provide confirmation number 36936589 to the operator. A simultaneous webcast of the call will be accessible via the Company's website at www.stryker.com. The call will be archived on this site for 90 days. A recording of the call will also be available from 8:00 p.m., Eastern Time, on Wednesday, April 23, 2014, until 11:59 p.m., Eastern Time, on Wednesday, April 30, 2014. To hear this recording you may dial (888) 843-7419 (domestic) or 630-652-3042 (international) and enter the",
                "1d_change": -1.5887042579,
                "index_price": -0.1098856591,
                "norm_price": -1.4788185988
            },
            {
                "index": 257,
                "date": "2014-03-24",
                "press_title": "Stryker Completes Acquisition of Patient Safety Technologies, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Completes-Acquisition-of-Patient-Safety-Technologies-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - March 24, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Patient Safety Technologies, Inc. Patient Safety conducts its business through its wholly owned subsidiary, SurgiCount Medical, Inc. Patient Safety's proprietary Safety-Sponge® System and SurgiCount 360TM compliance software help prevent Retained Foreign Objects (RFOs) in the operating room. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world. Please contact us for more information at www.stryker.com . Contacts For media inquiries please contact: Yin Becker,",
                "1d_change": -1.5887042579,
                "index_price": -0.1098856591,
                "norm_price": -1.4788185988
            },
            {
                "index": 258,
                "date": "2014-03-17",
                "press_title": "Stryker Announces Annual Meeting of Shareholders",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Announces-Annual-Meeting-of-Shareholders-20140317000000/default.aspx",
                "content": "Kalamazoo, Michigan - March 17, 2014 - Stryker Corporation (NYSE:SYK) announced that its 2014 Annual Meeting of Shareholders is scheduled as follows: April 22, 2014 - 2:00 p.m. Eastern Time   Radisson Plaza Hotel & Suites at The Kalamazoo Center   Kalamazoo, Michigan Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available in the Calendar of Events area of the Investor section of our website at www.investorevents.stryker.com . The telephone number to listen to the meeting is 888-771-4371 (U.S.) or 847-585-4405 (International) and the passcode is 36762234. A recording of the meeting will also be available from 4:30 p.m., Eastern Time, on Tuesday, April 22, 2014, until 11:59 p.m. on Thursday, May 22, 2014. To hear this recording, dial 888-843-7419 (U.S.) or 630-652-3042 (international) and enter the passcode 36762234. An archived copy of the webcast will continue to be available on our website until June 30, 2014. Stryker",
                "1d_change": 1.2019913236,
                "index_price": 1.5724364485,
                "norm_price": -0.3704451249
            },
            {
                "index": 259,
                "date": "2014-03-07",
                "press_title": "Stryker Completes Acquisition of Pivot Medical, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Completes-Acquisition-of-Pivot-Medical-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - March 7, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Pivot Medical, Inc. (Pivot). Pivot is a privately held business selling innovative products for hip arthroscopy with operating facilities in Sunnyvale, CA. As indicated in the February 19, 2014 press release, the transaction is expected to be neutral to Stryker's 2014 earnings per share excluding acquisition, integration-related and intangible amortization charges. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world and please contact us for more information at",
                "1d_change": 0.537878185,
                "index_price": -0.0719154661,
                "norm_price": 0.6097936511
            },
            {
                "index": 260,
                "date": "2014-02-25",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Present-at-Investor-Conference-20140225000000/default.aspx",
                "content": "Kalamazoo, Michigan - February 25, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: March 4, 2014 - 10:40 a.m. Eastern Time Cowen and Company 34th Annual Health Care Conference Boston, Massachusetts A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 30 days. Forward-Looking Statements Certain statements made in the presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures",
                "1d_change": -1.4668020711,
                "index_price": -0.1354896027,
                "norm_price": -1.3313124684
            },
            {
                "index": 261,
                "date": "2014-02-19",
                "press_title": "Stryker Announces Definitive Agreement to Acquire Pivot Medical, Inc.",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Announces-Definitive-Agreement-to-Acquire-Pivot-Medical-Inc/default.aspx",
                "content": "Kalamazoo, Michigan - February 19, 2014 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire Pivot Medical, Inc. (Pivot) in an all cash transaction. Pivot is a privately held business selling innovative products for hip arthroscopy with operating facilities in Sunnyvale, CA. Pivot was founded in 2007 with a focus on hip arthroscopy procedures treating femoroacetabular impingement syndrome (FAI). Pivot has a platform of innovative instruments and implants to efficiently access and restore the mobility of the hip with minimal incisions. Hip arthroscopy is the fastest growing procedure in Sports Medicine resulting from improved procedural solutions and growing demand for less invasive solutions. Pivot's innovative products will complement Stryker's existing Sports Medicine portfolio and provide Stryker's customers with a comprehensive offering to address the challenges of Sports Medicine procedures. \"The addition of Pivot Medical furthers our commitment to",
                "1d_change": 0.5444765289,
                "index_price": 0.0478320706,
                "norm_price": 0.4966444583
            },
            {
                "index": 262,
                "date": "2014-02-18",
                "press_title": "Stryker Announces Definitive Agreement to Acquire Berchtold Holding, AG",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Announces-Definitive-Agreement-to-Acquire-Berchtold-Holding-AG/default.aspx",
                "content": "Kalamazoo, Michigan - February 18, 2014 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire Berchtold Holding, AG (Berchtold) for an enterprise value of $172 million. Berchtold, a privately held business with operating facilities in Germany and the United States, sells world-class surgical infrastructure equipment. Berchtold has been providing customer-centric healthcare equipment for over 90 years with sales in 2013 of approximately $125 million. Their product portfolio includes surgical tables, equipment booms, and surgical lighting systems geared towards maximizing efficiency and safety in operating rooms and ICUs. Combining these complementary solutions with Stryker Endoscopy's existing operating room equipment portfolio will create a comprehensive, quality-focused offering equipped to satisfy a wide range of customer needs around the globe. \"We are committed to offering innovative, best-in-class operating room infrastructure equipment,\" said Timothy",
                "1d_change": -2.6580070424,
                "index_price": -0.5621342063,
                "norm_price": -2.0958728361
            },
            {
                "index": 263,
                "date": "2014-02-12",
                "press_title": "Stryker Declares a 15% Increase in Quarterly Dividend",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Declares-a-15-Increase-in-Quarterly-Dividend/default.aspx",
                "content": "Kalamazoo, Michigan - February 12, 2014 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has increased its dividend 15%, compared to the prior year, by declaring a quarterly dividend of $0.305 per share payable on April 30, 2014, to shareholders of record at the close of business on March 31, 2014. Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world and please contact us for more information at www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com For media inquiries please contact: <br",
                "1d_change": 1.8972584079,
                "index_price": 0.5306482663,
                "norm_price": 1.3666101417
            },
            {
                "index": 264,
                "date": "2014-02-07",
                "press_title": "Stryker to Present at Investor Conferences",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Present-at-Investor-Conferences-20140207000000/default.aspx",
                "content": "Kalamazoo, Michigan - February 7, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conferences: February 13, 2014 - 8:30 a.m. Eastern Time 2014 Leerink Global Healthcare Conference New York, New York February 25, 2014 - 9:40 a.m. Eastern Time Citi 2014 Global Healthcare Conference New York, New York A simultaneous webcast of the Company's presentations will be available on Stryker's website at www.stryker.com.  The presentations will be archived for 30 days. Forward-Looking Statements Certain statements made in these presentations may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely",
                "1d_change": 2.4496590448,
                "index_price": 1.3240041619,
                "norm_price": 1.125654883
            },
            {
                "index": 265,
                "date": "2014-01-22",
                "press_title": "Stryker Reports Fourth Quarter and Full Year 2013 Results and 2014 Outlook",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Reports-Fourth-Quarter-and-Full-Year-2013-Results-and-2014-Outlook/default.aspx",
                "content": "Kalamazoo, Michigan - January 22, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the fourth quarter and full year 2013: Fourth Quarter Highlights Net sales growth of 5.6% to $2.5 billion Reconstructive                          5.8% or 8.0% constant currency  MedSurg                                  5.4% or 6.6% constant currency  Neurotechnology and Spine        5.4% or 7.5% constant currency    Reported diluted net earnings per share increased 42.3% to $1.01 Adjusted diluted net earnings per share(1) increased 7.9% to $1.23 Full Year Highlights Net sales growth of 4.2% to $9.0 billion Reconstructive                         4.8% or 6.9% constant currency  MedSurg                                 2.9% or 3.8% constant currency  Neurotechnology and Spine       5.6% or 7.7% constant currency Reported diluted net earnings per share decreased 22.4% to $2.63 Adjusted diluted net earnings per share (1) increased 3.9% to $4.23 Cash flow from operations",
                "1d_change": -1.0413864514,
                "index_price": -0.8887260507,
                "norm_price": -0.1526604007
            },
            {
                "index": 266,
                "date": "2014-01-16",
                "press_title": "Stryker Corporation Named One of Fortune Magazine's \"100 Best Companies to Work For\"",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-Corporation-Named-One-of-Fortune-Magazines-100-Best-Companies-to-Work-For/default.aspx",
                "content": "Fourth consecutive year Stryker has been named to this list Ranked 42 out of 100 Kalamazoo, Michigan - January 16, 2014 - Stryker Corporation (NYSE:SYK) announced today that it has been named as one of the 2014 FORTUNE 100 Best Companies to Work For ® in its 17 th annual survey of top-rated workplaces in the United States. The list recognizes companies that have exceptional workplace cultures. This is the fourth consecutive year Stryker has been named to the list, and the company was ranked 42 out of 100. The full list and related stories are available at Fortune.com/best-companies . Kevin A. Lobo, President and Chief Executive Officer, congratulated all employees on earning this honor for the fourth year running. \"This is an amazing place to work. The culture here is a result of our employees' dedication and passion.\" \"Our commitment to growing talent and building on the strengths of our culture is stronger than ever and remains critical to our success,\" said Steve Benscoter, Vice",
                "1d_change": -0.0383879047,
                "index_price": -0.5052504111,
                "norm_price": 0.4668625064
            },
            {
                "index": 267,
                "date": "2014-01-02",
                "press_title": "Stryker to Present at Investor Conference",
                "release_url": "https://investors.stryker.com/press-releases/news-details/2014/Stryker-to-Present-at-Investor-Conference-20140102000000/default.aspx",
                "content": "Kalamazoo, Michigan - January 2, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: January 15, 2014 - 8:00 a.m. Pacific Time 32nd Annual J.P. Morgan Healthcare Conference San Francisco, California A simultaneous webcast of the Company's presentation will be available on Stryker's website at www.stryker.com .  The presentation will be archived for 30 days. Forward-Looking Statements Certain statements made in the presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures",
                "1d_change": -0.3741349511,
                "index_price": -0.7912104202,
                "norm_price": 0.4170754692
            }
        ]
    }
]